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Abstract 
 
Polarized epithelial cells form selective barriers between tissues and various 
body compartments that are essential for normal development and organ 
function.  A mature apical junctional complex (AJC), consisting of tight junctions 
(TJ), adherens junctions (AJ), and desmosomes is crucial for functional 
polarized epithelia.  Rho-GTPases are key regulatory proteins of many cellular 
processes, including epithelial adhesion and polarization.  These small 
GTPases are in turn controlled spatially and temporally by guanine nucleotide 
exchange factors (GEFs) that promote GTP-binding, resulting in their activation; 
and GTPase activating proteins (GAPs) that promote GDP hydrolysis, resulting 
in their inactivation. In this thesis I studied a novel junction associated GAP 
protein known as SH3BP1 in a variety of epithelia. SH3BP1 was identified in a 
functional siRNA screen that was designed to identify actin regulators of 
epithelial polarisation and differentiation. I will show that SH3BP1 localises to 
the early AJC when TJ and AJ are not yet properly separated.  SH3BP1 
regulation is important for tight junction formation and, its depletion affects 
polarity and junction integrity. I will demonstrate that SH3BP1 is functionally 
important in epithelial cell lines from different tissues as well as in organotypic 
three dimensional cultures. A major part of my thesis will focus on the 
demonstration that SH3BP1 is a crucial EGF receptor signalling effector that 
guides morphological alterations and actin dynamics. Using the A431 cell line 
EGF signalling model, I will demonstrate SH3BP1 is required to regulate both 
Rac1 and Cdc42 signalling, and subsequently its role in the recruitment of 
junctional proteins first to dorsal ruffles and then to forming tight junctions. I will 
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provide evidence that SH3BP1 forms a heteromeric complex with the scaffold 
JACOP/paracingulin and the actin capping regulator CD2AP that has a key role 
in the regulation of actin dynamics. Based on my data, I will propose a new 
model on how a negative regulatory complex guides cytoskeletal dynamics and 
junction formation and, thereby, promotes epithelial differentiation.  
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Chapter 1 – Introduction 
 
Overview 
 
Distinct types of cells cooperate to form functional complex organisms. One 
such cell type is represented by epithelial cells that allow separation of 
compartments of different composition and form protective layers that protect 
organisms from the environment. Epithelila cells have distinctive cell surface 
domains termed apical, basal and lateral; the latter are often combined to 
basolateral [1]. The apical surface mediates many tissue specific functions, 
such as terminal digestion and nutrient uptake in the case of intestinal epithelia. 
The basal surface contacts the extracellular matrix (ECM), and the lateral 
surface, is important for the formation of cell-cell contacts between adjacent 
cells. The basolateral domain also mediates many homeostatic functions, such 
as Na+ and K+ exchange by Na+K+-ATPase. This functional cell surface polarity 
requires the formation of biochemically distinct cell surface domains. 
Intriguingly, many fundamental molecular mechanisms that are required to the 
polarisation of epithelial cells also mediate functional polarisation of other cell 
types, such as neurons, or during different types of processes that require cell 
reorientation and polarity, such as migration [1-6]. The formation of cell-cell 
contacts between adjacent epithelial cells is essential for the formation of 
functional epithelial sheets capable to separate compartments of different 
composition. Epithelial cells form distinct types of cell-cell contacts: the most 
prominent ones are called cell junctions. At the apical end of the lateral 
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membrane resides the Apical Junctional Complex (AJC), which consists of the 
Zonula Occludens or the Tight Junction (TJ) and the Zonula Adherens or the 
Adherens Junction (AJ). A second adhesive junctions, desmosomes, form 
epithelial junctional complex together with the AJC [6, 7]. Epithelial cells also 
form gap junctions that allow exchance of ions and small hydrophilic molecules 
between neighbouring cells. Formation of these intercellular junctions is highly 
regulated and is required for epithelial cells to carry out their specific 
physiological roles during development and homeostasis. 
The formation and control of cell-cell junctions is a highly regulated process. 
This involves interplay between cellular signal transduction mechanisms that 
guide assembly and function of the cytoskeleton, or directly target specific 
junctional components altering their functional properties [8, 9]. An important 
molecular mechanism that is employed by many of these signal transduction 
pathways relies on molecular switches called Rho GTPases. These are small 
proteins that can hydrolyse guanine nucleoside triphosphate (GTP) to guanine 
nucleoside diphosphate (GDP) [10, 11]. GTP binding and hydrolysis represents 
a molecular switch mechanism: In the GTP-bound form, Rho GTPases are 
active and signal by binding and activating downstream effectors; GTP 
hydrolysis leads to a conformational switch, resulting in inactivation of the 
signalling activity.  Activation of Rho GTPases is stimulated by guanine 
nucleotide exchange factors (GEFs) that catalyse the exchange of GDP by 
GTP; inactivation by GTP hydrolysis is promoted by GTPase Activating Proteins 
(GAPs). GEFs and GAPs are thus of central importance for the orchestration of 
Rho GTPase signalling.  
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My thesis focuses on the mechanisms that regulate the assembly of epithelial 
junctions and, in particular, how Rho GTPase signalling guides junction 
assembly. I will particularly focus on the molecular processes that regulate Rho 
GTPase activity and how they are linked to the cytoskeletal rearrangements 
required for assembly of the AJC and epithelial differentiation.  
 
Cell-cell junctional complexes 
 
Intercellular junctional complexes are complex multi-protein strucures that share 
a basic architectural principal: they consist of transmembrane proteins that 
mediate cell-cell adhesion and are linked to cytosolic protein complexes that 
function as cytoskeletal linkers and signalling centres that guide junction 
assembly and function, and trasmit signals to the cell interior to guide cell 
behaviour and differentiation [12]. Epithelial cells form three main junctonal 
complexes (Figure 1.0). I will discuss these three junctions individually, both in 
terms of their main structural components as well as their signalling proteins, as 
each one has a unique composition and specific functions. 
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Figure 1.0 The structural organisation epithelial cell-cell adhesion complexes. 
(A) Adjacent epithelial cells adhere to one another by forming cell-cell junctional complexes. 
This so-called epithelial junctional complex is composed of TJs, AJs and desmosomes. TJs and 
AJs are connected directly to F-actin. (B) TJs are composed of transmembrane proteins, such as 
occludin, claudins and JAMs, bound to a cytoplasmic complex containing ZO proteins that 
providea link to the actin cytoskeleton. AJs are comprised of two main complexes: the E-
cadherin-catenin complex and the nectin-afadin complex.  
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Tight junctions 
 
TJs are located in the apical-most region of the lateral membrane [14]. They 
form a morpholoigical and functional border between the apical and basolateral 
domains of the plasma membrane, and act as semi-permeable gates between 
cells, regulating the flow of ions and solutes as well as passage of cells through 
the paracellular pathway. TJs also coordinate a range of signalling pathways, 
that regulate a variety of important biological mechanisms, including cell 
polarisation and differentiation, proliferation and migration [10, 15, 16]. 
In electron micrographs of ultrathin sections, TJs appear as so-called ‘kissing 
points’, apparent hemifusions of the outer leaflets of the plasma membrane of 
adjacent epithelial cells (Figure 1.1a). By freeze fracture electron microscopy, 
TJs appear as an arrangement of intramembrane strands, which form a mesh-
like network encircling the cells at the apical end of the basolateral membrane 
(Figure 1.1b) [10, 16]. Because of their morphological appearance, TJs have 
long been regarded as hemi-fusions of neighbouring plasma membranes. 
However, this model, which was proposed before junctional membrane poteins 
had been identified, has now mostly been discarded in favour of a protein-
mediated cell-cell adhesion model. Various studies have shown that TJs are 
composed of a number of components, including integral membrane and 
scaffolding proteins, as well as components of various signalling cascades and 
regulators of the actin cytoskeleton. 
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Figure 1.1 The tight junction structure by electron microscopy.  
(A) Shows pneumocytes in a newborn lamb lung with the TJ indicated with arrowheads. The AJ 
is found below the TJ.  (B) Shows a freeze fracture of a TJ. The TJ appear as a meshwork of 
intermembrane filaments, which encircles the cells. The strands consist of rows of 10nm 
diameter particles indicated by arrowheads. Scale bar 120nm.  
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Structural basis of tight junctions 
 
The molecular structure of TJs shares the same principle architecture with other 
junctional complexes. They are composed of mutiprotein complexes formed by 
three types of proteins: transmembrane proteins, cytoplasmic plaque proteins 
such as adaptors and cytoskeletal proteins, as well as signalling proteins such 
as transcription factors and protein kinases [8, 10]. 
Integral membrane proteins are crucial for the structural integrity of the TJ. 
These proteins are usually classified by how many times they travers the 
plasma membrane. TJs contain single-pass transmembrane proteins such as 
JAMs and CAR [17], three-pass transmembrane proteins such as Bves [18], 
and four-pass transmembrane proteins such as occludin, claudins, tricellulin 
and MarvelD3 [17, 19]. These proteins bridge the space between adjacent cells, 
mediate intercellular adhesion, and form the paracellular gate. With their 
cytoplasmic domains, they interact with cytoplasmic plaque components, which 
is thought to be important for junction assembly and regulation, as well as for 
the regulation of signalling mechanisms that guide cell behaviour [16, 20, 21].  
The cytoplasmic plaque contains multidomain proteins, such as ZO-1, ZO-2 and 
ZO-3, that function as scaffolding proteins. Many of these proteins have PDZ 
(PSD95/DlgA/ZO-1) homology domains that mediate interactions with other 
proteins and thereby promote junction assembly [22]. The plaque proteins serve 
as linkers between the transmembrane proteins and the actin cytoskeleton, and 
also function as adaptors for molecules involved in cell signalling [12, 21]. 
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The last group of TJ proteins includes amongst others, tumour suppressors 
such as the lipid phosphatase PTEN, regulatory proteins, and transcriptional 
and posttranscriptional regulators such as ZONAB [23]. These TJ associated 
proteins are involved in the regulation of junction function (e.g. paracellular 
permeability), but also of cell proliferation, cell polarity and differentiation, and 
gene expression [16]. 
 
Integral membrane proteins 
 
Occludin is a ~60 kDa tetraspan transmembrane protein that is the first 
transmembrane protein identified within TJs. Even though occludin is strongly 
associated with the junctional intermembrane strands, it seems that it is not 
essential for their assembly [15, 24]. This was demonstrated by Saitou et al. 
Using occludin deficient embryonic stem cells, which can form fully polarized 
epithelial cells with functional TJs [25]. However, occludin knockout mice exhibit 
complex gross and histological phenotypes resulting in inflammation, 
hyperplasia of gastric epithelia and testicular atrophy. Even though junctions 
can form in the absence of occludin, its depletion seems to cause moderate 
defects in tight junction stability [26, 27]. This may be explained by the 
possibility that occludin loss can be compensated for by other tetraspan 
proteins such as tricellulin and MarvelD3; however, depletion of MarvelD3, 
occludin and tricellulin together only led to a modest retardation of junction 
assembly [28]. As both the N-terminal and C-terminal domains of occludin 
interact with cytosolic plaque proteins, occludin has been linked to many 
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signalling pathways [24]. The C-terminal domain of occludin is crucially involved 
in many key interactions of occludin. This includes interactions with F-actin, ZO-
1, ZO-2, ZO-3, and Transforming Growth Factor Beta (TGFβ) Type 1 Receptor 
[20, 29, 30]. Occludin has also been suggested to affect activation of Rho 
GTPases [31], Mitogen Activated Protein Kinase (MAPK) and Akt signalling 
pathways [32]. Occludin has also been linked to the leading edge localisation of 
a number of polarity complex signalling molecules, such as atypical Protein 
Kinase C (aPKC), Par3 and PATJ during cell migration [33]. 
Claudins form a family with 24 members in humans and have a molecular 
weight of of 18-27 kDa. They are also tetraspan transmembrane proteins and 
are thought to constitute the backbone of the junctional intermembrane strands 
[26]. Claudins were originally discovered by Tsukita and colleagues who 
identified claudin-1 and claudin-2 [34]. The members of the claudin family 
contain two extracellular loops that vary in the number of charged residues they 
contain. This feature of claudins is thought to be crucial for the formation and 
selectivity of paracellular pores that control the ionic selectivity of TJs [35]. 
Claudins are expressed in a tissue specific manner. For example, claudin-5 and 
-15 are expressed only in endothelial cells; and different claudins exhibit 
different expression profiles along the renal nephron, which is thought to 
contribute to the distinct paracellular permeability properties in different nephron 
segments [36]. 
A study by Martinez-Estrada et al revealed that overexpression of Snail and 
Slug, members of the Snail superfamily of zinc-ﬁnger transcription factors, 
resulted in a decrease in transepithelial electrical resistance of MDCK cells and 
repression of expression of claudin-1, 3, 4 and 7 [37]. These transcription 
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factors also repress the genes encoding occludin and E-cadherin [38, 39]. Since 
the Snail superfamily of transcription factors has been shown to be important in 
epithelial to mesenchymal transition (EMT) [40], these results suggest that 
repression of claudins and other junction-associated proteins is results in 
progression of EMT and, consequently, cancer progression. Claudin family 
members associate with various PDZ domain containing adaptor proteins such 
as ZO-1, ZO-2, ZO-3, MUPP1 and with protein kinases such as WNK4, which 
phosphorylates claudin-1 to regulate paracelluar ion conductance, and matrix 
metalloproteinase’s such as matrix metalloproteinase 2 and matrix 
metalloproteinase 14, that are thought to regulate junctions proteolytically [41]. 
This suggests that different types of regulatory mechanisms target claudins to 
modulate paracellular ion selectivity and other permeability properties.  
MarvelD3 is a 40 kDa protein recently demonstrated to be an integral 
membrane protein of TJs [19]. There are two known isoforms of MarvelD3. 
These splice variants share the same 198 amino acid N-terminal cytoplasmic 
domain but vary in the region containing the transmembrane domains [19]. 
MarvelD3 shows a distant structural similarity to occludin within the region 
containing the transmembrane domains, which form a MARVEL (MAL and 
related proteins for vesicle trafficking and membrane link) domain; however in 
contrast to occludin, its C-terminal domain is shorter and its N-terminal domain 
longer [19]. Depletion of MarvelD3 by RNA interference,  resulted in no major 
changes in junctional integrity [19, 28]. The importance of MarvelD3 has not 
been fully established, as it was only recently discovered;  however, it may be 
important in the stabilisation of cell-cell adhesion, since the protein was found to 
be downregulated in Snail induced EMT in human pancreatic cells [42]. 
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Tricellulin is a~65 kDa transmembrane protein localised at the tricellular corners 
of epithelial cells [43]. Together with MarvelD3 and occludin, tricellulin 
comprises the tight junction-associated MARVEL domain subfamily. Tricellulin 
was shown to participate in the barrier function of TJs: depletion of tricellulin by 
RNA interference impaired barrier function and disorganized tricellular and 
bicellular TJ contacts at least in some model systems, suggesting that tricellulin 
is crucial in epithelial barrier formation and function  [43]. Tsukita and 
colleagues further found that upon depletion of occludin, tricellulin levels were 
increased, thus further supporting the proposal that distinct junctional 
membrane proteins can play compensatory roles  [44].  
Junctional Adhesion Molecules (JAMs) are a family of about 45 kDa 
glycosylated  transmembrane proteins that belong to the immunoglobulin 
superfamily [15]. JAMs are divided into two distinct groups. The first group 
contains JAM-A, JAM-B and JAM-C. They all have a class II PDZ binding motif 
located at the end of their C-terminus that can interact with adaptor molecules 
such as ZO-1 and Par3 [45, 46]. JAM-A has also been shown to bind a number 
of other proteins through its PDZ binding domain, including MUPP1, afadin/AF6 
(a protein associated with nectin-based AJs), CASK and PICK1 [41]. JAM-A is 
involved in the formation of the TJ barrier in endothelial and epithelial cells  [47, 
48], and also plays an important role in apico-basal polarity in epithelia. JAM-A 
has also been shown to regulate epithelial morphogenesis, as MDCK cells 
could no longer form cysts with a defined lumen in a three dimensional 
morphogenesis assay when JAM-A was depleted [49]. The second group of 
JAMs includes the Coxsackievirus and Adenovirus receptor (CAR), ESAM and 
JAM-D. CAR also seems to contribute to the barrier function of TJs. Cohen et al 
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demonstrated that overexpression of CAR in epithelial cells leads to an increase 
in transepithelial resistance (TER) [50]. CAR also interacts with ZO-1 [17]. JAMs 
are involved not only in barrier function but also in leukocyte trafficking during 
inflammation and angiogenesis [51, 52]    
 
Adaptor proteins 
 
The junctional membrane proteins are anchored in a complex protein network 
formed by different types of adaptor proteins. They are to some extent 
redundant in the structural organisation of the TJ, but also participate in various 
signalling pathways in which they seem to fulfill functions that are more specific. 
Some of the most studied adaptors are ZO-1, cingulin and paracingulin/JACOP. 
The adaptor protein  ZO-1 is the first TJ protein discovered. ZO-1 is a 210-225 
kDa protein that contains three PDZ domains, an SH3 domain, actin filament 
binding domain, as well as a gunylate kinase homolgy domain [53, 54]. 
Because of the latter domain, ZO-1 and proteins with a homolgous domain 
structure are often referred to as membrane-associated gunylate kinase 
homologues (MAGUKs); however, none of these proteins seems to possess 
kinase activity. Apart of the above mentioned membrane proteins, ZO-1 binds to 
multiple cytosolic proteins [29]. One such binding partner is the Y Box 
transcription factor ZONAB [55]. The interaction between ZO-1 and ZONAB is 
mediated by the SH3 domain of ZO-1 and results in cytoplasmic sequestration 
of the transcription factor and, hence, inhibition of its transcriptional activity. ZO-
1 and ZONAB expression and localization are cell density dependent: in 
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confluent cells, the expression of ZO-1 is  high and ZONAB low and, therefore 
ZONAB is sequestered at cell-cell junctions; in low confluent cells, expression of 
ZO-1 is low and of ZONAB high, resulting in transcriptionally active ZONAB 
[56]. ZO-1 can also interact with various other junctional proteins such as its 
close relatives ZO-2 and ZO-3, as well as other components of TJs (e.g., 
cingulin) and AJs (e.g., alpha-catenin, AF6/afadin) [24, 57]. 
Cingulin is a ~140kDa protein that contains a globular head domain, a central 
coiled coil domain that forms a rod and supports dimerisation, and a C-terminal 
tail domain. It was originally identified as it co-purified with myosin II [58]. 
Cingulin has been found to play an important role in RhoA signalling by 
recruiting the RhoA activators GEF-H1 and p114 RhoGEF to the TJ [59, 60]. As 
cells become more confluent, cingulin is thought to recruit and inactivate free 
GEF-H1 to the TJ, leading to reduced RhoA signalling in the cytoplasm and 
inhibition of cell proliferation. Nevertheless, at the junction itself, cingulin 
promotes RhoA signalling by recruiting p114RhoGEF.  
Paracingulin/JACOP is a ~160 kDa protein with strong similarity to cingulin. It 
possesses the same domain structure as cingulin, and the region that contains 
the rod and tail domains shares a 39% similarity with cingulin [61]. The head 
domains of both proteins have been shown to interact with ZO-1 at the junction, 
thus providing an additional link between ZO-1 and the cytoskeleton [61, 62]. In 
contrast to cingulin, however, paracingulin/JACOP does not localise exclusively 
to TJs but can also associate with AJs. Depletion of paracingulin/JACOP results 
in a delay in both TJ and AJ formation, suggesting that it functions in the 
regulation of junction assembly [63]. Depletion of paracingulin/JACOP also 
resulted in lower levels of active Rac1, which could be rescued by 
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overexpression of the Rac1 GEF Tiam1. Tiam1 was also reported to interact 
with paracingulin/JACOP [63]. As seen originally with cingulin, RhoA activity is 
increased in paracingulin depleted cells, which is thought to reflect an inhibitory 
interaction with GEF-H1 [63]. 
 
Signalling proteins 
 
The scaffolding and cytoskeletal proteins form what is known as a cytoplasmic 
plaque that recruits a large array of different signalling proteins [24, 56, 64]. 
Several of these proteins have already been mentioned as they bind to adaptor 
and transmembrane proteins. In principle, they can be divided according to their 
biological activities. For example, several protein kinases (e.g, WNK4a, CDK4) 
have been shown to associate with TJs and regulate paracellular permeability 
(e.g., WNK4a) or are part of mechanisms by which junction formation regulates 
proliferation (e.g., CDK4, a binging partner of ZONAB) [65]. Other examples are 
protein and lipid phosphatases such as PP2A and PTEN [66]. The tumour 
suppressor PTEN is a particularly intriguing example, as its activity at cell 
junctions is thought to be important for the generation and maintenance of cell 
polarity (see below). As already mentioned, TJs also harbour regulators of Rho 
GTPases (e.g, GEF-H1, p114RhoGEF), which will be discussed in more detail 
later.  
The final class of TJ-associated signalling proteins are transcriptional and 
posttranscriptional regulators. The first such protein that was discovered is 
ZONAB, a protein, as mentioned above, which is recruited to TJs by binding to 
ZO-1. ZONAB can regulate gene expression transcriptionally by binding to 
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specific promoter binding sites as well as posttrancriptionally by binding to 
specific mRNAs [55, 65]. Other examples, include symplekin, a component of 
the polyadenylation machinery and binding partner of ZONAB; as well as the 
transcription factors AP-1 and C/EBP that interact with ZO-2, a protein that can 
itself travel to the nucleus to bind SAF-B [67].  
 
Adherens junctions 
 
The zonula adherens or Adherens Junctions (AJs) are a major component of 
the intercellular junctional complex in epithelia and endothelia. AJs perform a 
number of functions such as to provide mechanical strength by interconnecting 
cell junctions and the actin cytoskeleton, to control the initiation of cell-cell 
adhesion and polarisation, and to regulate several intracellular signal 
transduction pathways [12, 68]. The AJ consists of two main adhesive protein 
complexes: the cadherin/catenin and the nectin/afadin complexes [69]. Each of 
these two complexes is explored in more detail below.  
 
Cadherin-catenin complex 
 
E-cadherin is a Ca2+-dependent, single-pass transmembrane glycoprotein that 
belongs to the classic cadherin family (N-, P- and R-cadherin being other 
members) of adhesion proteins and forms a complex with alpha- and beta-
catenin [70]. Classical cadherins have five extracellular repeat domains known 
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as extracellular cadherin (EC) domains. These domains are critical in the 
formation of interaction points between neighbouring cells and to initiate the 
formation of  the AJ [71]. The cytoplasmic domain of E-cadherin binds to 
catenins that provide a direct link to the actin cytoskeleton and nuclear 
functions. Thus, E-cadherin complexes are involved in actin rearrangements, 
endocytosis, protein degradation, intracellular signalling and gene transcription  
[12, 72]. Once E-cadherin forms initial extracellular contacts, the adjacent E-
cadherin molecules interact and seal along the periphery of the cell and 
strengthens the contact between adjacent cells, thus forming the early AJ [73]. 
The stability of E-cadherin/catenin/actin complexes is coupled by the actin 
binding protein EPLIN (Epithelial Protein Lost in Neoplasm), which itself is 
recruited by the cadherin-catenin complex to stabilise actin filaments [74]. Other 
actin binding proteins that bind to the cadherin-catenin complex include ZO-1, 
spectrin, vinculin, alpha-actinin, vezatin and the nectin-afadin complex [75]. 
Structually, the cytoplasmic domain of E-cadherin contains two distinct binding 
domains: a Juxtamembrane Domain (JMD) that binds p120 catenin [76], and a 
Catenin Binding Domain (CBD) that binds beta-catenin [77]. 
p120 catenin belongs to a subfamily of armadillo proteins, which have important 
roles in the regulation of cadherin adhesion [78]. p120 catenin was first 
identified by Reynolds et al as a substrate for Src tyrosine receptor kinase [79]. 
The protein, along with beta-catenin, was found to be tyrosine phosphorylated 
in v-Src transformed cells, as well as in response to various growth factors [78, 
79]. This resulted in a loss of epithelial integrity and more invasive 
characteristics [78]. p120 catenin was later classified as a member of the 
catenin family based on sequence homology to the beta-catenin armadillo 
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domain [12, 80]. Binding of p120 catenin with the JMD domain of E-cadherin is 
proposed to stabilize E-cadherin at the plasma membrane during intiation of the 
AJ. This was demonstrated with experiments making use of E-cadherin 
constructs carrying mutations in the JMD, which showed that p120 catenin upon 
binding to E-cadherin, increases the adhesiveness of cell-cell contacts [12]. 
Beta-catenin binds to the CBD domain of E-cadherin [81].This interaction is 
disrupted by tyrosine phosphorylation of beta-catenin at amino acids Y489 and 
Y654, while its binding to alpha-catenin is weakened by tyrosine 
phosphorylation at amino acid Y142. The kinases involved in these 
phosphorylation events are the tyrosine kinase Src and the EGF receptor, which 
phosphorylate amino acid Y654; Abl non-receptor tyrosine kinase, which 
phosphorylates amino acid Y489; and Fer kinase that phosphorylates amino 
acid Y142 [12]. It has also been suggested that BCL9-2, a transcription factor 
with an important role in EMT and invasion, regulates beta-catenin switching 
between its adhesive and transcription functionality. Phosphorylation at amino 
acid Y142 on beta-catenin favours BCL9-2 binding and results in shuttling of the 
protein to the nucleus and induction of gene transcription. This was further 
supported with siRNA-mediated knockdown of BCL9-2, which caused 
translocation of beta-catenin from the nucleus to the plasma membrane and a 
more epithelial-like phenotype [12]. 
Alpha-catenin is known to exist in two states: monomeric and homodimeric [12]. 
Initially it was thought that alpha-catenin provided the link between the E-
cadherin/beta-catenin complex and the actin cytoskeleton. However, Yamada et 
al recently demonstrated that a simultaneous interaction between E-
cadherin/beta-catenin/alpha-catenin and actin in vitro can not be established 
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[82]. It is thought that alpha-catenin allosteric switching between states only 
allows it to associate with either beta-catenin or actin, but not both proteins at 
once. Monomeric alpha-catenin binds beta-catenin, whereas in its homodimeric 
state it binds actin.  
 
Nectin-afadin complex 
 
Nectins are immunoglobulin (Ig) superfamily adhesion molecules (CAMs) that 
are involved in the structural integrity of cell-cell adhesion, as well as being in 
the regulation of a number of cellular processes including polarization, 
differentiation, migration, and survival [83, 84]. The nectin subfamily is 
comprised of four mammalian members (nectins 1-4). All nectins contain an 
extracellular domain comprised of three IgG-like loops and a cytoplasmic 
domain with a PDZ binding motif at their C-terminus [85]. The cytoplasmic 
domain of nectins interacts with the actin binding protein afadin/AF6 [85]. 
Afadin, a scaffolding protein, interacts with Ras/Rap family GTPase signalling 
components as well as other actin binding proteins such as alpha-catenin and 
ZO-1 [69]. Ikeda et al demonstrated that knockout of afadin had a detrimental 
effect on epithelial organization [86]. The formation of AJs by nectins, therefore 
requires afadin. Nectin-based adhesion has been proposed to be of primary 
importance for junction formation and is thought to trigger a complex signalling 
cascade that stimulates actin reorganisation and formation of stable cell 
junctions (Figure 1.2).  
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Nectin-Like Molecules (NECLs) comprise a family of five members with varying 
roles. They share similar domains to nectins, however, the crucial difference is 
that they cannot bind to afadin and are not part of the nectin-afadin complex 
[87]. 
There is also evidence for molecular crosstalk between the AJ and TJ. It has 
been shown that Nectin-2, the spliced form of AF6 and alpha-catenin interacts 
with ZO-1. JAM also binds to the PDZ domain of AF6 and forms a complex with 
ZO-1 [88, 89]. Another scaffolding protein which has been shown to bind both 
TJ and AJ components is protein interacting with C-kinase-1 (PICK-1), which 
binds both nectin and JAM [88]. However, it is not clear whether some of these 
interactions represent stable complexes or rather transition states during 
junction assembly, as has been demonstrated for the ZO-1/alpha-catenin 
interaction [90].   
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Figure 1.2 Nectin-induced intracellular signalling during the formation of 
adherens junctions.  
The schematic shows the structural basis of the nectin-afadin complex and how it is 
involved in the regulation of signalling networks that guide cytoskeletal organisation 
and junction formation. Diagram adapted from [87]. 
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Desmosomes 
 
Desmosomes, like AJ, are an adhesive cell-cell junction located in epithelial 
cells [91]. Desmosomes are disc-shaped symmetrical junctions, which are 
made up of three main types of proteins: cadherins, catenins (armadillo 
proteins) and plakin [92, 93]. The cadherin family members found in 
desmosomes are Desmocollin (Dsc) and Desmoglein (Dsg). The Dsc and Dsg 
cytoplasmic domains are in contact with the armadillo signalling proteins 
Plakoglobin (PG) and Plakophilin (PP). These  proteins form a cytoplasmic 
plaque that connects desmosomes to the intermediate filament cytoskeleton, 
thus offering structural stability to the desmosomes and thereby to the tissue as 
a whole [92, 94].  PG is found not only in desmosomes but also in the AJ. PG 
also binds to Desmoplakin (DP) a critical member of the plakin protein family 
that is essential for desmosomal adhesion and provides the link to the 
cytoskeleton via its interaction with keratin filaments [91, 95]. PP on the other 
hand associates with a variety of desmosomal components, including both Dsc 
and Dsg, PG, DP, and also directly binds to intermediate filaments [92, 95]. 
These interactions bring the cellular membranes into close contact to allow 
desmosomal cadherins to cluster and bind together via their extracellular 
domains and thus form stable desmosomes. 
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Formation of cell-cell junctions and establishment of 
cell polarity  
 
Formation of cell junctions requires series of cell shape changes and, 
depending on the model studied, active migration to allow neighbouring cells to 
approach and adapt to each other, initiation of cell-cell contacts and adhesion, 
followed by the maturation of stable cell junctions. This apparently simple 
sequence of steps is mediated by complex processes, which involve the 
formation of different types of stable and transient protein complexes and 
dynamic reorganization of the cytoskeleton, that ultimately lead to the formation 
of polarized epithelia with mature junctional complexes.  
The formation of cell junctions and epithelial polarization are closely intertwined 
processes, and many of the signalling proteins that regulate polarization 
transiently or stably associate with the junctional complex. The initial sensing of 
the cellular environment by the cells includes locating cells in close proximity 
and interactions with the extracellular matrix (ECM) [96]. Adhesion to the ECM 
is thought to provide a crucial spatial cue that is critical for the orientation of the 
apicobasal axis of polarization [96]. Cells can sense and modify the chemical 
composition as well as the assembly and stiffness of the ECM [97]. The 
importance of the ECM is shown by various studies that suggest that tumour 
progression and metastasis is linked to altered ECM composition and stiffness 
[98].  The correct adhesion of cells to the ECM is thought to be mediated 
primarily through the adhesion receptor family of integrins [99]. 
The molecular mechanisms that drive epithelial polarisation involve protein 
complexes that have not only been conserved through evolution but are also 
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important for the polarization of other cell types (e.g., neurons) and for dynamic 
processes that require repolarization of cells (e.g., migration). There are three 
main groups of polarity proteins that participate in these protein-protein 
interactions in a highly dynamic manner. These are the apical determinants 
which consist of Par3, Par6 and aPKC (atypical Protein Kinase C); and the 
Crumbs associated proteins consisting of a Crumbs homologue (in vertebrate 
epithelial, this is usually Crb3), PALS1 (Protein Associated with LIN-7, the 
vertebrate homologue of fly Stardust) and PATJ (PALS1 Associated Tight 
Junction Protein); as well as the the basolateral Scribble associated proteins 
that consists of Scribble (Scrib), Lgl (Lethal Giant Larvae) and Dlg (Discs large) 
[100, 101].  
 
Formation of cell-cell contacts 
 
Initiation of junction formation is mediated by the main adhesion receptors of 
AJs: E-Cadherin and nectins. Although many investigators favour models in 
which cell-cell adhesion is initiated by E-cadherin, extensive work perform by 
Takai's laboratory suggests that nectin-mediated cell-cell adhesion precedes E-
cadherin engagement (Figure 1.2)  [83, 84, 102] . According to the later model, 
nectin-engagement stimulates a series of signalling events, involving the 
tyrosine kinase src, as well as Rap and Rho GTPases, that initiate 
reorganization of the cytoskeleton and stimulate the formation of E-Cadherin-
based cell-cell contacts. However, it is not clear how far these sequence of 
events is influenced by the model system or experimental conditions analyzed. 
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Nevertheless, formation of TJs is downstream of  E-cadherin-mediated cell-cell 
contact formation, as blocking E-cadherin function also prevents TJ formation. It 
is thought that E-cadherin activation stimulates signalling pathways required for 
TJ formation [103, 104]. 
E-Cadherin-based cell-cell adhesion first appears as adjacent puncta that then 
start to merge and form larger plaques until continous junctional belts surround 
the cells [73, 76, 105]. This initial cell-cell contact recruits  the main components 
of AJs, such as alpha- and beta-catenin, but also components of TJs, such as 
ZO-1; hence, they are generally referred to as promordial junctions as they 
neither represent mature AJs nor TJs [66]. 
Formation of primordial junctions is initiated by dynamic actin-driven processes 
that allow cells to approach each other. This was first shown by Vasioukhin et al 
studying keratinocytes and stimulating junction formation either with a calcium 
switch protocol (i.e., cells are plated in low calcium medium that does not 
support junction formation,  and subsequent adhesion is initated by adding 
calcium, which is required for cadherin-mediated adhesion) or with a wound 
healing assay (i.e., monolayers or tissues are wounded, leading to cell 
migration to close the wound and reformation of cell junctions) [106]. They 
observed that formation of primordial junctions involved two rows of E-cadherin-
positive punctae. From these opposing punctae, bundles of actin filaments 
originated, and over time sealed to form a continuous contact line [106]. The 
actin-rich cell protrusions formed are called filopodia, a dynamic specialization 
of the plasma membrane (see below). However, initation of cell-cell contacts is 
not always mediated by filopodia but, depending on the cell model analysed, 
can also be driven by waves of lamellipodia, another type of dynamic actin-
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based plasma membrane specialization, that are forming and contracting until 
cell-cell adhesion occurs [107]. 
The formation of these early junctional punctae can be considered as Stage I in 
a three-stage model of junction formation [73, 106]. Stage II is then the 
formation of large E-cadherin-positive plaques that result from merging of 
neighbouring punctas. Simultaneously, actin filaments start to rearrange 
allowing the rapid spreading of E-cadherin along the contact site, a ‘zippering’ 
up of the contact site [73, 106]. 
Apart from the junctional proteins already mentioned, many regulators of the 
actin cytoskeleton and actin-binding proteins have been found to localize to 
early stage I and II cell-cell contacts, including Arp2/3 [108], alpha-actinin, 
vinculin, zyxin [109], Mena/VASP [110], and  formins [109, 111]. These proteins 
are thought to drive formation of filopodia and lamellipodia, respectively, 
permitting initial cell-cell contacts, and the actin filament reorganization required 
for the progression from stage I to stage II.  
The final stage of junction formation, Stage III, is the separation and maturation 
of primordial junctions into a mature junctional complex with distinct TJs and 
AJs. Junctional maturation involves the formation of a junctional actin ring and 
recruitment of TJ proteins such as JAM-A and components of polarity complex 
proteins [112]. Par3, which is recruited by JAM-A, and aPKC localize to early 
forming TJs, and have been shown to be important for TJ formation [113, 114]. 
aPKC is also required for emerging junctions to mature by stimulating 
maturation of TJs [115].  
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Cell polarization 
 
Interactions with the ECM are thought to provide the first cue that defines the 
axis of polarization. Therefore, organotypic culture systems have been 
established in which the cells are grown in a three-dimensional (3D) ECM, 
permitting the analysis of the molecular mechanisms that mediate epithelial 
polarization and differentiation in vitro under conditions more similar to those in 
vivo [116]. As this experimental system offers a more physiological 
experimental environment  than standard two-dimensional culture systems, it 
has been widely used to analyse the molecular mechanisms underlying 
epithelial polarization.  
When grown in a 3D ECM composed of collagen and/or Matrigel, epithelial cells 
form round spherical structures known as cysts. Differentiated cysts are well 
organized structures consisting of a monolayer of polarized cells, joined by 
intercellular junctions, around a central lumen with the apical membrane lining 
the lumen and the lateral membrane in contact with the ECM surrounding the 
cysts [116]. Figure 1.3  shows the different steps during cyst formation. Cellular 
cyst forms due to the initial contact of E-cadherin between two adjacent cells at 
the lateral surface and then develop into multicellular hollow cysts (Figure 1.3) 
[117]. 
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Figure 1.3 Illustration of cyst development. 
 
(A) A single MDCK cell (B) divides to form two cells joined by a lateral surface. (C) 
Morula like cells compact, (D) followed by continual cell division results in cell 
aggregation and cytoskeletal shape changes. (E) A polarised cyst forms with a liquid 
filled lumen with distinctive apical, basal and lateral surfaces. Cells embedded into an 
extracellular matrix can form an epithelial cyst within 5-8 days. Taken from [117]. 
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Lumen formation has been to attributed to two distinct mechanisms called 
hollowing and cavitation. Hollowing involves the trafficking and exocytosis of 
intracellular vesicles to the cell surface of opposing cells, delivering the apical 
determinants to form the lumen [1, 118]. This allows adjoining cells to orientate 
apically toward the lumen and the tissue expands in a highly polarised manner. 
This has been seen in kidney and vascular 3D models. Interplay between the 
Rho GTPase Cdc42, Par6 and aPKC is crucial for lumen formation during 
cystogenesis via hollowing. Enrichment of the phosphoinositide 
Phosphatidylinositol-4,5-biphosphate (PtdIns(4, 5) P2) at the apical membrane, 
a process that requires the lipid phosphatase and tumour suppressor PTEN, 
allows recruitment of Cdc42 and subsequent binding to Par6 and aPKC, 
promoting generation of apico-basal polarity and a single polarised lumen [1, 
118]. 
The second molecular mechanisms known as cavitation occurs when cells 
proliferate and the lumen is generated by apoptosis of cells in the middle of the 
structure. Cells not in contact with an ECM rapidly undergo apoptosis and are 
cleared, giving rise to an outer epithelial layer with a central lumen [1, 118]. 
Cavitation is seen in 3D cultures of mammary acini and in vivo in mouse 
mammary end buds. Proapototic Bcl-2 family proteins regulate cellular 
apoptosis of luminal clearing, although autophagy also seems to play a role 
[119]. Polarity proteins aPKC and Par6 also regulate apoptosis of luminal cells 
during epithelial morphogenesis [1, 120]. 
An important landmark of polarization in epithelial is the differential distribution 
of phosphoinositides in the inner leaflet of the plasma membrane. In 
mammalian epithelial cells, two versions of phosphoinositides distinguish the 
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apical and basolateral domains. Phosphatidylinositol-4,5-biphosphate (PtdIns(4, 
5) P2) is abundant in the apical membrane, while phosphatidylinositol-3,4,5-
triphosphate (PtdIns (3, 4, 5) P3) is found exclusively in the basolateral surface 
and is absent in the apical surface [121, 122]. Evidence for the importance of 
phosphoinositides in the maintenance of membrane identity and epithelial 
polarization was shown by two studies by Martin-Belmonte et al and Gassama-
Diagne et al., respectively. In the study by Martin-Belmonte et al, exogenous 
PtdIns (4, 5) P2 was added to the basolateral domain of epithelial cysts, 
resulting in a dramatic shrinkage of the lumen and redistribuiton of the apical 
markers gp135 and ezrin to basolateral surfaces, thus supporting the 
importance of PtdIns (4, 5) P2 for apical identity [121]. In a separate study by 
Gassama-Diagne, exogenous PtdIns (3 ,4, 5) P3 was added to the apical 
surface of MDCK cells and triggered the apical surface to acquire basolateral 
characteristics, indicating that PtdIns (3, 4, 5) P3 is an important determinant of 
basolateral surface identity and that PtdIns (4, 5) P2 and PtdIns (3, 4, 5) P3 play 
complimentary roles in the formation of apico-basal polarity [121, 122]. During 
the apical specification process during cyst formation, PTEN accumulation at 
apical poles leads to the enrichment of PtdIns (4, 5) P2, which then stimulates 
the apical recruitment of the Rho GTPase Cdc42 by annexin 2, a lipid binding 
protein. Cdc42 signalling then stimulates apical reruitment of a Par6/aPKC 
complex and apical expansion [121, 123]. Interestingly, Par3, a common 
component of Par6/aPKC complexes, does not associate with the apical 
membrane but remains at the junctional complex, suggesting that its function  is 
no longer required in the complex that stimulates apical expansion.  
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PTEN has also been linked to cell polarity in other experimental systems, where 
it seems to have a somewhat distinct function. PTEN had been shown to 
directly bind to Baz/Par3 in vitro and in vivo, and to colocalize with Baz/Par3 in 
the apical cortex of epithelia and photoreceptors in Drosophila [124, 125]. In 
Drosophia photoreceptor epithelial cells, this interaction stimulates recuitment of 
PTEN to the junctional complex leading to the preferential apical accumulation 
of PtdIns (3, 4, 5) P3  [125]. Thus, the interaction between Par polarity proteins 
and PTEN is important for the polarized distribution of phosphoinositides and 
the development of cell polarity in different systems.  
The polarity complexes that guide apical specification and cell junctions are 
closely interconnected and several components of these complexes have been 
shown to interact [101]. Formation of primordial junctions stimulates the 
recruitment of Par3/6 and aPKC to the forming junctional complex [126]. aPKC 
then phosphorylates JAM-A at S285 to promote the maturation of immature cell-
cell contacts [127]. In fully polarized cells, S285-phosphorylated JAM-A is 
localized exclusively at the TJs, and S285 phosphorylation of JAM-A is required 
for the development of a functional epithelial barrier as well as normal 3D cyst 
morphogenesis. aPKC also phosphorylates Par3, which promotes the above-
described apical exclusion and junctional retention of Par3 [115, 128]. Apical 
aPKC/Par6 complex also promotes apical accumulation of the Crumbs polarity 
complex, which is thought to be required for apical expansion and delineation 
from the maturing junctional complex. Crumbs complex compents have also 
been shown to interact with TJ proteins [59]. However, the functional relevance 
of these interactions remains to be determined.  
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Rho GTPases 
 
Rho GTPases are key components of the signalling mechanisms that guide 
epithelial junction formation and differentiation. They can cycle between active 
(GTP-bound) and inactive (GDP-bound) forms, and thus function as molecular 
switches [11, 129]. As mentioned above, cycling between GTP and GDP bound 
forms is catalyzed by intracellular proteins that stimulate the exchange of GDP 
by GTP - Guanine nucleotide Exchange Factors (GEFs) - or promote GTP 
hydrolysis - GTPase Activating Proteins (GAPs) [11, 129]. The exception are 
atypical Rho GTPases, which include RhoBTBs, RhoE and RhoH, that can be 
regulated at the expression level or by ATP hydrolyses as in the case of 
RhoBTB3 [130, 131]. However, I will focus my description on the main members 
of the Rho GTPase family - Cdc42, Rac1 and RhoA - as they have been directly 
linked to the regulation of epithelial junction formation and polarization. 
Moreover, the three GTP-binding proteins are key regulators of actin 
organization; hence, I will highlight in this context the type of actin-driven 
processes that are regulated by specific Rho GTPases [132, 133]. For efficient 
adhesion, cadherins and many other adhesion receptors needs to be 
associated with actin filaments; hence, regulation of the cytoskeleton is critical 
to understand epithelial junction formation, polarization and differentiation.  
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Cdc42 
 
Cdc42 was first identified in Saccharomyces cerivisiae as a temperature 
sensitive mutant of the cell cycle [134]. Subsequent work in various 
experimental models demonstrated that Cdc42 is an evolutionarily conserved 
regulator of cell polarization and plays fundamental roles in the regulation of the 
actin cytoskeleton [135]. As described above, one of the best known epithelial 
functions of Cdc42 is that of a regulator of the Par3/Par6/aPKC complex. Active 
Cdc42, as does active Rac1, can bind to Par6, which stimulates activation of 
aPKC [136]. This interaction is not only important during eithelial polarization, 
but also regulates microtubule orientation during directed cell migration, a 
process that also involves another Cdc42 effector, MRCK (myotonic dystrophy 
kinase-related Cdc42-binding kinase), that regulates nuclear positioning by the 
spatial regulation of myosin II activity [137]. Apart from Par6, Cdc42 and Rac1 
share several common effectors. Examples are PAKs (p21-activated protein 
kinases) that play important roles in the regulation of the cytoskeleton and cell 
shape [138, 139] . Another common binding partner is IQGAP1, a protein that 
can bind the GTP as well as the nucleotide-free GTPase, and links Cdc42 and 
Rac1 to regulation of microtubule organization and cadherin-dependent 
adhesion strength [140]. 
Cdc42 regulates fundamental processes that are driven by actin dynamics and 
induce membrane remodelling and cell shape changes. The quintessential 
example is the formation of filopodia [132, 135].  Filopodia have been described 
as tentacles that cells use to probe their environment. Induction and growth of 
filopodia requires actin polymerization [141]. Initiation of filopodia is stimulated 
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by the insulin-receptor substrate p53 (IRSp53). This is an I-BAR domain protein, 
which contains three domains: an N-terminal modified Bin-Amphiphysin-
Rvs161/167 (BAR) domain, a partial Cdc42/Rac Interactive Binding domain 
(CRIB) domain that can indeed interact with Cdc42 and Rac1, and a C-terminal 
SH3 domain [142, 143]. IRSp53 interacts with various actin binding proteins 
such as WAVE1, WAVE2, Mena, Pro/Shank, Dia1, dynamin1, N-WASP and 
Eps8. N-WASP is an important binding partner in this context, as it is required 
for IRSp53-induced filopodia.  
N-WASP is a close homologue of WASP, which is the product of the gene 
responsible for the Wiskott-Aldrich syndrome, and can directly link Cdc42 to 
actin polymerization by functioning as a nucleation promoting factor [141]. 
Although there are some inconsistencies between different experimental 
systems and laboratories, one important mechanism to initiate actin 
polymerization during filopodial induction relies on the Arp2/3 complex. The 
Arp2/3 complex utilises G-actin to initiate new barbed ends (the growing end of 
F-actin) on preexisting barbed ends [144]. However, it has been suggested that 
the classic Cdc42-N-WASP-Arp2/3- pathway for filopodia formation may not be 
entirely correct. A study by Snapper et al showed that the extension of filopodia 
can occur in the absence of N-WASP [145] and there is evidence that filopodia 
can form in an Arp2/3-independent manner [146]. Moreover, IRSp53 recruits a 
number of proteins to filopodia that regulate actin polymerisation and 
organization such as mDia1, MENA/VASP, actin-elongation-promoting protein, 
and EPS8 [141].  
These proteins have various activities. For example, Ena/VASP family proteins 
were found to interact with the tips of the growing filopodia, thus preventing 
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capping from taking place, and, in conjunction with the formin Dia2, providing 
actin monomers to the tip of the developing filopodium [147, 148]. Other 
proteins such as EPS8 promote actin filament bunding [141].  
During the addition of actin subunits to the end of protrusions during actin 
polymerisation, however, there comes a point when the growth of these 
protrusions must be terminated. This involves capping proteins binding to the 
barbed ends to stabilize these filaments. A good example of a capping protein is 
the capping protein CapZ. This capping protein, originally identified in muscle 
cells, is from a family of proteins that bind with a high affinity to the barbed ends 
of actin filaments to block their elongation [149]. This capping aspect is thought  
to be required for the spatio-temporal control of actin polymerisation in cells. For 
example depletion of CapZ has been demonstrated to induce aberrant 
formation of filopodia [150].  
Various proteins can uncap or inhibit activity of capping proteins at barbed 
ends. For example, polyphosphoinositides can uncap these actin barbed ends 
in vitro [109]. There are also proteins that inhibit capping such as CD2AP, a 
multiple SH3 domain containing protein that is required for the formation and 
maintenance of slit diapragham-like junctions, a specialized type of cell-cell 
junctions located in the kidney glomerulus, by linking the protein nephrin to the 
cytoskeleton [151]. CD2AP was found to interact with various actin regulating 
proteins such as cortactin, CapZ and capping protein (CP).  
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Rac1 
 
The Rac subfamily of Rho GTPases consist of four members: Rac1, Rac2, 
Rac3 and RhoG [152]. As mentioned above, Rac share several effectors with 
Cdc42 and have also been linked to junction formation and actin-driven 
membrane dynamics. However, instead of filopodia, Rac stimulates 
lamellipodial extensions and membrane ruffling [152]. Lamellipodia are also 
initiated through the activation of the Arp2/3 complex, a process that involves 
Rac activation of WAVE family proteins, which are nucleation promoting 
proteins like the Cdc42 effector N-WASP [153].  Rac also uses this actin 
polymerisation-driven pathway to regulate cellular movement. Rac activates 
WAVE, which in turn activates Arp2/3 that promotes actin polymerisation and 
pushes the leading edge forward [152]. 
 
Rho 
 
There are three distinct proteins within the Rho family: RhoA, RhoB and RhoC 
[154]. Rho proteins have been extensively studied in cellular responses mainly 
through the enzyme C3 transferase. This clostridial enzyme inhibits RhoA, 
RhoB and RhoC by ADP-ribosylation of Asn41 within the effector binding 
domain of the Rho protein [155]. Of all the Rho proteins, RhoA has been 
studied most exensively 
RhoA has been linked to a variety of actin dependent cellular processes. These 
include cell-cell adhesion, cell motility, platelet aggregation, contraction and 
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cytokinesis [156]. Ridley and Hall found direct evidence for the involvement of 
RhoA in the formation of stress fibres. Using a constitutively activated mutant 
(Val14RhoA), they found that it stimulates stress fibre formation [157]. This 
indicates that RhoA is a crucial player in the regulation of signal transduction 
pathways linking RhoA to the reorganization of the actin cytoskeleton. 
 
GEFs, GAPs and GDIs 
 
As mentioned previously, Rho GTPases exist either in a GDP-bound or in a 
GTP-bound state. Switching of states is regulated by two main classes of 
proteins: GEFs and GAPs (Figure 1.4). A third class of regulatory proteins are 
Guanine nucleotide Dissociation Inhibitors (GDIs), which regulate membrane 
association of the GTPases [11, 158, 159]. 
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Figure 1.4 The Rho GTPase molecular switch.  
Guanine Nucleotide Exchange factors (GEFs) are activators of Rho GTPases, while GTPase 
Activating Proteins (GAPs) are inactivators. GDIs sequester Rho GTPases in the cytosol. 
Adapted from [160]. 
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Guanine nucleotide Dissociation Inhibitors (GDIs) 
 
Three mammalian GDIs have been identified [161]. They are located in the 
cytosol, and form complexes with Rho GTPases in their inactive form. This 
prevents activation of the specific Rho GTPase by GEFs as well as restricting 
the normal translocation of the GTPase between the cytosol and membranes 
[154]. GDIs can also interact with active GTPases, thus preventing the GTPase 
from hydrolysing and interacting with downstream effectors [154]. 
 
Guanine nucleotide Exchange Factors  
 
GEFs are regulatory proteins that stimulate the activation of Rho GTPases by 
catalysing the exchange of GDP by GTP. The first Rho GEF was isolated from 
diffuse B-Cell lymphoma. It was found to transform fibroblasts and was hence 
given the name Dbl [162]. At the time the functional relevance of Dbl was not 
known. Hart et al further clarified its mechanistic properties by showing that Dbl 
catalyzed the exchange of GDP by GTP of Cdc42 [163]. Over 70 GEFs have 
now been identified in the human genome and many have not yet been 
characterized in great detail [159]. Most of these GEFs share two homology 
domains with Dbl that are arranged in tandem: the Dbl Homology (DH) and the 
Pleckstrin Homology (PH) domain. The DH domain is the actual catalytic 
domain that binds to Rho GTPases in their GDP-bound form and promotes 
nucleotide exchange. The function of the PH domain is not the same in all 
GEFs and has been linked to membrane association and regulation of GEF 
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activity by binding to phosphoinositides, as well as to a role in GTPase 
selectivity by binding to DH domain interacting GTPases [164, 165]. A second 
group of GEFs, the Dock180 related proteins, does not contain a DH domain 
but harbours two Dock-Homology Regions: DHR1 and DHR2. The latter domain 
acts as the exchange factor domain in these proteins and DHR1 functions as a 
regulatory domain that binds lipids and other proteins [166]. 
The exchange of GDP by GTP by Rho GTPases without GEFs is slow; GEFs 
speed up the exchange by several orders of magnitude [159]. This is achieved 
by modifying the Rho GTPase nucleotide binding site by inducing a 
conformational change in the nucleotide binding site that reduces the affinity for 
GDP and leads to GDP being replaced by GTP, which in turn displaces the 
GTPase from the DH binding pocket during the course of the exchange reaction 
[159]. 
 
GTPase Activating Proteins  
 
GAPs are negative regulators of Rho GTPase signalling and were initially 
identified by Garrett et al [167]. GAPs bind to GTP bound forms of Rho 
GTPases and enhance their GTPase activity. The first characterised GAP, 
Breakpoint cluster region protein (Bcr), was found to increase the intrinsic ability 
of Rac to hydrolyze GTP to GDP [168]. Since this initial description, there have 
been over 70 human GAPs discovered. Intriguingly, there are over three times 
more GAPs then there are Rho GTPases, and the numbers are similar for 
GEFs. Moreover, most GEFs and GAPs are not specific for a single Rho 
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GTPases. This vast excess in regulators has several potential explanations. 
Firstly, various GAPs and GEFs maybe expressed in a tissue specific manner; 
hence, the provide cell- and tissue-specific functions. Alternatively, GAPs or 
GEFs may regulate a specific pathway or process, and may function at specific 
subcellular sites. An example for this is provided by the two GEFs for RhoA 
GEF-H1 and p114RhoGEF, which both bind to the scaffold cingulin at TJs. 
p114RhoGEF is recruited to the forming junctional complex to form a complex 
with myosin II and stimulates junctional actinomyosin activity; GEF-H1 is active 
thoughout the cytoplasm and recruited to TJs at a later stage, where it is 
inactive, leading to downregulation of RhoA signalling pathways that stimulate 
cell proliferation [59, 60]. 
All GAPs contain a RhoGAP domain, which is comprised of a conserved 140-
150 amino acid sequence. Rho GAP and Ras GAP domains are related in 
terms of structure and functionality although the homology is low [169, 170].  
The GAP domain consists of 9 alpha helices and contains a highly conserved 
arginine residue that is critical for activity of the GAP. This arginine residue is 
present on a loop in the RhoGAP domain, and binding of the GAP to the Rho 
GTPase allows the arginine finger residue to enter the Rho GTPase active site, 
where it neutralises a negatively charged phosphate group to promote GTP 
hydrolysis [169-171]. 
 
Regulation of GAPs 
 
Physiological regulation of Rho GTPase signalling is highly regulated; so, one 
would expect that GAPs are regulated as well to ensure correct termination of 
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Rho GTPase signalling steps. Indeed, there is evidence for the regulation of 
GAPs, the main mechanisms by which GAPs are regulated rely on 
phosphorylation, lipid binding and protein binding, and subcellular targeting. 
There is increasing evidence that GAPs are regulated by kinases. p190 
RhoGAP a GAP for RhoA was found to be phosphorylated and activated by the 
non-receptor tyrosine kinase Src, leading to decreased levels of RhoA [169]. As 
well as activation of GAPs by phosphorylation, inhibition of GAP activity may 
occur. Liu et al demonstrated in their study that the Cdc42 GAP TCGAP was a 
substrate of the src non-receptor tyrosine kinase family member Fyn. Using 
HEK293T cells, Fyn phosphorylated and inactivated TCGAP, thereby promoting 
Cdc42 signalling [172]. Similarly, the Rac1 GAP, CdGAP can be 
phosphorylated by the MEK-ERK pathway, resulting in inactivation of its GAP 
activity toward Rac1 in vivo and in vitro [173]. 
GAP activity can also be regulated by binding to lipid molecules. The best 
example of this is the Rac GAP β2-chimaerin. This GAP contains a C1 domain, 
which is a 50 amino acid motif known to bind phorbol ester and 
phosphatidylserine. The association of β2-chimaerin with phospholipids such as 
phosphatidylserine  increases its GAP activity toward Rac in a concentration 
dependent manner and also stimulates recruitment of the GAP to the plasma 
membrane [174, 175]. 
GAPs can also be regulated by various protein-protein interactions. Binding of 
CdGAP to the endocytic scaffold and GEF intersectin, is thought to induce a 
conformational change on CdGAP that inhibits its GAP activity. It is thought this 
is due to the action of the C-terminal proline rich regions found in CdGAP that 
inhibits its N-terminal Rho GAP domain. Subsequently, intersectin recruits 
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various other proteins to the complex, which are involved in actin dynamics, 
such as WASP, and activates the Rho GTPase Cdc42 [169, 176]. 
It thus seems that the diversity of GAPs with a multitude of different protein 
domains enables cells to control Rho GTPase signalling in response to different 
types of signals and at different subcellular sites. A key domain found in a small 
number of GAPs is the BAR domain, which has also been linked to regulation of 
GAP localization and activity.  
 
BAR domain containing GAPs 
 
A small group of Rho GAPs contain Bin/Amphiphysin/Rvs (BAR) domains. BAR 
domains are found in many proteins that regulate actin remodelling and 
membrane dynamics (e.g., IRSp53) and have also been identified in some 
GAPs, one of which has been shown to associate with TJs. My work has led to 
the identification of two new junction-associated BAR domain-containing GAPs. 
BAR domains can mediate binding to different ligands, including membranes 
and other proteins. Many BAR domains bind membranes in a curvature 
sensitive manner and can even bend membranes, which is thought to be of 
functional importance for the role of such proteins in membrane and actin 
remodelling [177-180]. Crystal structure studies of BAR domains revealed that 
they are composed of three anti parallel coiled coil helices that can promote 
homodimerisation [178, 180, 181]. 
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BAR domains can be classified into three distinct types. The first is the classical 
BAR domain, which includs N-BAR domains and other lipid binding domains; N-
BAR domains differ from classical BAR domains by the presence of an 
amphipathic helix positioned at the N-terminus of the BAR domain. This extra 
amphipathic helix enhances binding to liposomes [181]. The N-BAR domain 
causes curvature in membranes by interacting with negatively charged residues 
on membrane lipid head groups and remodels the membrane to adapt to the 
curvature presented by the N-BAR domain surface [182]. The second type is 
the F-BAR domain (Fes/CIP4 homology BAR), which also binds lipids, contains 
three pairs of conserved basic residues in its structure and is involved in 
membrane tubulation [181]. F-BAR domains are found in many actin regulatory 
proteins such as Transducer of Cdc42-dependent actin assembly (Toca-1).The 
third type is the I-BAR domain, which have a cigar-like shape. Positively 
charged residues aid in its interaction with the plasma membrane [181]. I-BAR 
domain of IRSp53 is thought to link it to the membrane and at the tip of filopodia 
[181]. 
Different types of BAR domains have been found in several proteins that also 
have a Rho GAP domain. Examples include oligophrenin-1, a protein that has 
been linked to mental retardation, and GRAF1, a GAP that has been linked to 
regulation of endocytosis and acute myologenous leukaemia [183, 184]. In 
some GAPs, the BAR domain has an autoinhibitory function [185]. A BAR 
domain GAP of particular importance for my thesis is SH3 Binding protein 1 
(SH3BP1), which was originally identified by Cicchetti et al. who found that it 
binds to the SH3 domain of the non-receptor tyrosine kinase Abl in vitro [186]. 
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SH3BP1 contains a N-terminal BAR, a Rho GAP, and a C-terminal SH3 binding 
domain. The GAP domain that has been shown to stimulate GTP hydrolysis by 
Rac1 and Cdc42 in vitro; and overexpressed SH3BP1 suppresses PDGF 
induced membrane ruffling supporting its negative role in Rac signalling [187]. 
Weak GAP activity toward RhoA was also reported [188]; however, the 
physiological relevance of this activity is not clear. It has recently been shown 
that regulation of Rac by SH3BP1 at the leading edge is important for cell 
migration [189]. Leading edge targeting seems to involve binding to the exocyst, 
a complex involved in plasma membrane tethering of secretory vesicles.  
SH3BP1 has a similar domain structure as Rich1/Nadrin [190-192]. Rich1 was 
found to be an important component of TJs [193, 194]. Rich1 is recruited and 
inactivated at the TJ by the scaffold protein angiomotin (Amot). The polarity 
proteins Pals1, PATJ and Par3 were found to interact with the Amot complex, 
which also contains the tumour suppressor Merlin/NF2. Rich1 function is 
important for Cdc42 and Rac regulation, and thereby regulates apical 
polarization. It is not known whether other BAR domain GAPs play a role in the 
regulation of cell-cell junctions and epithelial polarization. 
 
Rho GTPases and junction formation 
 
The formation of epithelial junctions has been shown in numerous studies to be 
dependent on Rho GTPases. Both constitutively active and dominant negative 
forms of Cdc42, Rac1 and RhoA disrupts the epithelial junctional complex to 
varying degrees, with the CA forms of RhoA and Cdc42 having the strongest 
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effect on the TJ proteins occludin, ZO-1, claudin-1, claudin-2, and junctional 
adhesion molecule (JAM)-A [195-197]. 
Studies by various labs indicated that cell-cell adhesion and E-cadherin 
activation stimulate activation of Rac in different cell types [198-200]. Active 
Rac1 was found localised to the leading edge of contacting lammelipodia 
subsequently preceding junction formation using a biosensor in live MDCK 
cells; active Rac has also been localised to established cell-cell contacts in 
keratinocytes using a recombinant effector protein as a probe [201]. It thus 
seems that induction of cell-cell adhesion stimulates Rac activation in different 
cell types. Moreover, E-cadherin ligation using coated beads or plating cells on 
E-cadherin also stimulates Rac activation, indicating that E-cadherin 
engagement is an important driver of Rac activation [200, 202].  
There are conflicting reports regarding the activation of Cdc42 by newly forming 
contacts. In some laboratories and cell types, Cdc42 has been shown to be 
activated by newly developing E-cadherin based contacts [203]. Conversley in 
keratinocytes, E-Cadherin engagement does not activate Cdc42 but rather 
leads to a decrease in total levels of active Cdc42 [204]. The reason for these 
different results are not clear. However, it is possible that they are due to the 
cell types analysed or to the conditions used, as additional cell-cell adhesion 
proteins can contribute to Cdc42 activation that may be expressed in different 
amounts in different tissues or whose engagement may be influenced by the 
experimental conditions. A prominent example are nectins, that, upon ligation, 
stimulate activation of both Cdc42 and Rac [205]. 
Early studies on RhoA activation suggested that E-Cadherin engagement 
results in a slow but steady decrease in total levels of RhoA activity (5). 
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However, calcium induced cell-cell adhesion in keratinocytes induces active 
RhoA levels, and Rho is required for E-cadherin recruitment to nascent cell-cell 
contacts (10). Similarly, activation of RhoA was reported at forming cell-cell 
contacts in MDCK and Caco-2 cells [60, 201]. Similarly to Rac and Cdc42, it 
thus seems that there are cell type and experimental condition dependent 
variations. An important contribution to the conflicting results is likely to be 
made by the method that is used to monitor activation. Measurements of total 
levels of active GTPases are very accurate but may not detect activation 
occuring in response of induction of adhesion if the same GTPase is inactivated 
concurrently at other subcellular sites. Hence, different cell types may lead to 
different results. It is thus clear that methods for the measurment of spatial 
activation of GTPases need to be employed to reach definitive conclusions.  
During junction formation, the main function of RhoA seems to be myosin II 
activation [206]. Activated RhoA bound to Rho-associated protein kinase 
(ROCKs), which subsequently phosphorylated and inactivate myosin light chain 
phosphatase and also seemed to phosphorylate myosin light chain inself, which 
led to an increase in myosin II activity along the junctional complex. At least in 
part, this mechanism is stimulated by the recruitment of a RhoA GEF, 
p114RhoGEF, to forming TJs, resulting in juntional actinomyosin contraction 
and formation of functional TJs in intestinal and corneal epithelial cells [60]. 
Another GEF for RhoA, ARHGEF11, has recently also been shown to interact 
with ZO-1 and to regulate TJ formation in mammary epithelial cells [207]. It is 
currently not clear whether different epithelial cells rely on different GEFs for 
RhoA or whether indeed multiple RhoA GEFs are required in a given cell type. 
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The mechanisms that inactivate RhoA throughout the cytoplasm have also been 
investigated. GEF-H1, which accumulates at mature TJs, is a major activator of 
RhoA throughout the cytoplasm [208]. During junction assembly, it binds to 
cingulin, a junctional scaffold protein, resulting in junctional sequestration and 
The mechanisms that inactivate RhoA throught the cytoplasm have also been 
investigated. GEF-H1, which accumulates at mature TJs, is a major activator of 
RhoA throughout the cytoplasm [208]. During junction assembly, it binds to 
cingulin, a junctional scaffold protein, resulting in junctional sequestration and 
inhibition of its GEF activity [59]. Formation of AJs also inhibit RhoA signalling. 
p190 RhoGAP is recruited to AJs in response to Rac activation by binding to 
p120 catenin, resulting in activation of its GAP activity, hence, leading to 
reduced RhoA signalling [209].  In contrast, a recent paper suggested that the 
AJ-associated Ect2, a GEF for RhoA and Cdc42, stimulates RhoA signalling at 
the junction and that this is required for stable AJs [210].  However, an earlier 
paper suggested that junctional Ect2 functions as a GEF for Cdc42, and 
associates and regulates the Par3/Par6/aPKC complex [211]. Another regulator 
of RhoA-associated with AJs is ARHGAP10, which is thought to regulate alpha-
catenin recruitment [212]. However, as ARHGAP10 can also inactivate Cdc42, 
it is not clear whether this is due to RhoA or Cdc42 signalling. Finally, the 
motorized RhoA GAPs  myosin 9A and 9B have been shown to associate with 
the AJC and regulate junction assembly [213-215]. There relative importance 
seems to depend on the cell type and conditions analyzed.  
Junction formation as well as various other processes is also dependent on 
interactions of GEFs and GAPs with cytoskeletal components. For example, 
Ect2 is known to be important during cytokinesis. During mitosis, the dissolution 
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of the nuclear envelope allows the release of Ect2 and subsequently allows it to 
localise with microtubules and the mitotic cleavage furrow where it is believed to 
activate RhoA [216]. Recently, it has also been shown to promote mitotic cell 
rounding prior to cytokinesis [217]. GEF-H1 is another GEF that interacts with 
microtubules and microtubule binding inhibits its GEF function [218]. In 
Drosophila, the protein DRhoGEF2 seems to be related to GEF-H1 and is also 
regulated by microtubule binding [219].  
Cdc42 and Rac1 have also both been linked to junction formation and, to some 
extent, seem to be able to perform similar functions. The function of both Cdc42 
and Rac had originally been analyzed by the expression constitutively active 
and dominant-negative constructs in different types of epithelial cells and were 
found to regulate assembly of a functional epithelial junctional complex [195, 
220-224]. Moreover, siRNA-mediated depletion of Cdc42 and genetic deletions 
of the Cdc42 gene have also been shown to disrupt epithelial junction formation 
[225, 226]. Furthermore, Rac1 becomes activated in response to initial E-
cahderin ligation and, at least in some cell systems, is required for the 
stablization of cell junctions by promoting F-actin association and reorganization 
at forming junctions [227]. As Cdc42 and Rac1 share many common effectors 
that regulate junction assembly and dynamics (e.g., PAKs; Par3/Par6/aPKC 
complex), it is not as such surprising that they can regulate similar processes 
and might thus be the underlying reason why different epithelial cell models 
and/or different experimental conditions have led to different requirements for 
Cdc42 and Rac1 for junction formation [106, 204, 225, 226, 228].  
Several GEFs for Cdc42 have been shown to associate with the AJC. As 
mentioned above, Ect2 had been shown to drive junctional Cdc42 activation 
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and stimulation of the Par3/Par6/aPKC complex [211]. The GEF Tuba was 
shown associate with TJs by binding to ZO-1, and its depletion resulted in a 
delay in the formation of junction assembly [229]. Tuba has also been shown to 
regulate cyst morphogeneiss by guiding mitotic spindle polarity in cyts and 
driving apical Cdc42 activation during lumen formation [230-232]. Similarly, the 
GEF ITSN2 has been demonstrated to regulate spindle polarity and cyst 
morphogenesis [233]. 
Rac activation has also been studied and best understood junctional Rac GEF 
is TIAM1, which stabilises AJs  [234]. TIAM1 binds to Par3, resulting in the 
stimulation of function TJ assembly [113, 235]. Different modes of TIAM1 
recruitment to junctions have been described and it has also been shown to 
bind to paracingulin/JACOP [63]. The GEF Trio has also been shown to be 
recruited to AJs and that it regulates a Rac-depenent pathway that suppresses 
E-cadherin transcription [236]. Rac activity at AJs is also promoted by 
stabilization due to a feedback loop with Ajuba, a protein that becomes 
activated by the Rac effector kinase PAK1 and subsequently stabilises GTP-
bound Rac [237]. 
Junctional Cdc42 and Rac activity can also be regulated by GAPs. The best 
known example was mentioned above, Rich1, a GAP that is important for 
epithelial polarization and is recruited to TJs [193, 194]. ARHGAP12, which can 
also stimulate Cdc42 and Rac, has also been shown to accumulate at AJs 
[238]. It is downregulated by HGF signalling and prevents scattering and Rac 
activation if overexpressed, suggesting that it is important for the stabilization of 
AJs, as Rac activation can also stimulate junction dissociation [239, 240]. 
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There is thus compelling evidence for the functional importance of the main Rho 
GTPases RhoA, Rac1 and Cdc42 for the assembly and regulation of AJs and 
TJs. While the first Rho GEFs and Rho GAPs have beed identified that are 
important for these functions, we are still lacking sufficiently detailed information 
to understand the orchestration of Rho GTPase signalling at epithelial junctions.  
 
EGFR signalling 
 
Many growth factors bind and stimulate transmembrane proteins with 
cytoplasmic tyrosine kinase domains. Stimulation of such growth factor 
receptors leads to dramatic changes in signalling pathways that regulate cell 
differentiation, morphology, cytoskeletal organization and junction formation. 
Many of these pathways involve Rho GTPases. The receptor for epidermal 
growth factor (EGFR) is of central importance in epithelial cells. 
The structure of EGFR is comprised of an extracellular domain, involved in 
binding to EGF ligand, a membrane spanning segment, and the cytoplasmic 
tyrosine kinase domain [241]. Upon EGF binding, the receptor undergoes 
dimerization and its tyrosine kinase activity is switched on. Various tyrosine 
residues located on target proteins as well as the receptor itself are 
consequently phosphorylated. Upon activation, the receptor is internalised via 
endocytosis, which is not only important for signalling but also for terminating 
the signal once the receptor reaches late endosomes [241-243]. 
EGFR activation results in the stimulation of multiple signalling pathways that 
can lead to Rho GTPase activation. A main pathways is Ras signalling, which 
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leads to activation of Raf and Erk signalling. Erk can stimulate GEFs such as 
GEF-H1 and thereby stimulate RhoA activation [244]. EGFR also regulates 
phosphatidylinositol 3-kinase activation (PI3K), which activates the production 
of PtdIns (3, 4, 5) P3, leading to the stimulation of Akt, which leads to the 
stimulation of Vav2, a GEF for multiple Rho GTPases. EGFR also stimulates 
the activation of the tyrosine kinase src, a major upstream regulator of Rho 
GTPases [245]. 
The overall response of EGF signalling depends on the cell type and the 
experimental conditions. In some epithelial cells, EGF signalling induces 
dissolution of cell junctions and cell scattering; in other cells, EGF induces 
junction formation and differentiation [246-251]. Similarly, EGFR signalling is 
important for normal development and maintenance of the skin, but can cause 
cell transformation and skin cancer if deregulated [252].  
Rho GTPases have been linked to both processes: EGF-induced scattering and 
EGF-induced junction formation. Scattering induced by increased EGF-
signalling is a Rac1-dependent process and involves a recently identified 
effector, armus, that regulates E-cadherin degradation [253]. In another study 
Toca1 was activated by EGF stimulation and was shown to play an important 
role in actin remodelling during cell migration. Depletion of Toca1 resulted in a 
decrease in filopodia [254]. Toca1 in conjunction with Abelson-interacting 
protein 1 (Abi1) is also important for the regulation of actin nucleation, as their 
absence impairs localization of Arp2/3 [254]. This links to an earlier study that 
showed that EGF induced Cdc42 was required for the translocation of Arp2/3 to 
the leading edge of motile cells [254, 255]. On the other hand, in confluent 
cultures of the keratinocyte cell line A431, EGF induces increased levels of 
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active Rac1 and Cdc42; The levels of activated Cdc42 and Rac1 at the plasma 
membrane increased in a diffuse manner before being found present in 
membrane associated ruffles and lamellipodia [256]. Activity of Rac1 subsided 
rapidly after EGF stimulation, whereas levels of Cdc42 activity remained high 
[256, 257]. Interestingly, A431 cells start to form TJs if stimulated by EGF and 
AJs remain assembled [258]. Whether induction of TJ formation is a Rho 
GTPase-dependent is not known yet.  
 Deregulation of EGF receptor signalling is an important disease mechanism. 
The EGF receptor is found to be upregulated in a number of cancers. Further 
exploration of the genome found mutations in the EGF receptor gene in cancers 
such as lung [259]. Thus the EGF receptor has become a focal point for the 
development of cancer therapy. Upregulation of the EGF receptor is also 
correlated with a poor prognosis during cancer progression. EGF receptor 
upregulation has also been linked to polycystic kidney disease and a EGFR 
specific tyrosine kinase inhibitor resulted in therapeutic benefits in mice [260]. 
Thus, EGF is an important growth factor in health and disease, and a potential 
therapeutic target for different types of disease conditions. 
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Experimental plan  
 
The focus of this project is on the regulation of Rho GTPases in the context of 
epithelial junction formation and maintenance, and, in particular, the negative 
regulation of these small GTP binding proteins by the GAP protein SH3BP1. 
This protein was chosen to study further as it was identified in siRNA based 
functional screen using the human epithelial colon adecarcinoma cell line Caco-
2 as a regulator of epithelial junction assembly. I have analyzed the role of 
SH3BP1 in two types of epithelia: Caco-2 cells and A431 cells, in order to 
determine the function of SH3BP1 in junction formation and maturation, and to 
identify the molecular mechanism by which it supports epithelial differentiation. 
 
Hypothesis 
 
Research by various laboratories demonstrated that inactivation as well as 
over-stimulation of Rho GTPase signalling prevents normal formation of the 
AJC. Hence, proper spatial and temporal control of Rho GTPase activation and 
inactivation appears to be required for junction assembly. We have therefore 
hypothesized that specific negative regulators of Rho GTPases exist that are 
recruited to sites of actin-driven membrane remodelling and junction formation 
to ensure proper timing of Rho GTPase signalling.  
 
 
76 
 
Specific Aims 
 
Aim 1 - To perform a function siRNA screen to identify negative regulators of 
Rho GTPases in the context of junction stability. 
 
Aim 2 - To determine the role of SH3BP1 in early assembly and maturation of 
the AJC in distinct epithelial cell models.  
 
Aim 3 - To identify interaction partners of SH3BP1 and to design a model for 
SH3BP1 function. 
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Chapter 2 
 
Materials and Methods 
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Chapter 2 - Materials and Methods 
 
All materials used are from Sigma unless otherwise stated 
 
DNA cloning techniques 
All the DNA constructs used in the project are listed in table 2.0: 
 
 
Name of Plasmid 
 
 
Description 
 
 
 
 
pcDNA4/TO/Myc-His- 
A/B – HA Full length  
SH3BP1 
 
HA tag added to N-terminus of vector using XhoI junction.  
 
Human SH3BP1. Made by PCR using an SH3BP1 EST clone  
(MRC Geneservice) as template and the following primers: 
 
Forward: 
 
5’-CGCGGATCCATGCAGGACCTGCCAGGCAACGACAACAGCAC 
CGCCGGCCTCGAGATGATGAAGAGGCAGCTGCACCGC – 3’ 
 
Reverse: 
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5’ – AAGCTCTAGATCAGTTGGTCTCTGAGGCAAGGCTC – 3’ 
 
BamHI/XbaI fragment cloned in to BamHI/XbaIpcDNA4/TO/Myc- 
His-A/B – HA 
 
 
pcDNA4/TO/Myc-His- 
A/B – HA SH3BP1 BAR  
domain mutant  
 
HA tag added to N-terminus of vector using XhoI junction.  
 
Human SH3BP1 BAR domain mutant. Made by PCR using an  
SH3BP1 EST clone (MRC Gene service) as template and the 
following primers: 
 
 
Forward: 
 
5’ – CGCGGATCCATGCAGGACCTGCCAGGCAACGACAACAGCA 
CCGCCGGCCTCGAGATGATGAAGAGGCAGCTGCACCGC – 3’ 
 
 
Reverse: 
 
5’ – CAAGCTCTAGACTACGAAGGGGAGTGGTCTGCTTGG – 3’ 
 
BamHI/XbaI fragment cloned in to BamHI/XbaIpcDNA4/TO/Myc- 
His-A/B – HA 
 
 
pcDNA4/TO/Myc-His- 
 
HA tagged Human SH3BP1 (R312) mutant. Made by single step  
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A/B – HA Full length  
SH3BP1 (R312A) 
PCR mutagenesis using pcDNA4/TO/Myc-His-A/B – HA Full  
length SH3BP1 as A template and the following primers: 
 
Forward:  
 
GAGGGTCTCTTCGCTCTGGCTGCTGGG 
 
Reverse: 
 
CCCAGCAGCCAGAGCGAAGAGACCCTC 
 
The arginine residue was converted to an alanine residue. 
 
 
pGEX-4T-3 GST SH3BP1 
Full Length 
 
Human SH3BP1 Full length. Made by PCR using  
pcDNATO/myc-his-A/B – HA Full length SH3BP1 as template and  
the following primers: 
 
Forward: 
 
GCGAATTCCATGATGAAGAGGCAGCTGCACCGCATGCG  
 
Reverse: 
 
GGCGGCCGCCTCAGTTGGTCTCTGAGGCAAGGCTCCTGGG 
 
EcoRI/NotI fragment cloned in to EcoRI/NotIpGex-4T-3. 
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pGEX-4T-3 GST SH3BP1  
BAR domain mutant 
This was made by subcloning the SH3BP1 BAR domain mutant  
fragment from the pcDNA4/TO/Myc-His-A/B – HA to the  
pGex-4T-3 GST SH3BP1 using a BamHI/XbaI Restriction digests. 
 
 
pGEX-4T-3 GST SH3BP1  
C-Terminal domain  
mutant 
 
 
Human SH3BP1 C-Terminal domain mutant. Made by PCR using  
full length SH3BP1 as template and the following primers: 
 
Forward: 
 
GCGAATTCCCTCTTCTCAGCTGTTACCCTCCAGGACACAGTC 
 
Reverse: 
 
GGCGGCCGCCTCAGTTGGTCTCTGAGGCAAGGCTCCTGGG 
 
EcoRI/NotI fragment cloned in to EcoRI/NotIpGex-4T-3. 
 
 
pCAGGSneodelEcoRI 
HA tag JACOP 
 
 
Kindly provided by Dr Mikio Furuse, Kyoto University, Japan. 
 
pcDNA4/TO/myc-his- 
A/B - HA Full length  
 
SH3BP1 siRNA resistant  
mutant 
 
 
Human SH3BP1 siRNA resistant construct. Made by PCR using  
full length SH3BP1 as a template and the sequence changed from: 
 
GATGACAGCCACCCACTTC 
 
To: 
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 AATGACAGCAACACACTTC 
 
 
pcDNA4/TO/myc-his- 
A/B - HA Full length  
SH3BP1 (R312A) siRNA 
resistant mutant 
 
 
 
Human SH3BP1 siRNA resistant R312A mutant. Made by PCR 
using full length SH3BP1 R312A as a template and the  
sequence changed  
from: 
 
GATGACAGCCACCCACTTC 
 
To: 
 
AATGACAGCAACACACTTC 
 
 
Table 2.0 List of DNA constructs used in project. 
Primers used to generate the constructs are listed. Nucleotide bases highlighted in red indicate 
enzyme restriction sites or bases altered by site directed mutagenesis. 
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Polymerase chain reaction 
 
Table 2.1 shows concentrations of individual components used for PCR 
reactions. 
 
Product Volume 
Primers (Provided by MWG) 1µl each primer  
10x Buffer with MgCl2 (Roche) 5µl 
dNTP mix (1.25mM each) (Promega) 8µl 
Template DNA  1µl 
Expand High Fidelity PCR Enzyme (Roche) 0.5µl 
H2O 29µl 
10% DMSO  5µl 
  
Table 2.1 PCR reaction constituents. 
 
The Biometra T3 Thermocycler PCR machine (Anachem) was programmed 
with the following settings: Initialising step, 95oC for 2 minutes; 30 cycles of 
denaturation at 94oC for 30 seconds, annealing at 60oC for 30 seconds and 
extension at 72oC for 2 minutes; final elongation step at 72oC for 10 minutes. 
84 
 
PCR products were run on low melt agarose gels, bands were excised and 
DNA purified. 
 
DNA agarose gel electrophoresis 
 
Preparation of 1% agarose gels was performed using either standard agarose 
(Invitrogen) or low melt agarose (Bioproducts Ltd) combined with either TBE for 
standard agarose or TAE for low melt agarose (both National Diagnostics, 
USA). To the dissolved agarose, Gel red at a 1 in 10,000 dilution (Biotium, 
USA) or ethidium bromide at 0.5 mg/ml was added to stain the DNA. A 1KB 
DNA marker (Invitrogen) was loaded alongside the samples, and 6x DNA 
loading buffer (0.25% Bromophenol blue, 0.25% Xylene cyanol FF and 30% 
glycerol) was added to the samples. Low melt agarose gels were run at 75mV 
and standard agarose gels at 120mV. The gels were imaged using a UV 
transilluminator-based digital imaging station (Syngene). 
 
Low melt agarose DNA purification using silica beads 
 
To each sample excised agarose gel slice 1ml of 6M sodium iodide was added. 
Samples were then placed in a water bath at 70oC for 10 minutes. Once melted, 
40µl of silica beads were added and resuspended by inverting the tubes. After 
10 minutes, the samples were centrifuged at 10,000 rpm for 1 minute, and the 
supernatants were discarded. The pelleted beads were then washed three 
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times with 1ml of ice-cold wash buffer (50mM NaCl, 10mMTris HCL (pH 7.5), 
2.5mM EDTA and 50% (v/v) ethanol) centrifuging each time for 1 minute at 
10,000 rpm. After the final centrifugation, the resulting DNA pellets were 
suspended in 40µl of distilled water. The samples were incubated in a heating 
block at 70oC for 10 minutes and then centrifuged for 1 minute at 10,000 rpm. 
The supernatants containing the purified DNA were then transferred to fresh 
tubes for further processing.  

Low melt agarose DNA ligation procedure 
 
After melting agarose slices at 70oC, 3l of vector (~50ng) and 7l of DNA 
insert (~10 - 50ng) were mixed. For background tubes, the insert DNA was 
replaced with H2O. The tubes were reincubated at 70
oC for 10 minutes to 
ensure that the agarose did not start to gel. During this time, an ice bucket was 
prepared containing fresh microcentrifuge tubes containing 10µl of a master 
ligation mix that was prepared by mixing 7 parts of distilled water, 2 parts of 10x 
DNA ligase buffer, and 1 part of T4 DNA ligase (NEB). Ten microlitres of the 
DNA mix was then added to the 10µl of ligation mix, pipetted once up and 
down, and placed on ice.  The samples were placed in a refrigerator overnight. 
The next day, the samples were incubated a further 2-3 hours at ambient 
temperature before transformation. 
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TA cloning kit ligation using PCR 2.1 vector (Invitrogen) 
 
The purified DNA inserts were first incubated with Taq polymerase by adding 
1µl of 10x PCR buffer, 1µl dNTPs (1.25mM of each) and 0.2µl Taq polymerase 
to 8µl of the DNA sample. The tubes were then incubated at 72oC for 10 
minutes. A ligation mix was then prepared that contained 4µl of the above 
solution, 2µl H2O, 2µl of the PCR 2.1 vector, 1µl 10x buffer and 1µl T4 DNA 
ligase. The ligation was allowed to proceed for 2 hours at ambient temperature 
and then overnight at 4oC.  
 
Transformation of ligated DNA using competent bacteria 
 
Frozen competent DH5α E.coli were left to thaw on ice. Once thawed, 1.7µl 
1.4M β-mercaptoethanol was added per 100µl of bacterial suspension. After 10 
minutes, 100µl of bacterial suspension were added to each DNA sample to be 
transformed. Transformations were then incubated on ice for 30 minutes before 
applying a heat shock in a 42oC water bath for 45 seconds. The samples were 
immediately placed on ice and, after 3 minutes, 1ml lysogeny broth (LB) was 
added to each sample. The transformed bacteria were then allowed to recover 
at 37oC for 60 minutes before plating on LB-agar plates containing 100µg/ml 
ampicillin or 50µg/ml kanamycin. Plates were left overnight at 37oC. When 
transforming TA ligation samples, IPTG (Roche; 1mM final concentration) and 
X-gal (40µg/ml final concentration) were added to the LB-agar plates to identify 
colonies harbouring a plasmid with insert by blue/white selection. 
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Preparation of competent E.coli bacteria DH5α or BL21pLysS 
 
A colony of bacteria was grown in LB medium overnight in suspension culture. 
The following day, 4ml of the culture was added to 400ml of LB and incubated 
at 25ºC with vigorous shaking until the OD600 was between 0.4 and 0.6. The 
culture was chilled for 20 minutes on ice and spun at 4000 rpm for 10 minutes 
at 4ºC. The pellet was resuspended in 150ml ice-cold TB buffer (10mM Pipes-
KOH pH 6.7, 15mM CaCl2, 0.25M KCl and 55mM MnCl2). The bacteria were 
pelleted again by spinning at 4ºC for 10 minutes. The supernatant was 
discarded and the pellet resuspended in 30ml TB. After adding 2.25ml DMSO, 
the suspension was left on ice for 10 minutes. Finally, 500µl aliquots of bacteria 
were prepared and snap frozen using liquid nitrogen. The competent bacteria 
were stored at -80ºC and defrosted on ice before being used for transformation.  
 
Site-directed mutagenesis 
 
Table 2.2 shows the concentrations of individual component used for site-
directed mutagenesis reactions. 
 
Product Volume 
Primers  2µl of each primer (80ng/µl) 
10x Pfu Buffer (Stratagene)  5µl 
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dNTP mix (2mM each) (Promega) 5µl 
Template DNA  2µl and 1µl  
PfU enzyme (Stratagene) 1µl 
H2O 14µl 
Betaine (5M) 15µl 
Mgcl2 (25mM) 4µl 
 
Table 2.2 Site-directed mutagenesis constituents.  
 
The Biometra T3 Thermocycler PCR machine (Anachem) was programmed 
with the following settings: Initialising step at 95oC for 2 minutes; 30 cycles of 
denaturation at 95oC for 30 seconds, annealing at 48oC for 30 seconds, and 
extension at 68oC for 2 minutes per kB of template length; and a final elongation 
step at 68oC for 12 minutes. After the PCR, the wild type DNA was removed 
from the mixture by DpnI restriction enzyme digestion (NEB; 25l of the PCR 
reaction, 5l of 10x Buffer 4, 19l of H2O, and 1l of DpnI were mixed). The 
digestion mixtures were incubated at 37oC for 1hour before inactivating DpnI by 
incubating at 80oC for 20 minutes.As a negative control,1l WT DNA in 24l 
H2O were used instead of the 25l PCR mix. 4l of the digests were 
transformed into competent DH5α cells. 
 
89 
 
Protein analysis 
 
 
Immunoblotting techniques 
 
Cells were washed three times with PBS before lysing the cells in 1.5x Laemmli 
sample buffer (3% SDS, 15% glycerol, 0.5M Tris HCL pH 6.8, 0.0015% 
bromophenol blue and 100mM DTT; 100l/well of a 48-well plate) and 
homogenising with a 25 gauge needle (BD). Proteins were resolved by running 
Tris-buffered gels at a constant voltage of 25mV per gel using Hoefer Might 
Small twin gel systems. The transfer was performed using wet transfer systems 
(BioRad) at 4oC and nitrocellulose membranes (LI-COR). The transfers were 
allowed to proceed for two to three hours, depending on the size of the proteins 
to be analysed. The membranes were then stained with amido black (0.1% 
Destain, which contained 20% methanol and 7.5% acetic acid) followed by 
destaining for 30 minutes. The membranes were rinsed with water and 
neutralised with PBS for 5 minutes. The membranes were subsequently 
blocked with 5% milk in PBS containing 0.1% Tween-20 for one hour. Finally, 
primary antibody was then added, and the membranes were incubated at 
ambient temperature overnight or at 4oC for longer periods of time. The 
membranes were then washed three times for 20 minutes with PBS/0.1% 
Tween-20. The secondary antibody was then added in PBS/0.1% Tween-20 
and incubated for two hours. Finally, the membranes were washed again three 
times for 20 minutes each with PBS/0.1% Tween-20, and twice for 10 minutes 
with PBS only. If antibodies against phosphorylation sites were used, PBS was 
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replaced by TBS. The immunoblots were developed either by enhanced 
chemiluminescence (ECL; GE Healthcare) using X-ray film, if horseradish 
peroxidase-conjugated antibodies were used, or with an Odyssey infrared 
imager (LI-COR) if fluorescently labelled antibodies were employed. 
 
Co-immunoprecipitation (Co-IP) 
 
Cells were seeded at 20% confluence using a 15cm plate. Cells were left for 3-5 
days in order to allow them to form TJs and polarize. The day before cells were 
ready, immunobeads were prepared by adding 3g of antibody to 50l of 
Protein A or Protein G beads (G.E Healthcare or Generon). Once cells were 
90% confluent, they were washed with cold PBS. Shortly before use cocktails of 
protease (PMSF, aprotinin, benzamidine, pepstatin, and leupeptin) and 
phosphatase inhibitors (NaF, sodium pyrophosphate, and sodium 
orthovanadate) were added to the extraction buffer (0.5% TX100 in PBS). Cells 
were harvested in extraction buffer (using 2ml per plate). Cells were scraped 
and sucked up using a syringe with a 23 gauge needle (BD) into a 50ml tube. 
Cell extracts were passed three times through a 23 gauge needle and were 
then incubated on ice for 15 minutes. The samples were then divided into 
microcentrifuge tubes and 100µl (30% w/v) inactive Sepharose beads were 
added to each tube (G.E Healthcare), mixed by inverting twice, and left on ice 
for 15 minutes, occasionally inverting the tubes. Tubes were then spun at 
13,000 rpm for 10 minutes at 4oC. Corresponding supernatants were then first 
pooled before dividing them into the tubes containing the immunobeads; an 
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aliquot was kept as a total input control. The tubes were incubated on an end-
over-end shaker at 4oC for 2 hours. Finally, the immobeads were washed twice 
with PBS-0.5% Triton-X100 and once with PBS before adding 50µl 1.5x 
Laemmli sample buffer and heated at 70oC for 10 minutes. 
 
Fusion protein expression and purification  
 
Preparation of pGEX-4T-3 fusion proteins for use in GST pull-
downs 
 
Fusion protein constructs were made in pGEX-4T-3. The plasmids were 
transformed into BL21pLysS competent E-Coli and plated on an LB agar plate 
containing 50µg/l ampicillin and 34µg/l chloramphenicol. The next day 
colonies were picked and inoculated in 100ml of LB containing ampicillin and 
chloramphenicol. The suspension cultures were incubated overnight at 37oC. 
The next day, the bacterial cultures was spun at 6000 rpm for 15 minutes (using 
250ml centrifuge tubes), and the pellets were then resuspended in 500ml of 
fresh LB containing ampicillin and 0.5mM IPTG. The cultures were then 
incubated on a shaker for 1-2 hours at 25oC. The bacteria were then pelleted at 
6000 rpm for 15 minutes at 4oC, and extracted with 30ml of lysis buffer (PBS, 
0.5% Triton X-100, 1mM DTT) containing protease inhibitors (50g/ml 
benzamidine, 1mM PMSF, 10g/ml aprotinin, 10g/ml pepstatin A, 10g/ml 
leupeptin and 1mM DTT). The samples were then left on ice for 30 minutes 
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before sonicating three times for 10 seconds. The sonicated samples were then 
centrifuged for 10 minutes in an SS-34 rotor at 10000 rpm (using 30ml 
centrifuge tubes). The samples were then divided into 5ml aliquots and frozen. 
To test protein induction, 300l of extracts were added to 200µl lysis buffer and 
40l glutathione beads (30% slurry). The samples were then incubated on a 
rotator for 2 hours. Samples were then washed with PBS/0.5% Triton-X100 
followed by PBS.  The washed beads were resuspended in 1.5x sample buffer 
(50l) and the samples were analysed by SDS- PAGE and Coomassie staining. 
The gels were then imaged on the Odyssey infrared imager (LI-COR). 
 
pGEX-4T-3 fusion protein purification 
 
To every 30ml of bacterial extract, 2ml of 30% slurry of glutathione beads were 
added and placed on a rotor shaker at 4oC for two hours. The samples were 
then loaded into purification columns (Pierce) with filters that had been pre-
equilibrated with lysis buffer. The columns were then washed with lysis buffer 
until eluates had an OD280 of 0.02 or smaller. The fusion proteins were then 
eluted with 1.5ml 25mM reduced glutathione in 10mM Tris pH 8.0. Three 
elutions were performed and collected in 2 ml tubes and OD280 was read. In 
cases where the three elutions were not efficient, 2 further elutions using SDS 
elution buffer (0.125ml SDS 10%, 9.5ml of water and 0.5ml of Tris 1M pH 8) 
were performed. The samples were then dialyzed against PBS at 4oC for 24 
hours. The dialysis buffer was changed twice during this time. The samples 
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were then split into small aliquots and frozen at -20oC. An aliquot was analysed 
by SDS-PAGE, and concentrations were assessed with a BSA standard curve. 
 
GST pull-down 
 
Fusion protein sample supernatants were thawed on ice, and loaded onto 40l 
glutathione Sepharose beads (30% w/v) and placed on a rocker for 2 hours. 
Lysates were prepared with extraction buffer (0.5% TX-100 and 1x PBS) as 
described above for immunoprecipitation. Fusion protein loaded beads were 
then washed three times with lysis buffer before incubating with the cell extracts 
for two hours on a an end-over-end shaker. Samples were washed and 
analysed by SDS-PAGE as described for immunoprecipitates.  
 
Basic tissue culture techniques 
 
Cell culture 
 
Caco-2 (Human Epithelial Colorectal Adenocarcinoma), A431 (epidermoid 
carcinoma), HCE (Human Corneal Epithelial), and MDCK (Madin-Darby canine 
kidney) cells were cultured in DMEM (PAA) containing 10% Foetal Bovine 
Serum (FBS) (PAA) (20% FBS in the case of Caco-2 cells). 
Penicillin/streptomycin (PAA) was added to the media that contained 10 units/ml 
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of penicillin and 10µg/ml of streptomycin. Depending on the experiments, cells 
were grown in 6, 12, 24, 48 or 96-well plates (Nunc). Cells were passaged after 
detaching them by incubating with 0.05% Trypsin/EDTA (PAA) for 15 minutes in 
the incubator. For siRNA experiments cells were transfected at 20% confluence, 
and for transient transfections at 60% confluence. 
 
Stable cell lines generation techniques 
 
Picking clones 
 
After transfection, the cells were split into 15-cm dishes and grown in medium 
containing the appropriate selection antibiotics (neomycin, 1g/ml; and 
puramycin, 1g/ml;).  The cells were left to grow for a few weeks until the 
colonies reached a size of 0.5-1cm diameter. To pick the colonies, the cells 
were incubated with Trypsin/EDTA solution until they began to round up. The 
trypsin was aspirated and the plate left in the incubator at 37oC for a further 5 
minutes. Individual clones were then transferred to a 48-well plate. After picking 
the clones, the remainder of the cells were washed off with 6ml full media and 
plated in a 6 well dish. This represented the pool of clones.  
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Immunofluorescence techniques 
 
Fixation techniques 
 
Methanol fixation (-20oC) 
 
Cold methanol (-20oC) (Fisher Scientific) was added to cells plated on glass 
coverslips, and the cells were transferred to -20oC for 5 minutes. The methanol 
was discarded and the samples were rehydrated with PBS at room 
temperature. The PBS was then discarded and blocking solution (PBS/1% BSA 
/20mM glycine/0.1% NaN3) was added for 15 minutes. Cells were stored in 
blocking solution or stained immediately. 
 
Triton X-100 (0.1%) extraction/-20oC methanol fixation 
 
Cells were cooled on ice for 1 minute. Triton X-100 (Sigma) (0.1%) in BB buffer 
(100mM KCl, 3mM MgCl2, 1mMCaCl2, 200mM Sucrose and 10mM Hepes pH 
7.1) was added and incubated for 1 minute on ice. The Triton-X100 solution 
was discarded and a standard -20oC methanol fixation was carried out as 
explained above.  
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Paraformaldehyde fixation/0.3%Triton X-100 permeablisation 
 
Paraformaldehyde (PFA) solution (3% in PBS) was added to the cells and left 
for 30 minutes at room temperature. The PFA solution was discarded and PBS 
containing 0.3% Triton X-100 and 0.3% BSA were added. After 5 minutes, the 
permeabilization solution was discarded and the cells were washed twice with 
blocking buffer. Samples were then stored in blocking buffer until they were 
stained with antibodies. 
 
Staining of cells plated on coverslips 
 
The selected primary antibodies were diluted in blocking solution and added to 
the fixed cells. The primary incubation was either at room temperature for 2 
hours or at 4oC overnight. The cells were washed three times in PBS and the 
fluorescent secondary antibodies, also diluted in blocking solution were added, 
the samples were left in the dark for 2 hours. The cells were then washed three 
times with PBS, and each well was filled with 1ml of PBS to facilitate removal of 
coverslips for mounting. The coverslips were mounted on slides (VWR) using 
Prolong Gold Antifade Mountant (Invitrogen).  
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Transfection techniques 
 
Transfection using Lipofectamine 2000 
 
Cells were trypsinizedand plated so that they were ~60% confluent on the day 
of transfection.  For cells plated in 48 well dishes, 0.3µg of DNA was added per 
sample in 25l OptiMem (PAA). A separate tube was prepared for the 
transfection reagent comprising per well 2l Lipofectamine transfection reagent 
(Invitrogen) and 23l OptiMem. The tubes were incubated at room temperature 
for 5 minutes. The diluted DNA and Lipofectamine 2000 samples were then 
combined and left at room temperature for another 20 minutes. During this time, 
200µl DMEM containing 10% FBS was added to each well. The 50µl of 
Lipfectamine/DNA complexes were then added to the cells. After 4 hours, the 
transfection mix was aspirated and replaced with 350µl DMEM/10% FBS. Cells 
were analysed after 24 hours at 37oC. 
 
Transfection using jetPEI 
 
Cells were trypsinized and plated so that they were ~60% confluent on the day 
of transfection.  For cells plated in 48 well dishes, 0.5µg of DNA was added per 
sample in 25µl 150mM NaCl. A separate tube designated B was prepared for 
the transfection reagent comprising per well 1l jetPEI transfection reagent 
(Polyplus) and 25l 150mM NaCl. Both tubes were vortexed for 10 seconds. 
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Tube B was then added to the DNA containing tube and this tube was vortexed 
for 10 seconds before being left at room temperature for 20 minutes. During this 
time, 250l DMEM containing 10% FBS was added to each well. The 50l of 
jetPEI/DNA complexes were then added to the cells. Cells were analysed after 
24 hours at 37oC. 
 
Calcium phosphate transfection 
 
Cells were plated the day before transfection at 60% confluence in a 6-well 
plate. Plasmid DNA was precipitated by adding 10g DNA to 200µl 2x Hepes 
buffer pH 7.1. To this 200µl CaCl2 was added drop-wise while vortexing. The 
precipitate was formed by leaving the tube for 30 minutes at room temperature. 
The 400µl solution was then added to the cells after the medium had been 
aspirated. The cells were then incubated at 37oC for 30 minutes and 3ml of full 
medium was added. The next day the medium was removed and a glycerol 
shock was performed for 2 minutes using 12.5% glycerol in DMEM containing 
10mM Hepes (pH 7.4). Each well was rinsed once with 3ml PBS and 3ml full 
medium were added. Cells were left to express the specified protein for 48 
hours at 37oC. 
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siRNA transfection using Interferin 
 
Cells were plated the day before transfection so that they were 20-30% 
confluent. The transfections were prepared by adding 0.5l-1l 20µM siRNA 
(Dharmacon) to 50l OptiMem for each transfection in a 48-well plate. After 5 
minutes, 1l Interferin transfection reagent (Polyplus Transfections) was added, 
and the mix was vortexed for 10 seconds. After 20 minutes at room 
temperature, 200l DMEM/10% FBS was added and mixed gently by inverting 
the tubes three times. The mix was added to the cells and left for 24 hours. 
Fresh medium was then added and the cells were cultured for a further 48-72 
hours. If larger wells were transfected, the volumes used were proportionally 
increased. For all experiments requiring replating (i.e., FRET and Ca-switch 
assays), cells were transfected with siRNAs in 6-well plates.  
 
Culture of Caco-2 epithelial cells in 3D cultures 
 
For 3D morphogenesis, siRNA-transfected Caco-2 cells were plated on top of a 
layer of growth factor-reduced Matrigel (BD Biosciences) [137, 261]. Briefly, 
coverslips in 48-well plates were covered with 90l of Matrigel (9.3mg/ml) and 
left to polymerise for 45 minutes. Then, 10,000 cells were plated in 300l of low 
glucose medium containing 2% Matrigel. After 48 hours, the medium was 
replaced with fresh medium containing 2% Matrigel and 0.1g/ml cholera toxin. 
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After another 48 hours, the medium was carefully replaced with fresh 
medium/Matrigel/cholera toxin mix. The samples were then fixed 10 hours later. 
 
3D culture fixation and staining conditions 
 
Cells were fixed using 3% paraformaldehyde. The samples were then washed 
twice with PBS for 5 minutes and incubated for 30 minutes with a 
BSA/SDS/Triton-X100 blocking solution (1% BSA, 0.1% NaN3, 20mM glycine, 
0.1% SDS and 1% Triton-X100 in PBS) to permeabilize. Cells were stained 
using blocking solution and primary antibody overnight at 4oC. Cells were 
washed three times with PBS and once using blocking solution. Secondary 
antibody staining and washes were carried out as for the primary antibody. 
Cells were then mounted face up, Prolong Gold was added on top of the cells 
that were then covered with a 22mm x 22mm square coverslip, and sealed with 
superglue around the edges. 
  
Cyst Quantification 
 
 
Quantification of lumen size diameter was performed using the measuring tool 
in Image J. Only cysts that had reached a minimal size of 30µm diameter were 
considered for the morphological quantification to avoid bias because of the 
smaller cysts. 
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Calcium switch assays 
 
Cells that had been transfected with siRNAs for 24 hours in 6-well plates were 
trypsinised for 20 minutes in order to ensure absence of cell-cell adhesion, and 
pipetted once to disperse. Cells from three wells were pooled for each 
experiment by resuspending them in 14ml of medium. The tubes were spun at 
1000 rpm for 5 minutes, and the cells were resuspended in 6ml of low calcium 
medium (Sigma, spinner culture medium with 2mM glutamine/1mM sodium 
pyruvate), penicillin/streptomycin and 5% dialysed FBS. The cells were pelleted 
again and resuspended in low calcium medium. This was performed twice in 
order to remove the calcium. To the basolateral chamber of the Transwell 
plates, 1.5ml of low calcium medium was added. Cells were resuspended in 
2.5ml low calcium medium for four filters or 3.6ml for six glass coverslips, and 
600l of samples were plated. The cultures were then incubated at 37oC for 16-
24 hours. Junction formation was then induced by carefully aspirating the low 
calcium medium and adding calcium containing medium (0.5ml into the apical 
chamber and1.5ml into the basolateral chamber of Transwell cultures; 600l per 
48 well). The cultures were then incubated at 37oC for 30 minutes before 
starting to measure transepithelial electrical resistance (TER). TER was 
measured with a silver/silver-chloride electrode to determine the voltage 
deflection induced by an AC square wave current of ± 20 µA at 12.5 Hz using 
an EVOM (World Precision Instruments, Sarasota, FL). After 48 hours, 
paracellular permeability in the apical to basolateral direction was determined 
using 4kD FITC-conjugated Dextran (1mg/ml) and 70kD Rhodamine B-
conjugated dextran (2mg/ml) over a time period of 3 hours. Fluorescence was 
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then determined with a FLUOstar OPTIMA microplate reader (BMGLabTech, 
Offenburg, Germany). Cells were removed at the indicated timepoints and fixed. 
 
G-LISA Rho GTPase activation assay 
 
Rho GTPase activities were determined using the G-LISA kit from Cytoskeleton 
Inc. (U.S.A). All names of buffers and components refer to reagents provided by 
the kit. Cells were washed on ice with cold PBS and immediately lysed in lysis 
buffer as recommended by the manufacturers of the kit. To a 96-well plate, 10l 
of sample and 300l of precision red solution were added, and protein 
concentrations were determined using a plate reader. Protein concentrations 
were subsequently equalised by the addition of lysis buffer. For Cdc42, 
0.25mg/ml was used, and for RhoA and Rac1 1mg/ml. The extracts were added 
to specific Rho GTPase assay wells and left at 4oC on a rocker at 300 rpm. 
Incubation times were 15 minutes for Cdc42 and 30 minutes for Rac1. The 
samples were then washed twice with wash buffer and vigorously tapped onto a 
tissue to remove residual buffer that may cause background. To the wells 200l 
of antigen presenting buffer was then added and left for 2 minutes. The samples 
were then washed three times with wash buffer, again removing residual buffer 
by tapping onto a tissue. Primary antibody was prepared and added to the 
wells. The plates were left at room temperature on a rocker at 300 rpm as 
indicated by the manufacturer’s protocol. Samples were washed three times 
with wash buffer and vigorously patted in between each wash. The secondary 
HRP-conjugated antibody was added to the cells, followed again by incubating 
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the plate at room temperature on a rocker as indicated in the protocol. After 
incubation the samples were then washed three times with wash buffer, 
removing residual buffer each time by tapping onto a tissue. HRP bound to the 
wells was then measured colourimetrically using the substrates and buffers 
provided by the kit.  
 
Fluorescence resonance energy transfer (FRET) 
 
For FRET experiments, siRNA transfected cells were plated into ibidi 8-well 
chamber slides. After 48 hours, the cells were transfected with pRaichu-Cdc42 
plasmid [262]. After another 24 hours, FRET signal distribution was analysed 
using a Leica SP2 microscope (63x/1.4 objective, 37oC, in medium with 10 mM 
Hepes, pH 7.4) and Leica LCS FRET software using the donor recovery after 
acceptor bleaching protocol. Bleaching of the YFP signal was set to 30%. The 
shown FRET efficiency maps were then generated using the Leica LCS 
software by calculating the FRET efficiency according to the formula [(Dpost-
Dpre)/Dpost]*100 (D represents donor intensity). For quantification, CFP images 
were subtracted and mean FRET intensities were quantified with ImageJ. For 
each image, all cell-cell contacts were quantified and as many internal areas; 
averages of all cell-cell contacts and all internal areas in a field then gave one 
value each per imaged field, and these values were used for the final statistical 
analysis. Normalisations were performed by dividing mean values obtained for 
specific fields by the mean values obtained for the entire field imaged. 
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siRNA library screen 
 
Caco-2 cells were used for the siRNA screen. The cells were seeded onto glass 
coverslips in 48-well plates so that they reached 20-30% confluence after 20 
hours (~20,000 cells/well). Cells were seeded onto glass coverslips and the 
following day transfected as indicated using the standard Interferin transfection 
method described above. Each siRNA was transfected into cells on three 
coverslips in different plates. After 24 hours, the medium was replaced, and 
after another 48 hours in culture the cells were fixed with the methanol protocol. 
The cells were then processed for immunofluorescence and analysed by 
epifluorescence microscopy. The phenotypes were assessed qualitatively and 
divided into three groups according to the severity of the phenotype: strong, 
mild, and normal. The screen was first performed with a pool of siGenome 
siRNAs targeting Rho GTPases and GAPs (Dharmacon). Identified hits from the 
primary screen were then assayed again using chemically modified siRNAs that 
are thought to exhibit less off-target effects (Dharmacon).  
 
Microscope methodology 
 
All epifluorescent images of fixed specimens were acquired with a Leica DMIRB 
fluorescent microscope using a 63x/1.4 oil immersion objective fitted with a 
Hamamatsu C4742-95 camera and simple PCI software. Confocal images were 
acquired with a Zeiss LSM 700 confocal laser scanning microscope or a Leica 
SP2 confocal microscope using 63x/1.4 immersion oil objectives. Zeiss 518F 
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immersion oil was used for all objectives. Images were acquired at ambient 
temperature using ZEN 2009 or Leica LCS, respectively. Images were adjusted 
for brightness and contrast with Adobe Photoshop. Time-lapse movies of A431 
cells expressing a EGFP-actin construct were recorded at 37oC using a Zeiss 
Axiovert 200M microscope with a 40x/0.6 objective and a Hamamatsu C4742-
95 camera. Movies were acquired with simple PCI software, recording images 
every 5 seconds. 
 
Statistical analysis 
 
Averages and standard deviations were calculated and provided in the graphs. 
Respective n values are provided in the figure legends. The indicated p values 
were obtained with two-tailed Student’s t-test. 
 
Antibody specificity 
 
All secondary fluorescent antibodies were tested in the laboratory, in order to 
rule out non specific staining and possibility of bleed through the channels. 
Therefore potential for staining patterns to be non specific is unlikely. 
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Antibodies 
 
 
Antibodies used are listed in alphabetical order in table 2.4 with the host 
species in which they were raised, where they were sourced from, and the 
dilutions/concentrations used for immunfluorescence (IF), immunoblotting (IB) 
and immunoprecipitation (IP). ‘Poly’ refers to polyclonal antibodies. Table 2.5 
shows the corresponding secondary antibodies used. 
 
 
Antibody Host 
Species 
Clone 
number 
Source IB 
Dilution 
IF 
Dilution 
IP 
Dilution 
(ug) 
Alpha-tubulin Mouse 1A2 Matter Lab 1:20 - - 
Alpha-catenin Rabbit Poly Sigma 1:2000 1:1000 3 
Beta-actin Mouse AC-74 Sigma - 1:2000 - 
Beta-catenin Rabbit Poly Sigma 1:2000 1:1000 3 
CapZ1 Mouse 7 Santa Cruz 1:100 1:50 - 
CD2AP Mouse B4 Santa Cruz 1:1000 1:200 3 
Cdc42 Mouse P1 Santa Cruz 1:500 - - 
Cdc42-GTP Mouse Mono New East 
Bioscience 
- 1:100 - 
Cingulin Rabbit H-180 Santa Cruz 1:1000 1:500 - 
Cofilin Mouse Mono BD 1:500 - - 
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DPPIV Mouse 3/775/42 Matter Lab - 1:500 - 
E-cadherin Mouse Mono BD 1:1000 1:500 3 
Erk 1/2 Rabbit Poly Cell  
Signalling 
1:1000 - - 
GP73 Rabbit Poly Matter Lab - 1:500 - 
GST Rabbit AH Matter Lab 1:1000 - - 
HA tag Mouse Mono Matter Lab 1:5 1:10 - 
HA tag Rabbit 4325 Matter Lab - 1:500 - 
HA tag Rat Mono Roche 1:2000 1:1000 - 
JACOP Rabbit H-188 Santa Cruz 1:1000 1:400 - 
JACOP Rabbit Poly Furuse - - 3 
Na
+
K
+ 
Pump Mouse Mono Matter Lab - 1:500 - 
Occludin Mouse Mono Invitrogen 1:2000 1:1000 3 
OPHN1 Rabbit H-100 Santa Cruz - 1:200 - 
p120 catenin Mouse Mono BD 1:1000 1:500 3 
Phospho Cofilin Rabbit Poly Cell  
Signalling 
1:500 - - 
Phospho Erk 1/2 Mouse Mono Cell 
Signalling 
1:1000 - - 
Rac1-GTP Mouse Mono New East 
Bioscience 
- 1:100 - 
SH3BP1 Goat Poly Everest 1:1000 1:200 3 
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Trio Rabbit Poly Matter Lab - - 3 
ZO-1 Mouse Mono Invitrogen 1:2000 1:1000 3 
ZO-1 Rabbit 4913 Matter Lab 1:1000 1:300 3 
ZO-2 Rabbit 4915 Matter Lab 1:1000 1:300 3 
ZO-3 Rabbit 4917 Matter Lab 1:1000 1:300 3 
 
Table 2.4 List of primary antibodies used during project. 
 
 
Antibody 
(Host species) 
Target 
Species 
Source IB  
Dilution 
IF  
Dilution 
A488 (Donkey) Rabbit Invitrogen - 1:300 
A488 (Donkey) Rabbit Invitrogen - 1:300 
A488 (Donkey) Mouse Invitrogen - 1:300 
A555 (Donkey) Mouse Invitrogen - 1:300 
A555 (Donkey) Rabbit Invitrogen - 1:300 
A545 (Donkey) Goat Invitrogen - 1:300 
Horseradish 
peroxidase 
(Goat) 
Mouse Jackson  
Immunoresearch 
1:3000 - 
Horseradish 
peroxidase 
Rabbit Jackson 
Immunoresearch 
1:3000 - 
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(Goat) 
Horseradish 
peroxidase 
(Donkey) 
Goat Jackson 
Immunoresearch 
1:3000 - 
FITC (Donkey) Rabbit Jackson 
Immunoresearch 
- 1:300 
FITC (Donkey) Mouse Jackson  
Immunoresearch 
- 1:300 
FITC (Donkey) Goat Jackson 
Immunoresearch 
- 1:300 
FITC (Donkey) Sheep Jackson  
Immunoresearch 
- 1:300 
FITC (Donkey) Rat Jackson  
Immunoresearch 
- 1:300 
Cy3 (Donkey) Mouse Jackson  
Immunoresearch 
- 1:300 
Cy3 (Donkey) Rabbit Jackson  
Immunoresearch 
- 1:300 
Cy3 (Donkey) Goat Jackson 
Immunoresearch 
- 1:300 
Cy5 (Donkey) Mouse Jackson 
Immunoresearch 
- 1:300 
Cy5 (Donkey) Rabbit Jackson - 1:300 
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Immunoresearch 
Cy5 (Donkey) Goat Jackson 
Immunoresearch 
- 1:300 
Infrared 680 
(Donkey) 
Rabbit LI-COR 1:10000 - 
Infrared 680 
(Donkey) 
Mouse LI-COR 1:10000 - 
Infrared 680 
(Donkey) 
Goat LI-COR 1:10000 - 
Infrared 800 
(Donkey) 
Rabbit LI-COR 1:10000 - 
Infrared 800 
(Donkey) 
Mouse LI-COR 1:10000 - 
Infrared 800 
(Donkey) 
Goat LI-COR 1:10000 - 
 
Table 2.5 List of secondary antibodies used during project. 
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siRNA Oligonucleotides 
 
Tables 2.6-2.10 are a complete list of siRNAs used and their corresponding 
targets. The siRNAs were purchased from Dharmacon. The pools used 
comprise four individual oligonucletides used as a pool during the screen, or 
two distinct siRNAs in the case of SH3BP1 and CD2AP for further validation. 
 
Gene Accession 
Number 
Sequence 
CDC42 NM_001791 GGAGAACCAUAUACUCUUG 
CDC42 NM_001791 GAUUACGACCGCUGAGUUA 
CDC42 NM_001791 GAUGACCCCUCUACUAUUG 
CDC42 NM_001791 CGGAAUAUGUACCGACUGU 
RAC1 NM_018890 CGGCACCACUGUCCCAACA 
RAC1 NM_018890 AGACGGAGCUGUAGGUAAA 
RAC1 NM_018890 UAAGGAGAUUGGUGCUGUA 
RAC1 NM_018890 UAAAGACACGAUCGAGAAA 
RAC2 NM_002872 GAGAUGGGGCCGUGGGCAA 
RAC2 NM_002872 CAGCCAAUGUGAUGGUGGA 
RAC2 NM_002872 CCAAUGUGAUGGUGGACAG 
RAC2 NM_002872 ACAAGGACACCAUCGAGAA 
RAC3 NM_005052 AAACUGACGUCUUUCUGAU 
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RAC3 NM_005052 GGAGAUUGGCUCUGUGAAA 
RAC3 NM_005052 ACGUGAUGGUGGACGGGAA 
RAC3 NM_005052 CGAGAAUGUUCGUGCCAAG 
RHOA NM_001664 AUGGAAAGCAGGUAGAGUU 
RHOA NM_001664 GAACUAUGUGGCAGAUAUC 
RHOA NM_001664 GAAAGACAUGCUUGCUCAU 
RHOA NM_001664 GAGAUAUGGCAAACAGGAU 
RHOB NM_004040 GCAUCCAAGCCUACGACUA 
RHOB NM_004040 ACACCGACGUCAUUCUCAU 
RHOB NM_004040 CAUCCAAGCCUACGACUAC 
RHOB NM_004040 CAACUGCUGCAAGGUGCUA 
RHOBTB1 NM_014836 AAAUGAAGCUGCCUGUUUA 
RHOBTB1 NM_014836 GAACUUGGCUUACCAUACU 
RHOBTB1 NM_014836 GGACGUGACAUUUAAAUUG 
RHOBTB1 NM_014836 GAACACCCGUUAUCCUUGU 
RHOBTB2 NM_015178 UGACAUGGAUUAUGAAAGG 
RHOBTB2 NM_015178 GACCGUCGCUUUGCUUAUG 
RHOBTB2 NM_015178 CCCGAGACGUGGUAGAUGA 
RHOBTB2 NM_015178 GGACAACGCCGUGGGUAAG 
RHOBTB3 NM_014899 ACAGAUGGCCGUCGAAUAU 
RHOBTB3 NM_014899 GUAAUUACAUGGAAGCAAA 
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RHOBTB3 NM_014899 CAACCUGGCUACUUCAUUU 
RHOBTB3 NM_014899 CAACGUUAAUGACAAGUUU 
RHOC NM_175744 GGAGAGAGCUGGCCAAGAU 
RHOC NM_175744 AUAAGAAGGACCUGAGGCA 
RHOC NM_175744 GGAUCAGUGCCUUUGGCUA 
RHOC NM_175744 GAGAGCUGGCCAAGAUGAA 
RHOD NM_014578 UGAACAAGCUCCGAAGAAA 
RHOD NM_014578 GAUUGGAGCCUGUGACCUA 
RHOD NM_014578 CCGAACAGCUUUGACAACA 
RHOD NM_014578 AGACGUCGCUGCUGAUGGU 
RHOF NM_019034 GGGAGAAUGUGGAGGACGU 
RHOF NM_019034 CGGCCGGGCAAGAAGACUA 
RHOF NM_019034 AGAUCGUGAUCGUGGGCGA 
RHOF NM_019034 ACGACAACGUCCUCAUCAA 
RHOG NM_001665 CUACACAACUAACGCUUUC 
RHOG NM_001665 CCAGUCCGCCGUCCUAUGA 
RHOG NM_001665 GCAACAGGAUGGUGUCAAG 
RHOG NM_001665 CGUCAUCUGUUUCUCCAUU 
RHOH NM_004310 CAAGUGGAUUGGUGAAAUU 
RHOH NM_004310 GAGUACAGCAGGUGUUUGA 
RHOH NM_004310 GCUCAGCCCUUAGCAAUCG 
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RHOH NM_004310 GGCCAACCAUAACUCAUUC 
RHOJ NM_020663 AGAAACCUCUCACUUACGA 
RHOJ NM_020663 CCACUGUGUUUGACCACUA 
RHOJ NM_020663 UCGUAAACCCUGCCUCUUA 
RHOJ NM_020663 CCCGUUUGCUGUAUAUGAA 
RHOQ NM_012249 UACCGGAACUUAAGGAAUA 
RHOQ NM_012249 AGAAUAGGAUCAAGAUGUA 
RHOQ NM_012249 UAGCAAGACUGAAUGAUAU 
RHOQ NM_012249 GAACAAGGACAGAAACUAG 
RHOT1 NM_018307 GAACUCAACUUCUUUCAGA 
RHOT1 NM_018307 GAACCAGUAUACAGAAAUA 
RHOT1 NM_018307 GAACAUAUCAGAGCUCUUU 
RHOT1 NM_018307 CAGAAUACCUUGCUUAAUC 
RHOT2 NM_138769 UCUCAGAGCUGUUCUACUA 
RHOT2 NM_138769 ACGAAGAGCUCAACGCUUU 
RHOT2 NM_138769 GGACGUGCGCAUCCUGUUA 
RHOT2 NM_138769 GAGAAGAUUCGAACUAAGU 
RHOU NM_021205 GUACUGCUGUUUCGUAUGA 
RHOU NM_021205 GAACGUCAGUGAGAAAUGG 
RHOU NM_021205 CAGAGAAGAUGUCAAAGUC 
RHOU NM_021205 AAGCAGGACUCCAGAUAAA 
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RHOV NM_133639 GAGGGACGAUGUCAACGUA 
RHOV NM_133639 GAAGAAACUGAAUGCCAAA 
RHOV NM_133639 GUAUUUGACUCGGCUAUUC 
RHOV NM_133639 GCUCAGCCUUGACGCAGAA 
RND1 NM_014470 CGACUCGGAUGCAGUAUUA 
RND1 NM_014470 GAACAGAGGGUGGAGCUUA 
RND1 NM_014470 GCCAAAAGCUGUUCCAUUA 
RND1 NM_014470 GAACUCAUCUCUUCUACCU 
ARHN NM_005440 GAACUACACUGCGAGCUUU 
ARHN NM_005440 GACAUUAGCCGACCAGAAA 
ARHN NM_005440 ACACAAGGAUCGAGCCAAA 
ARHN NM_005440 UCAGGGAUGUCUUCCAUGU 
ARHE NM_005168 AGAAUUACACGGCCAGUUU 
ARHE NM_005168 GAACGUGAAAUGCAAGAUA 
ARHE NM_005168 GAAAUUAUCCAGCAAAUCU 
ARHE NM_005168 UAGUAGAGCUCUCCAAUCA 
 
Table 2.6: Primary screen (siGenome siRNAs) for Rho GTPases 
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Gene Accession 
Number 
Sequence 
ABR NM_001092 GAAGAUCUCUGCCCUCAAG 
ABR NM_001092 CAACCUGGCUACCGUGUUU 
ABR NM_001092 GAAGAGAUCUACAUUAACC 
ABR NM_001092 CAGAGGAACUCAAAGUGAA 
ARHGAP1 NM_004308 GCCAAGUGCUCAAAUAUGA 
ARHGAP1 NM_004308 GGAGACUGUUGCCUACUUA 
ARHGAP1 NM_004308 GGCAGGAGAUGACAAGUAU 
ARHGAP1 NM_004308 GAUCUGACCUUGGAUGACA 
FLJ20896 NM_024605 GUGAAACACUUAACAAAUG 
FLJ20896 NM_024605 GAAGUGAAGACAAUAACAA 
FLJ20896 NM_024605 GGAGAAUUCUGCAGAUUGG 
FLJ20896 NM_024605 GAAUAUUGUUGUGGAAAUC 
ARHGAP11A NM_014783 UACAGACUCUUAUCGAUUA 
ARHGAP11A NM_014783 GUUCGAAGAUCUCUGCGUU 
ARHGAP11A NM_014783 GGUAUCAGUUCACAUCGAU 
ARHGAP11A NM_014783 AAGCGUACAUUGCCAGUAG 
ARHGAP15 NM_018460 GAAAUGAGUUCCUUCUACA 
ARHGAP15 NM_018460 GAUGCAAUAUAUCGAGUUA 
ARHGAP15 NM_018460 GAACCUAUAUCCAGACACA 
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ARHGAP15 NM_018460 GCACUGAAUUGCUAAGUCA 
ARHGAP17 NM_018054 GCAGACAUGUACAACUUUA 
ARHGAP17 NM_018054 AAACAGAAGUCCUUAGUGA 
ARHGAP17 NM_018054 GGGAGCAGCUUGCAAGAUU 
ARHGAP17 NM_018054 CUGAAGAGGUGGAAUUUAA 
ARHGAP18 NM_033515 GGAAACAGAAGGCCUCUUA 
ARHGAP18 NM_033515 UGACAGCGCUAUUAGAACA 
ARHGAP18 NM_033515 CGAGGCAUCUAACCUUGUU 
ARHGAP18 NM_033515 CCAUGCACUUAUUGAUUAA 
ARHGAP20 NM_020809 GCACUCACCUGGACAACUU 
ARHGAP20 NM_020809 GCUCAUUAAUCAGAGUUUA 
ARHGAP20 NM_020809 GAAUUGUGCCUACUCUAAA 
ARHGAP20 NM_020809 CCAUCCGGCUCAUCAGUAA 
ARHGAP21 NM_020824 UAAAGAAGCUGUCAUCCUA 
ARHGAP21 NM_020824 GGAGACAGCUCUUCAGUUC 
ARHGAP21 NM_020824 AAAGGAAACUUCUCAGUAA 
ARHGAP21 NM_020824 GUAAAUCACUUGCAUCAGA 
ARHGAP22 NM_021226 CUAGGAAGCUUGACUGUUG 
ARHGAP22 NM_021226 GGGAUCAGCUUUUCUACUA 
ARHGAP22 NM_021226 AUUACAACCUGCUCAGAUA 
ARHGAP22 NM_021226 GGGAUUUAUUUCUCUACAA 
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ARHGAP23 XM_290799 GAAGACGGCCCUGCCCAUA 
ARHGAP23 XM_290799 GGAACGAGCCGUAUUCUGG 
ARHGAP23 XM_290799 GGGAAAGCGUCAUUGGGAA 
ARHGAP23 XM_290799 GAAUGGAGGCCGUGGAGGA 
ARHGAP24 NM_031305 AGAACAAGCUGGAGAGUUA 
ARHGAP24 NM_031305 GGAGGAUACUGUUCGUUAU 
ARHGAP24 NM_031305 CGAGAGAGGAAACACAAUA 
ARHGAP24 NM_031305 GGUCUUUGGUCCUAAUAUC 
ARHGAP25 XM_376060 GGACUUCCACCUACGAUAA 
ARHGAP25 XM_376060 GAUCAGAGACCAUGAAGUC 
ARHGAP25 XM_376060 GCAGGUUCCUACAUGAAAU 
ARHGAP25 XM_376060 CAAGAGCUACGAAAGGAAA 
ARHGAP26 NM_015071 GAACAUGACUCAGAACUUU 
ARHGAP26 NM_015071 CCAAACAGCAUCCUUAAUU 
ARHGAP26 NM_015071 CAUAGGAGAUGCAGAAACA 
ARHGAP26 NM_015071 GAAAGAAUCUCAGCUUCAG 
LOC201176 NM_199282 CCGAGUCGCUGACCAGUUA 
LOC201176 NM_199282 GAAAGCGGCUCCGGAAGAA 
LOC201176 NM_199282 GGACUCCUCUGUUCGAUGG 
LOC201176 NM_199282 GCACUUCCGCCAGUUCAUU 
ARHGAP28 NM_001010000 GAAGCAAACACUCUGAUUA 
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ARHGAP28 NM_001010000 CCAUUCAACUCAACAAUCA 
ARHGAP28 NM_001010000 GAAUAUAUACCUGCCUUCA 
ARHGAP28 NM_001010000 GUGAAGAACUUGAUGCCAA 
ARHGAP4 NM_001666 CGCAAGAGCUCCCUCAAGA 
ARHGAP4 NM_001666 GCUGAGAUCUGCGUUGAAA 
ARHGAP4 NM_001666 GGAGACAUGGAGAAGUUUA 
ARHGAP4 NM_001666 GACAGACCAUUGAGACAGA 
ARHGAP5 NM_001173 GUACGAAUUUGCAACCAUA 
ARHGAP5 NM_001173 UGAAAGCGCUCGUUCCAAA 
ARHGAP5 NM_001173 GAGAGCAGAUUUCCAGUUA 
ARHGAP5 NM_001173 UGAGAUCACUGCUAAAUUU 
ARHGAP6 NM_001174 AAACUUAGCCACCAUAUUU 
ARHGAP6 NM_001174 GUACACAGCUUUCAUCAAC 
ARHGAP6 NM_001174 GAAACUGGAUUCACUAGGA 
ARHGAP6 NM_001174 CAUCAUCGCUGUUGUGCAA 
ARHGAP8 NM_181334 ACAAGGAGUUCGAUAGGAA 
ARHGAP8 NM_181334 GAUAGGAAGUACAAGAAGA 
ARHGAP8 NM_181334 GCAUACAAGGAGUUCGAUA 
ARHGAP8 NM_181334 CCGUGAACUUUGACGACUA 
ARHGAP9 NM_032496 GAACAAUGAUGUCCUGCAA 
ARHGAP9 NM_032496 GAAGAGACCGCCCUUACAA 
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ARHGAP9 NM_032496 GAAGGUCGGUUAGAUUUGG 
ARHGAP9 NM_032496 GGGCCGAAGUUGUUUCAUG 
BCR NM_004327 GUAAAGCUCUCGGUCAAGU 
BCR NM_004327 GCAUUCCGCUGACCAUCAA 
BCR NM_004327 CAGGAGCGCUUCCGCAUGA 
BCR NM_004327 CAGAAGAAGUGUUUCAGAA 
CENTD1 NM_015230 GCAAGAAGCUUUAAAUUGA 
CENTD1 NM_015230 GAACCCGACUGUAGUAUUA 
CENTD1 NM_015230 GAUGGAAGCAGAAGAAUUA 
CENTD1 NM_015230 CAAAGAGGACUUCUAUUUA 
CENTD2 NM_015242 GAGAAGGAGUGGCCUAUUA 
CENTD2 NM_015242 GCAGGGAUCUUACAUCUAU 
CENTD2 NM_015242 GGAGAUCACUGCCAUUGUG 
CENTD2 NM_015242 ACAAGAAUCUAGAGGAGUA 
CENTD3 NM_022481 GAACUUGGCUCUGCUGUUU 
CENTD3 NM_022481 GGAGGAGUCUGAUGUACUU 
CENTD3 NM_022481 GGAGAAAUAUAAAGAUGUG 
CENTD3 NM_022481 CCAGACAGCUCCCAAAUCU 
CHN1 NM_001822 GAAUAUAGACCUCCUGUUU 
CHN1 NM_001822 UAUGAGAUCUCCAGAACUA 
CHN1 NM_001822 CAAUUCCACUCAUUACAUA 
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CHN1 NM_001822 GACCUACACUUUGGCUUUA 
CHN2 NM_004067 UCAAGAAAGUGUACUGUUG 
CHN2 NM_004067 GAAGAGGUUUGAGUCGAUU 
CHN2 NM_004067 UGAUAACACUGUACAUAGA 
CHN2 NM_004067 CGAUAUAUCUGCCAAUGUC 
DLC1 NM_006094 UUAAGAACCUGGAGGACUA 
DLC1 NM_006094 GUACGAAAGAGGAGCGUUU 
DLC1 NM_006094 UUAAAGAAGUCAAAGAGAA 
DLC1 NM_006094 GCAUGUACUUAGAGGGCUU 
GMIP NM_016573 GAACUGGACUUGCGGCUCA 
GMIP NM_016573 GAACGUGACCCUUGAGAUG 
GMIP NM_016573 GAAGUGCACGGCUGAGAUA 
GMIP NM_016573 CGAGUGUCCUCAAGCGAUU 
GRLF1 NM_024342 UCAGCGAGAUCCAAUGUAA 
GRLF1 NM_024342 GGAGGAAUCUGUAUACAUG 
GRLF1 NM_024342 GAACAGCGAUUUAAAGCAU 
GRLF1 NM_024342 GAUGGGCUGUCUUUCAUUA 
INPP5B NM_005540 GAAGAGGAUUACACCUAUA 
INPP5B NM_005540 GCAUCUGCGUUGUGAAUUC 
INPP5B NM_005540 ACUUGGAGCUCUUCGUAAA 
INPP5B NM_005540 AACAGGAGCAUGCAGCUUA 
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MYO9A NM_006901 GAAAGAAGCUUAGCCCUUA 
MYO9A NM_006901 GAUAAUACCUGCUGCAUAA 
MYO9A NM_006901 GAACAUACAUUACGGAUAU 
MYO9A NM_006901 GAACAAAGGCUAAGAGAAA 
MYO9B NM_004145 GAACCGAAAUGUCAAGAUU 
MYO9B NM_004145 CCAAGUACGUGAAGAUGUA 
MYO9B NM_004145 GCUCUCAGGUCGACUCUAA 
MYO9B NM_004145 GCAAAGCUCAGAAGAAGAA 
NF1 NM_000267 CACCGAGUCUUACAUUUAA 
NF1 NM_000267 GGAAUAAGAUGGUAGAAUA 
NF1 NM_000267 GAUAGAAGCUACAGUAAUA 
NF1 NM_000267 CAACAAAGCUAAUCCUUAA 
OCRL NM_000276 GAAAUUACCUCCCAAGUUG 
OCRL NM_000276 UGAAAUCCCUGAUGAGGAA 
OCRL NM_000276 UGACAUAGCUUCUAACAGU 
OCRL NM_000276 GAAAGGAUCAGUGUCGAUA 
OPHN1 NM_002547 GAAAGAAUCUCAGUUACAA 
OPHN1 NM_002547 GCGAGAGGCUCAAGUGUUA 
OPHN1 NM_002547 GAACAUAGUGGUGGAAAUA 
OPHN1 NM_002547 GCUAGUGAUUUGCUGAUUA 
PLXNA1 NM_032242 GAACGUGCCUGACCUCUCA 
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PLXNA1 NM_032242 GCAGAUCGAUGACGACUUC 
PLXNA1 NM_032242 GCAGUGAACCGCAUCUAUA 
PLXNA1 NM_032242 GCACCAACCUGGCCACUGU 
PLXNB1 NM_002673 GAGAGGAGCCGACUACGUA 
PLXNB1 NM_002673 GCAGAGACCUCACCUUUGA 
PLXNB1 NM_002673 GCAAACAUCUGAUAACAUG 
PLXNB1 NM_002673 UCACAGACCUCAUGACUGA 
PLXNB2 XM_371474 GCAACAAGCUGCUGUACGC 
PLXNB2 XM_371474 ACCAAUACACGCAGAAGUA 
PLXNB2 XM_371474 UGAACACCCUCGUGGCACU 
PLXNB2 XM_371474 CGGCAGAUGGUGCAGGUCA 
RACGAP1 NM_013277 CAAAUUAUCUCUGAAGUGU 
RACGAP1 NM_013277 CCACAGACACCAGAUAUUA 
RACGAP1 NM_013277 GAACAUCAGCUUCUCAAGA 
RACGAP1 NM_013277 GUAAUCAGGUGGAUGUAGA 
RALBP1 NM_006788 GAAUGUAACUAUCUUCUGA 
RALBP1 NM_006788 GAUCAGCCCUACUAAGUUU 
RALBP1 NM_006788 GAACGAAGAGCUGGAAAUA 
RALBP1 NM_006788 GAAGGCAUCUACAGAGUAU 
SH3BP1 NM_018957 GACCUGUACCACUUUGUUA 
SH3BP1 NM_018957 GAUGACAGCCACCCACUUC 
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SH3BP1 NM_018957 CAUCGAGGCCUGCGUCAUG 
SH3BP1 NM_018957 GAGCGCAGACACCCUCUUC 
SRGAP1 NM_020762 CAUGAGGGCUUAGACAUUA 
SRGAP1 NM_020762 UUAACGAUCUGAUUUCUUG 
SRGAP1 NM_020762 GACCAGAGUAACCAUGAUA 
SRGAP1 NM_020762 GCAAUACACGGGCUUCAAU 
SRGAP2 XM_059095 GAGACUACCUCGGUUGAAG 
SRGAP2 XM_059095 GGAAAGGACAGGCUGAGUA 
SRGAP2 XM_059095 CCAAAGAAGGGCCAGAUAA 
SRGAP2 XM_059095 GCGGACAGAUUGCAGUCUA 
SRGAP3 NM_014850 CCAAUGAGCUCUACACAGU 
SRGAP3 NM_014850 GCACGGCUCUGCACGAGUU 
SRGAP3 NM_014850 GAAUAUGAAGCCCAAAUAA 
SRGAP3 NM_014850 CAGAACUGCUCAUGCGUUA 
STARD13 NM_052851 GAUGUGAACUUCCAAAGGA 
STARD13 NM_052851 CCAAGGCACUUUCUAUUGA 
STARD13 NM_052851 GGGCAACUUUCCACACUUA 
STARD13 NM_052851 GAAAGUUCCCGACUACAAA 
STARD8 NM_014725 GAAGAAGGACACUCCAUUU 
STARD8 NM_014725 CGACGUGGCUGACCUGCUA 
STARD8 NM_014725 GAACCUGCGUCAAAUGAAU 
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STARD8 NM_014725 GAACCCACCUUUGCCUCUA 
TAGAP NM_054114 UGAAACAGGUUGCAGAUAA 
TAGAP NM_054114 GACCAGAGCCUGUCAUUUG 
TAGAP NM_054114 ACACUAAACGCCAAUAAUA 
TAGAP NM_054114 AGAAGGACCUGAACAACAA 
 
Table 2.7: Primary screen (siGenome siRNAs) for GTPase Activating Proteins (GAPs). 
 
 
Gene Sequence 
Rho GTPases  
  
CDC42 CGGAAUAUGUACCGACUGU 
CDC42 GCAGUCACAGUUAUGAUUG 
CDC42 GAUGACCCCUCUACUAUUG 
CDC42 CUGCAGGGCAAGAGGAUUA 
RAC1 GUGAUUUCAUAGCGAGUUU 
RAC1 GUAGUUCUCAGAUGCGUAA 
RAC1 AUGAAAGUGUCACGGGUAA 
RAC1 GAACUGCUAUUUCCUCUAA 
RHOA CGACAGCCCUGAUAGUUUA 
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RHOA GACCAAAGAUGGAGUGAGA 
RHOA GCAGAGAUAUGGCAAACAG 
RHOA GGAAUGAUGAGCACACAAG 
RHOBTB1 GAACUUGGCUUACCAUACU 
RHOBTB1 GGACGUGACAUUUAAAUUG 
RHOBTB1 GAACACCCGUUAUCCUUGU 
RHOBTB1 GACAGACGCUUUGCAUAUG 
RHOBTB3 ACAGAUGGCCGUCGAAUAU 
RHOBTB3 CCGGAAAUGUCGUUGCUUA 
RHOBTB3 GAAGAGUCCCACUGACAUU 
RHOBTB3 CCAUGAACCUUGAUAUAGU 
RHOQ CACCUAGAAUGUAAGUUAA 
RHOQ GCAGUUGGUCCCUAAGUGA 
RHOQ GAGCGACAACUUAUAUACA 
RHOQ GUAAUAAGGUCAUAACUGC 
 
Table 2.8: Secondary screen (on-Target plus siRNAs) for Rho GTPases. 
 
Gene Sequence 
GAPS  
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MYO9A GAACAUACAUUACGGAUAU 
MYO9A CUCCAAAGGCUAAGCGCAA 
MYO9A AAACAAUGGCUUCGAGAUU 
MYO9A GCGUAUUCGUCGAGGAAAC 
MYO9B CCAAGUACGUGAAGAUGUA 
MYO9B GCUCUCAGGUCGACUCUAA 
MYO9B CAGGGAAGGUGAAAUAUCA 
MYO9B UGAAACCCUUCUAGUCGUA 
OPHN1 GAAAUGGGCUUUAGGAAUA 
OPHN1 CAACAUGGGAGUAAUCUUU 
OPHN1 CUAGUGAUUUGCUGAUUAA 
OPHN1 GUAUAUAAGCUACCAGAAA 
PLXNA1 GGACAUAUGCCAUGCGGGU 
PLXNA1 CAUGAUUGUGCUAGCGUUU 
PLXNA1 CGUCCAAGAUCGUGCGGCU 
PLXNA1 GGAAGAAGUUUGCGUCUGU 
PLXNB1 GCUCAGAUUUGGCGCUGUU 
PLXNB1 UCAGAGAGGAUGUGGAGUA 
PLXNB1 CUGAGGUUCUGGAUCAAUA 
PLXNB1 GAGAGGAGCCGACUACGUA 
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SH3BP1 UGGAGAUUCAGGCCGAUUA 
SH3BP1 GAGGGAGAACCACGGCCAA 
SH3BP1 UCCAGAAGCUCGUGUCCGA 
SH3BP1 GCCCAGUCUCUUUGAGUAA 
SRGAP3 GAACUGCUCAUGCGUUAUC 
SRGAP3 GGACCUAUCUCUCAGCUGA 
SRGAP3 CAACGCAGCUAUAAGCAAA 
SRGAP3 GAGGAGAAGCAGUUCAAUA 
STARD13 GGAUGAAAGUUCCCGACUA 
STARD13 GUUAAUUGGAGGACCGGUA 
STARD13 GCUUAUGAUGUGGCGGAUA 
STARD13 GUACAGACAACCCGGUCAU 
STARD8 AUCCAGAACCUGCGUCAAA 
STARD8 GACAUGACGAUUUGGCAUA 
STARD8 GCUUAUGGUAGUGGGCUAA 
STARD8 CCACUUUCCUCCAGAUCUA 
 
Table 2.9 Secondary screen (on-Target plus siRNAs) for GAPS. 
 
 
Gene Sequence 
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CapZ1 GAUGGGCAACAGACUAUUA 
CapZ1 UGAAAGACCAUUAUUCCAA 
CapZ1 CACUAACUGUUUCGAAUGA 
CapZ1 UCUGUACUGUUUAUGCUAA 
CD2AP GGGCGAACUUAAUGGUAAA 
CD2AP GAGCAAAUGAAGUGUAAUA 
CGNL1 (JACOP) GCAGGGAGCUCGCAGAAAU 
CGNL1 (JACOP) CGGAGUACCUGAUUGAAUU 
CGNL1 (JACOP) CGAGUAAAGUGCUGGAUGA 
CGNL1 (JACOP) GGGAGAAAUACGACAGUUA 
SH3BP1 GAUGACAGCCACCCACUUC 
SH3BP1 UGGAGAUUCAGGCCGAUUA 
 
Table 2.10 siRNAs used during SH3BP1 validation and interaction studies. 
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Chapter 3: siRNA Screen of GTPase Activating Proteins 
in Caco-2 Cells 
 
Part of this chapter was published: J Cell Biol. 2012 Aug 20;198(4):677-93.  
 
Introduction to chapter 3 
 
TJs and AJs are crucial components of epithelial cells. They mediate cell-cell 
adhesion, regulate epithelial differentiation and tissue formation, and are 
essential for the formation of epithelial tissue barriers as they regulate 
paracellular diffusion. TJs also function as morphological and functional borders 
between apical and the basolateral cell surface domains. Rho GTPases play 
fundamental roles in the regulation of epithelial physiology and function. They 
regulate junction assembly and polarisation, but are also components of 
signalling pathway that originate at junctional complexes and guide epithelial 
behaviour, such as cell proliferation and migration. In this chapter, I will show 
the results of an siRNA screen designed to identify GTPase Activating Proteins 
(GAPs) and Rho GTPases that are important functional components of Rho 
signalling mechanisms that guide formation of epithelial tight and adherens 
junctions. 
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Results – Chapter 3 
 
Identification of junctional associated negative regulators of 
Rho GTPases 
 
Although different members of the Rho GTPase family have been linked to 
epithelial junction formation and differentiation, our knowledge is still limited to 
the main members Cdc42, Rac1 and RhoA, and little is known about their 
regulators. In the case of Rho GTPase regulators, some GEFs have been 
identified, but our understanding of functionally important GAPs and which Rho 
GTPases they regulate is still very limited. Hence, we decided to screen for 
functionally important Rho GTPases and Rho GAPs using a siRNA-based 
approach.  
 
The human intestinal epithelial cell line Caco-2 was used as a model system, as 
it forms polarized monolayers with functional TJs and can be efficiently 
transfected with siRNAs [60]. As a positive control we first performed a siRNA 
transfection experiment with siRNAs targeting Cdc42, as this Rho GTPase is an 
evolutionarily conserved regulator of cell polarisation [263]. Transfection of 
siRNAs targeting Cdc42 led to spread cells and a disrupted distribution of the 
TJ protein ZO-1 and the AJ protein beta-catenin, and an effect on polarity with a 
disorganised expression of the apical marker DPPIV and the basolateral protein 
Na+K+ATPase. We also observed an effect on cytoplasmic polarity with a 
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scattering of the Golgi marker GP73 (Figure 3.0). Immunoblotting demonstrated 
that depletion of Cdc42 was indeed efficient (Figure 3.1). 
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Figure 3.0 Cdc42 depletion affects polarisation and junction formation. 
Caco-2 cells were transfected with either control siRNAs or a pool of Cdc42-directed siRNAs. 
After 72 hours, the cells were fixed with methanol. Coverslips were stained for the indicated 
proteins. Shown are epifluorescent images of markers for TJ (ZO-1) and AJ (beta-catenin), as 
well as an apical (DPPIV), a basolateral (Na+K+ ATPase) and a golgi (GP73) marker. Shown 
are representative images obtained during establishment of the screening assay. Comparable 
images were obtained during the screen. Scale bar 10µm. 
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Figure 3.1 Depletion of Cdc42 in Caco-2 cells is efficient. 
Whole cell lysates from Caco-2 cells transfected with either control siRNAs or a pool of Cdc42-
specific siRNAs were analysed by immunoblotting for Cdc42. Alpha-tubulin was used as a 
loading control. This shown immunoblot is a representative of the obtained when the screening 
protocol was established. Depletion of proteins during the actual screen was not followed as 
antibodies against most proteins are not available. 
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We next employed a siRNA library of GAPs and Rho GTPases that contained 
pools of four siRNAs targeting each protein. As previously for the Cdc42 
depletion test, Caco-2 cells grown on glass coverslips were transfected with 
siRNAs and were then fixed three days later and stained for junctional and 
polarisation markers to assess the effect on cell morphology, junction formation 
and polarisation.  
The screen was performed in two rounds. In the first round (performed by 
K.Matter), a set of four different oligos was used in a pool for each protein. This 
resulted in a number of candidate proteins that might regulate junction formation 
and differentiation.  These hits were then screened a second time (performed 
by C.Zihni and A.Elbediwy). For this second screen, pools of new siRNAs were 
employed that carried modifications to reduce off-target effects. Most of these 
siRNAs also targeted different sequences to the original siRNA library (see 
Materials and Methods).  
The siRNA transfections were evaluated by epifluorescence microscopy on a 
qualitative level. The phenotypes of the siRNA transfections were grouped into 
four categories. Samples that looked like the control siRNA transfections were 
classed as ‘Normal’. Transfections that led to somewhat flatter and larger cells 
with intact junctions were considered ‘Mild’. ‘Moderate’ phenotypes were 
allocated to transfections that led to flattened cells and at least partially 
disrupted junction assembly. ‘Severe’ represents the class of siRNA 
transfections with the strongest phenotypes, such as the one of Cdc42.  
Of all the Rho GTPases, only siRNA transfections targeting RhoA and Cdc42 
were classified as hits with a severe phenotype (Figure 3.2). In fact, their 
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phenotypes were very similar. Surprisingly, siRNAs targeting Rac1 had no 
effect. Given this surprising result with Rac1, we repeated the Rac1 depletions 
in two separate experiments. However, still only a mild effect on the TJ marker 
ZO-1 was observed (Figure 3.3).  
 
 
 
 
 
 
 
 
 
138 
 
 
 
Figure 3.2 Functional siRNA screen of Rho GTPases and GAPs. 
Primary screen (scr) was performed using siGENOME siRNAs for the proteins indicated. 
Secondary screen was peformed using more specific on target siRNAs. Colours indicate 
severity of phenotype. ‘Normal’ refers to samples that looked like control cells. Transfections 
that led to flatter and larger cells with intact junctions were considered ‘Mild’. ‘Moderate’ 
phenotypes were allocated to transfections that led to flattened cells and at least partially 
disrupted junctions. ‘Severe’ represents the class of siRNA transfections with the strongest 
phenotypes, such as the one of Cdc42. 
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Figure 3.3 Rac1 depletion mildly affects the AJC. 
Caco-2 cells were transfected with either control siRNAs or a pool of Rac1 directed siRNAs. 
After 72 hours, the cells were fixed with methanol. Coverslips were stained for the indicated 
proteins. Yellow arrows indicate areas of the TJ marker ZO-1 affected by Rac1 depletion. 
Shown are epiflourescent images of markers for TJ (ZO-1) and AJ (beta-catenin). Scale bar 
10µm. 
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The GAPs with the strongest hits in the screen were the Cdc42/Rac1 GAP 
SH3BP1, the RhoA GAPs OPHN1 and MYO9A, and two RasGAPs that function 
as RhoGTPase effectors, PLXNA1 and PLXNB1 [264, 265].Depletion of these 
proteins led to reduced junctional staining for markers of both TJ and AJ, and a 
mislocalisation of polarity apical and basolateral polarity markers (Figure 3.4). 
The phenotypes of siRNAs targeting these proteins were all considered as 
moderate: they were not as severe as those of Cdc42 and RhoA depletions but 
considerably more striking than those of, for example, Rac1.  
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Figure 3.4 GAPs with strongest phenotypes in screen. 
Caco-2 cells were transfected with either control siRNA or a pool of specific siRNAs targeting 
the proteins shown. The screen was performed in triplicate and carried out twice. The cells were 
transfected with the standard siRNA/Interferin protocol, grown for 72 hours and then fixed with 
methanol. Samples were stained as indicated. Yellow arrows point out areas where the staining 
for the TJ marker ZO-1 is disrupted. Note that cells with a moderate phenotype were more 
spread than control cells and therefore they appeared larger. Shown are epifluorescent images. 
Scale bar 10µm. 
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Regulation of RhoA is crucial during epithelial junction formation [60, 228]. Two 
of the GAPs identified regulate RhoA signalling. MYO9A has previously been 
published to associate with the junctional complex in Caco-2 cells [213]. 
OPHN1 also associates with the junctional complex as both endogenous and 
transfected OPHN1 were found to associate with cell-cell contacts in MDCK, 
Caco-2 and HCE cells (Figure 3.5, 3.6 and 3.7); and this staining was found to 
be specific as upon depletion of OPHN1, the junctional pool disappeared 
(Figure 3.7a), which was confirmed by immunoblotting (Figure 3.7b). OPHN1 
has been shown to have GAP activity for RhoA, Rac and Cdc42 in vitro using a 
Rho GTPase and GST-tagged OPHN1 pulldown assays in order to measure 
GTP hydrolysis; however, its main function in vivo seems to be regulation of 
RhoA. This was suggested by OPHN1 deficient mice that show defects in 
endocytosis of synaptic vesicle endocytosis; a cellular function that is thought to 
lead to mental retardation in humans [183, 266]. 
Depletion of SH3BP1 caused one of the strongest phenotypes from all the 
GAPs screened. SH3BP1 had previously been discovered as an SH3 binding 
protein and ligand for the non receptor tyrosine kinase Abl and was shown to 
have GAP activity for Cdc42 and Rac in vitro [186, 187]. Given the strong 
phenotype of Cdc42 depletion, SH3BP1 was chosen to be analysed further in 
experiments described in the following chapters.  
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Figure 3.5 Endogenous OPHN1 localises to the AJC. 
Caco-2 cells were fixed with methanol and stained for OPHN1 (green) and ZO-2 (red). Shown 
are epifluorescent images focusing on cell junctions and OPHN1. Scale bar 10µm. 
 
 
 
Figure 3.6 Transfected OPHN1 localises to the junctional complex. 
MDCK cells were transfected with HA-tagged OPHN1. After 24 hours, the cells were fixed 
with methanol and stained for the HA tag (green) and ZO-1 (red). Scale bar 10µm. 
 
144 
 
 
 
Figure 3.7 OPHN1 depletion reduces the junctional pool of the protein.   
(A) HCE cells were transfected with either control siRNAs or a pool of OPHN1-specific 
siRNAs. Cells were stained for OPHN1. Shown are epifluorescent images. Arrows indicate 
junctional OPHN1 staining. (B) The levels of OPHN1 depletion were assessed by 
immunoblotting. Alpha-tubulin was used as a loading control. Arrow indicates correct band of 
OPHN1. Scale bar 10µm. 
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Chapter 3 - Discussion 
 
In this part of the project, I wanted to identify Rho GTPases and GTPase 
Activating Proteins important for the maintenance of TJs and AJs in the 
intestinal epithelial cell line Caco-2. I employed a qualitative functional siRNA 
screen together with a library targeting Rho GTPases and GAPs.  
From 71 candidates screened, 2 Rho GTPases, and 5 GAPs gave the strongest 
phenotypes. These positive hits had an effect on junction morphology, classified 
as either moderate or severe. The strongest candidates were naturally the Rho 
GTPases Cdc42 and RhoA. This was as expected as they have crucial roles in 
the formation of the AJC and cell polarity [11, 66, 223, 267]. However, it was 
surprising the weak effect of Rac1 depletion. Rac1 had previously been 
reported to be crucial for the formation of adherens junctions in other cell types 
than what was here analysed [223]. This weak phenotype might be due to a 
number of possibilities. Perhaps the most likely reason is that cells derived from 
different epithelial tissues might have different requirements for specific Rho 
GTPases. For example, many effectors are shared by Cdc42 and Rac1 [171, 
268] and, hence, different tissues might rely on either Cdc42 or Rac1. On the 
other hand, it could also be that depletion of Rac1 was inefficient or occurred 
more slowly. However, even when the Rac1 depletion was repeated in separate 
experients, there was only a mild phenotype (Figure 3.3). This was also 
confirmed using a Rac1 specific inhibitor (NSC23766), which had also a mild 
effect on assembly of the AJC (data not shown). Finally, it could also be that the 
type of assay or proteins used to monitor assembly of the AJC affects the 
readout. For example, monitoring junction assembly during an assay that 
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involves proliferation of cells and dynamic formation of new cell borders might 
be different to one that is based on a calcium switch (i.e., cells plated in low 
calcium that are stimulated to form junctions by adding calcium). Hence, while 
our screening assay allowed us to identify proteins important for epithelial 
junction formation and polarisation, the lack of a phenotype in response to 
specific siRNAs such as those targeting Rac1 does not exclude that such 
proteins are of importance under different conditions or in other epithelial cell 
types. Therefore, the advantage of performing such a functional siRNA screen 
is the potential to identify multiple proteins involved in cell-cell adhesion in a 
short period of time. The disadvantage of the screen, however, is that negative 
results are not conclusive and may be due to inefficient depletion of a protein. 
Neverthess, the screen allowed us to identify candidate regulators of epithelial 
junction formation and differentiation that had not previously been identified; 
hence, the screen successfully delivered what it was designed for. 
The Rho GAPs with the strongest phenotypes were the Cdc42/Rac1 GAP 
SH3BP1 and the RhoA GAPs OPHN1 and MYO9A. Some GAPs, which were 
expected to affect junction formation and polarity, such as the RhoA GAP p190 
and the Cdc42 GAP Rich1 were found to have only a mild or normal phenotype. 
Rich1 was previously found to be important for the polarisation of MDCK cells 
[193]. Conversley, p190 was found to inactivate RhoA upon engagement of 
cadherins in vivo [269]. The lack of phenotype in our screen for GAPs such as 
Rich1 and p190 could be due to a few reasons as discussed above for Rac1.  
The RhoA GAP OPHN1 has been shown in vitro to have also RhoGAP activity 
toward Cdc42 and Rac1, but has been shown to regulate RhoA in vivo [266]. 
OPHN1 depletion led to a disruption of TJ and AJ, and polarity markers were 
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disorganised. MYO9A is also a GAP for RhoA, and, similarly, depletion led to a 
defect in junction assembly. MYO9A also has an important role in epithelial 
differentiation, and MYO9A deficiency in vivo in mice results in an imbalance of 
homeostasis and fluid retention in the brain (hydrocephalus) [213]. The final 
Rho GAP whose depletion caused a phenotype, SH3BP1, had the strongest 
phenotypes of the GAPs in the siRNA screen and was an ideal candidate to 
study further. It caused a strong disruption of the TJ marker ZO-1 and the AJ 
marker beta-catenin. In the following chapters, I will describe experiments 
designed to elucidate the role of SH3BP1 in epithelial junction formation and 
differentiation.  
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Chapter 4: SH3BP1 Regulates Epithelial Junction 
Formation and Rho GTPase Activity 
 
Parts of this section were published in the J. Cell Biol. (2012), 198(4):677-93. 
 
Introduction to chapter 4 
 
This chapter focuses on the GTPase activating protein SH3BP1, a protein 
identified in a siRNA screen for Rho GTPases and GTPase activating proteins 
functionally relevant for the formation of epithelial junctions. SH3BP1 had 
initially been discovered in a cDNA library screen using the SH3 domain of the 
non-receptor tyrosine kinase Abl as a probe and had been shown to be a GAP 
for Rac1 and Cdc42 in vitro [186, 187]. Here, I describe data that demonstrate 
that different types of epithelial cells require SH3BP1 to form intercellular 
junctions, and that the GAP is required for normal organisation of the actin 
cytoskeleton. My data establish that SH3BP1 is a novel junction-associated 
inhibitor of Cdc42 and Rac1 activity, which aids in the formation of junctions, 
and that its membrane recruitment is stimulated by EGF signalling. 
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Results – Chapter 4 
 
SH3BP1 depletion affects junctions in various epithelia 
 
The siRNA screen in chapter 3 suggested that SH3BP1 is a regulator of 
junction assembly. To validate this phenotype, I first tested whether transfection 
of individual siRNAs also inhibited junction assembly and whether they indeed 
reduced expression of SH3BP1. Junction assembly was analysed by staining 
sets of TJ and AJ markers. Staining of TJ markers revealed that depletion of 
SH3BP1 led to flatter cells that did not assemble continuous junctions (Figure 
4.0). Some markers were more strongly affected than others with, for example, 
ZO-1 still being recruited to cell-cell contacts and ZO-3 appearing completely 
dispersed. Staining for the AJ markers E-cadherin, alpha-catenin and p120 
catenin in depleted cells resulted in a more disrupted and discontinuous 
junctional distribution, indicating that AJ assembly was also defective (Figure 
4.0). I next stained for the actin cytoskeleton using fluorescent phalloidin for F-
actin in Caco-2 cells and found that depletion resulted in a loss of the normal 
apical F-actin organisation and a thinning of perijunctional F-actin (Figure 4.1). 
This defect in actin organisation was confirmed by staining with antibodies 
against actin. There was also an increase in basal actin fibres that resembled 
stress fibres. Stress fibre formation is generally attributed to enhanced RhoA 
activation, but SH3BP1 is no effective GAP for RhoA [186, 187, 189]. However, 
It has been well documented that disassembly of junctions can result in 
activation of RhoA due to effects on p190RhoGAP and GEF-H1 [209, 270, 271]. 
It is thus likely that defects in junction assembly lead to enhanced stress fibre 
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formation. Moreover, stress fibres maybe more evident as the depleted cells 
become more spread, allowing easier visualization of the stress fibres in 
comparison to more compact cells. 
Quantification of the junctional proteins and F-actin stains revealed significant 
differences between cells transfected with control and SH3BP1-targeting 
siRNAs (Figure 4.2). The efficiency of SH3BP1 protein depletion was validated 
by immunoblotting extracts derived from cells transfected with a pool as well as 
two individual siRNAs targeting SH3BP1 (Figures 4.1 and 4.2). Depletion was 
found to be very efficient with at least a 60% reduction in expression. These 
data thus indicate that SH3BP1 is important for the regulation of the actin 
cytoskeleton and the normal assembly of TJs and AJs. 
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Figure 4.0 SH3BP1 depletion disrupts normal assembly of the apical junctional 
complex. 
 
Caco-2 cells were transfected with either control siRNA or a pool of SH3BP1 specific siRNAs. 
After 96 hours, the cells were fixed with methanol. Coverslips were stained for TJ: (A) ZO-1, 
(B) ZO-3 or AJ: (C) E-cadherin, p120-Catenin or alpha-catenin. Shown are epifluorescence 
images of cell junction markers. Corresponding western blot can be seen in Figure 4.1. Scale 
bar 10µm. 
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Figure 4.1 SH3BP1 depletion affects the actin cytoskeleton. 
Caco-2 cells were transfected with either control siRNA, two different individual SH3BP1 
specific siRNAs or a pool of SH3BP1 directed siRNAs. After 96 hours, the cells were either 
fixed with paraformaldehyde, permeabilised with Triton X-100 and stained for (A) F-actin or 
(B) lysed with sample buffer and processed for immunoblotting. Alpha-tubulin was used as a 
loading control. (C) For the beta-actin staining, the cells were fixed in methanol and labelled 
with antibodies specific for beta-actin. Shown are epifluorescence images. Cells were taken at 
same magnification. Yellow arrows denote apical F-actin, and red arrows denote perijunctional 
F-actin. Experiment was performed three times. Scale bar 10µm. 
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Figure 4.2 SH3BP1 siRNA efficiency and quantification of depletion-induced 
phenotypes. 
(A) Caco-2 cells were transfected with either control siRNA, two different individual SH3BP1 
specific siRNAs or a pool of SH3BP1 directed siRNAs. After 96 hours, extracts were collected 
and immunoblotted for SH3BP1. Alpha-tubulin was used as a loading control. (B) A 
quantification of the effect on the subcellular distribution of F-actin (counting cells with 
strongly induced basal F-actin; mean basal actin intensity increased by >60% in SH3BP1-
depleted cells) and three junctional markers (counting cells with discontinuous, irregular 
junctional staining). Shown are means +/- 1 SD, representing the cells in at least five different 
fields per condition (n ≥ 5). Note that assembly of tight and adherens junctions were affected, 
but different components are affected to different extents. 
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Figure 4.3 SH3BP1 depletion affects epithelial differentiation. 
Caco-2 cells were transfected with either control siRNA or a pool of SH3BP1 directed siRNAs. 
After 96 hours, the cells were either fixed with paraformaldehyde or lysed with sample buffer 
and processed for immunoblotting. Coverslips were (A) stained for differentiation markers 
(Apical) DPPIV and  (Basolateral) Na
+
K
+
 ATPase or (B) blotted for these and SH3BP1. Alpha-
tubulin was used as a loading control. Shown are epifluorescence images (A) and protein 
expression (B) of polarisation markers. Experiment was performed three times. Scale bar 10µm. 
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In order to further clarify if the flattened cell phenotype seen upon SH3BP1 
depletion was due to a loss of polarisation and differentiation, I decided to 
analyse the expression and distribution of cell surface markers in SH3BP1 
depleted cells. The apical marker DPPIV and the basolateral marker Na+K+ 
ATPase were used. Apical staining of DPPIV was significantly reduced in 
depleted cells, and antibodies against Na+K+ ATPase resulted in a more 
disrupted and disorganised staining (Figure 4.3). Immunoblotting revealed the 
levels of expression of the cell surface markers were not affected. Confocal 
microscopy of samples stained for occludin and alpha-catenin further 
demonstrated that the depleted cells had lost their columnar appearance and 
were flatter and failed to assemble distinctive tight and adherens junctions 
(Figure 4.4). Thus, confirming that SH3BP1 is important for the differentiation of 
polarized epithelial cells.  
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Figure 4.4 SH3BP1 depletion results in a loss of cell polarity.  
Caco-2 cells were transfected with either control siRNA or a pool of SH3BP1 specific siRNAs. 
After 96 hours, the cells were either fixed with methanol for immunofluorescence or lysed with 
sample buffer and processed for immunoblotting. (A) The cells on coverslips were stained with 
antibodies against occludin (red) and alpha-catenin (green), and then analysed by confocal 
microscopy. Shown are sections representing the imaged areas and representative Z-line scans. 
(B) The levels of SH3BP1 depletion were assessed by blotting. Alpha-tubulin was used as a 
loading control. Experiment was performed twice. Scale bar 10µm. 
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Prior to analysing the molecular mechanism by which SH3BP1 regulates 
junction assembly, I wanted to test two aspects important to understand the 
biological significance of the defect in Caco-2 cells observed upon down-
regulation of SH3BP1. Firstly, I wanted to know where it localises, as this would 
tell me whether the effect on junction assembly is likely to be direct, and, 
secondly, I wanted to test whether SH3BP1 is of functional relevance in 
different types of epithelial cells or whether its importance is restricted to 
intestinal epithelial cells.  
Firstly, I analysed the subcellular distribution of SH3BP1. By indirect 
immunofluorescence, I found that anti-SH3BP1 antibodies stained both 
intercellular junctions as well as the cytoplasm. However, only the junctional 
staining disappeared following SH3BP1 depletion, suggesting that a part of the 
cytoplasmic staining is likely to reflect non-specific signal (Figure 4.5). These 
observations thus indicate that SH3BP1 can associate with epithelial 
intercellular junctions.  
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Figure 4.5 SH3BP1 associates with cell-cell contacts. 
Caco-2 cells were transfected with either control siRNA or a pool of SH3BP1 directed siRNAs. 
After 96 hours, the cells were either extracted with Triton X-100 and then fixed with methanol 
for immunfluorescence or lysed with sample buffer and processed for immunoblotting. (A) 
Coverslips were stained for SH3BP1. Shown are epifluorescence images. (B) The levels of 
SH3BP1 depletion were assessed by blotting. Alpha-tubulin was used as a loading control. 
Experiment was performed 4 times. Scale bar 10µm. 
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Next I wanted to determine if the phenotype of SH3BP1 detected Caco-2 cells 
could be seen in other epithelial cells; so, I analysed Human Corneal Epithelial 
(HCE) cells. As above, the cells were transfected with control and SH3BP1-
specific siRNAs and were then stained for TJ and AJ markers. The TJ marker 
ZO-1 was found to be significantly reduced from the junction although a faint 
junctional staining persisted as in Caco-2 cells. The AJ marker beta-catenin was 
disrupted with thin protrusions emitting from the membrane, resembling 
possible microspikes, filopodia or retraction fibres (Figure 4.6). The latter 
possibility is unlikely, however, as SH3BP1-depleted cells were flatter, more 
spread, and still in contact with their neighbours; it seems difficult to combine 
cell retraction with maintenance of cell-cell contact. 
Further trying to explore the actin organisation defect observed in depleted 
SH3BP1 samples, I decided to use the epidermoid epithelial cell line A431, a 
keratinocyte-derived cell line. A431 cells overexpress EGF receptor and are 
known to form filopodia [272, 273]. F-actin staining indeed suggested the 
existence of short basal filopodia in control cells (Figure 4.7).  Upon depletion of 
SH3BP1, the cells also started to spread out more and formed long F-actin-rich 
protrusions, suggesting that loss of SH3BP1 triggered increased growth of 
filopodia. As filopodia formation is stimulated by Cdc42 signalling, this suggests 
that depletion of SH3BP1 leads to deregulation of Cdc42 activation.  
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Figure 4.6 SH3BP1 depletion affects the apical junctional complex in HCE cells. 
HCE cells were transfected with either control siRNA or a pool of SH3BP1 specific siRNAs. 
After 96 hours, the cells were either extracted with Triton X-100 and fixed with methanol for 
immunofluorescence or lysed with sample buffer and processed for immunoblotting. (A) Shown 
are epifluorescent images of cell junction markers ZO-1 (TJ) and beta-catenin (AJ). (B) The 
levels of SH3BP1 depletion were assessed by blotting. Alpha-tubulin was used as a loading 
control. Experiment was performed twice. Scale bar 10µm. 
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Figure 4.7 SH3BP1 depletion affects actin cytoskeleton in A431 cells. 
A431 cells were transfected with either control siRNA or a pool of SH3BP1 specific siRNAs. 
After 96 hours, the cells were either fixed with paraformaldehyde and permeabilised with Triton 
X-100 for immunofluorescence or lysed with sample buffer and processed for immunoblotting. 
(A) Cells were stained for F-actin.(B) The levels of SH3BP1 depletion were assessed by 
blotting. Alpha-tubulin was used as a loading control. Shown are epifluorescence images. 
Experiment was performed three times. Scale bar 10µm. 
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SH3BP1 is important for the formation of functional epithelial 
junctions 
 
Having established that SH3BP1 depletion results in the deregulation of 
epithelial junction assembly and differentiation, I next investigated whether the 
GAP was important for initial junction formation to further understand the 
molecular mechanism involved. To investigate de novo junction formation, a 
calcium switch assay was performed in Caco-2 cells depleted of SH3BP1. 
Transepithelial Electrical Resistance (TER), which measures ion conductance 
over an epithelial layer, was measured over a period of 48 hours in order to 
assess barrier formation. The levels of TER were clearly affected by depletion 
of SH3BP1, as depleted cells exhibited a reduction of 50% in TER after 48 
hours in comparison to control cells. To assess the permeability further, two 
different size dextran tracers were used and found to diffuse more easily across 
the monolayers formed by SH3BP1 depleted cells. These data thus indicate 
that SH3BP1 depleted cells failed to form functional tight junctions (Figure 4.8). 
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Figure 4.8 SH3BP1 regulates epithelial barrier formation. 
Caco-2 cells were transfected with either control siRNA or a pool of SH3BP1 specific siRNAs, 
and were subsequently trypsinised and reseeded in low calcium medium on filters for 16 hours 
in order to prevent junction formation. Normal calcium medium was reintroduced and junction 
formation was followed during the next 48 hours by measuring transepithelial electrical 
resistance (TER) (A) and paracellular permeability (B). Paracellular permeability was assessed 
using two different fluorescently labelled dextrans. Data shown are the average and SD of 
triplicates. Bar graphs represent averages and the error bars 1 SD, n = 3. (C) Expression levels 
of SH3BP1 depletion were assessed at the end of experiments and alpha tubulin was used as a 
loading control. 
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In a morphological analysis of samples replenished with calcium and stained 
with the TJ marker ZO-1, I observed that junction formation was severely 
disrupted with a clear delay in TJ junction formation (Figure 4.9). This was also 
evident in samples labelled for the AJ markers E-cadherin and p120 catenin 
(Figure 4.10). As expected, the F-actin stain revealed a severe delay in the 
formation of the perijunctional actin ring with a disrupted and disorganised 
appearance upon SH3BP1 depletion (Figure 4.11).  
Since it seems SH3BP1 is important for early junction formation, it was 
important to analyse how early SH3BP1 localised to the forming junctional 
complex. Analysis of SH3BP1 localization during a calcium switch revealed that 
SH3BP1 localizes early to cell-cell contacts, with junctional SH3BP1 being 
observed as early as 30 minutes with the initial stages of E-cadherin based 
junction formation (Figure 4.12). 
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Figure 4.9 SH3BP1 is important for de novo TJ formation. 
Caco-2 cells were transfected with control siRNA, two different individual SH3BP1-specific 
siRNAs or a pool of SH3BP1 directed siRNAs and were plated in low calcium medium. (A) 
Cells were fixed in methanol at the indicated timepoints after being transferred to calcium 
medium and immunostained for ZO-1. Shown are epifluorescent images. (B) Expression levels 
of SH3BP1 depletion were assessed at the end of the experiment and alpha tubulin was used as 
a loading control. Experiment was performed three times. Scale bar 10µm. 
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Figure 4.10 SH3BP1 is important for de novo AJ formation. 
Caco-2 cells transfected with either control siRNA or a pool of SH3BP1-directed siRNAs were 
plated in low calcium medium. Cells were fixed in methanol at the indicated timepoints after 
being transferred to calcium medium and immunostained for (A) E-cadherin and (B) p120 
catenin. Shown are epifluorescence images. Expression levels of SH3BP1 were assessed in 
figure 4.11. Experiment performed three times. Scale bar 10µm. 
168 
 
 
 
Figure 4.11 SH3BP1 is important for actin cytoskeleton organisation. 
Caco-2 cells were transfected with either control siRNA or a pool of SH3BP1 specific siRNAs 
and were plated in low calcium medium. Cells were fixed in paraformaldehyde and 
permeabilised with Triton X-100 at the specified timepoints after reintroduction of calcium 
medium and were then (A) stained for F-actin. Shown are epifluorescent images. (B) Expression 
levels of SH3BP1 depletion were assessed at the end of the experiment and alpha-tubulin was 
used as a loading control. Experiment was performed twice. Scale bar 10µm. 
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Figure 4.12 SH3BP1 localises early to the forming adherens junctions. 
Caco-2 cells were plated in low calcium medium. Cells were extracted in Triton X-100 and 
fixed in methanol at the indicated timepoints after being transferred to calcium medium and 
immunostained for SH3BP1 and E-cadherin. Arrows represent areas in which SH3BP1 and E-
cadherin localize to junctions. Shown are epifluorescence images. Experiment was performed 
three times. Scale bar 10µm. 
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Addition of calcium to A431 cells resulted in the formation of filopodia-like cell-
cell contacts followed by AJ formation over the course of a few hours and 
resulted in continuous E-cadherin staining after 24 hours. In depleted cells, 
however, the rounded cells of early time points spread out normally and formed 
contacts, but they did not progress beyond the stage of forming intercalating 
filopodia-like protrusions. These protrusions were again seen upon staining of 
F-actin, suggesting that SH3BP1 depleted cells fail to form junctions upon initial 
contact formation (Figure 4.13). Thus, I conclude that SH3BP1 associates with 
intercellular junctions early during junction formation and seems to be required 
for the transformation of early cell-cell contacts to mature junctional complexes. 
The induction of protrusion formation during cell spreading and initiation of cell-
cell contacts also seems difficult to reconcile with protrusions representing 
retraction fibres.  
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Figure 4.13 SH3BP1 depleted cells have a delay in adherens junction formation 
and display pronounced actin-based protrusions. 
A431 cells were transfected with either control siRNA or a pool of SH3BP1-specific siRNAs 
and were plated in low calcium medium. Cells were fixed in paraformaldehyde and 
permeabilised with Triton X-100 at the timepoints of calcium reintroduction specified and were 
then stained for (A) E-cadherin and (C) F-actin. (B) Expression levels of SH3BP1 depletion 
were assessed at the end of the experiment and alpha-tubulin was used as a loading control. (D) 
Shows a 2x zoom of control and depleted F-actin staining clearly showing longer filopodia in 
SH3BP1 depleted conditions. Shown are epifluorescence images and zoomed basal images. 
Experiment was performed twice. Scale bar 10µm. 
172 
 
SH3BP1 localisation in different epithelia 
 
I next investigated the subcellular localization of SH3BP1 in different epithelia 
more precisely to start to understand the mechanism by which it affects 
epithelial differentiation. In Caco-2 cells, SH3BP1 localizes to the AJC and its 
distribution overlaps with markers for TJs and AJs (Figure 4.14). Further 
analysis using confocal microscopy suggested that SH3BP1 localizes more 
toward the AJ than the TJ (Figure 4.15). However, its distribution did not 
precisely overlap with either of the two markers, indicating that it is not 
exclusively associated with a specific junction.  
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Figure 4.14 SH3BP1 is localized to the AJC in Caco-2 cells. 
Caco-2 cells were immunostained with SH3BP1 (Red), occludin (Blue) and beta-catenin 
(Green) after being fixed with methanol. Shown are epifluorescence images. Experiment was 
performed three times. Scale bar 10µm. 
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Figure 4.15 SH3BP1 is localized between the TJ and AJ in Caco-2 cells. 
Caco-2 cells were fixed with methanol and stained with antibodies against SH3BP1 (red), ZO-1 
(green), and beta-catenin (blue) and then analysed by confocal microscopy. Shown are sections 
representing the imaged areas and representative Z-line scans taken. Experiment was performed 
three times. Scale bar 10µm. 
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I next analysed the distribution of SH3BP1 in A431 cells as they allow the 
analysis of actin reorganisation and cell-cell junction formation in response to 
EGF receptor activation [274]. Therefore, analysis of junction formation can be 
studied in response to a physiological stimulus as opposed to manipulation of 
external calcium concentrations. In serum-starved A431 cells, ZO-1 is initially 
non-junctional but, upon EGF addition, is recruited to cell-cell junctions [274]. 
When this experimental protocol was applied to study SH3BP1, the GAP was 
recruited to dorsal ruffles within 5 minutes of EGF treatment. At dorsal ruffles, 
SH3BP1 co-localised with ZO-1 and F-actin; dorsal ruffle formation preceded 
junction formation (Figure 4.16). Given the role of EGF in the mobilisation of 
SH3BP1 from the cytosol to membranes, I next analysed whether EGF 
signalling could also stimulate junctional recruitment of SH3BP1 in Caco-2 cells. 
Serum-starved Caco-2 cells had only little SH3BP1 at junctions but recruitment 
was stimulated by the addition of EGF within 5 minutes (Figure 4.17). 
Conversely, if EGF receptor signalling was blocked in cells grown in standard 
serum-containing medium using the EGF receptor tyrosine kinase inhibitor 
PD153035 [275], the levels of junctional SH3BP1 were reduced in comparison 
to controls (Figure 4.17). These data indicate that growth factor signalling can 
stimulate SH3BP1 recruitment to sites of dynamic actin remodelling, such as 
dorsal ruffles, or that are enriched in F-actin, such as cell-cell junctions. Addition 
of EGF promotes a number of processes that involve Rho GTPases and 
stimulate actin dynamics [276]; hence, SH3BP1 maybe required for Rho 
GTPase regulation during such dynamic cellular processes.  
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Figure 4.16 SH3BP1 is recruited to dorsal ruffles upon EGF stimulation of A431 
cells. 
Serum-starved A431 cells were stimulated with 100ng/ml EGF for specified timepoints, and 
immunostained with SH3BP1 (Red), F-actin (Blue) and ZO-1 (Green). Shown are 
epifluorescence images. Experiment was performed three times. Scale bar 10µm. 
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Figure 4.17 Regulation of SH3BP1 localisation by EGF signalling. 
(A) Serum-starved Caco-2 cells were stimulated with 100ng/ml EGF for specified timepoints, 
and immunostained with antibodies against SH3BP1 and ZO-1. (B) Caco-2 cells were incubated 
with 3M PD153035 for 24 hours or the same volume of DMSO used for the inhibitor as a 
control before fixation. The samples were subsequently immunostained for SH3BP1. Shown are 
epifluorescence images. Experiment was performed three times. Scale bar 10µm. 
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Given the role of EGF signalling in the localisation of SH3BP1, I next asked 
whether SH3BP1 plays a role in EGF-induced processes. As an experimental 
model, I employed A431 cells, as they lack ZO-1 at cell-cell junctions, and, if 
serum-depleted junctional ZO-1 can then be induced upon EGF stimulation 
[274, 277]. Upon depletion of SH3BP1, EGF stimulation did no longer lead to a 
continuous junctional distribution of ZO-1, but the junctional staining remained 
disrupted and discontinuous even at later timepoints (Figure 4.18). I also 
stained for the AJ marker beta-catenin. Unlike ZO-1, beta-catenin was present 
at junctions in unstimulated A431 cells. Nevertheless, depletion of SH3BP1 also 
led to disorganisation and discontinuous junctional distribution of beta-catenin 
with the peak of disruption occurring at the later timepoints of EGF stimulation 
(Figure 4.19). 
I next analysed how depletion of SH3BP1 affects the actin cytoskeleton during 
EGF stimulation. A clear effect was observed in SH3BP1-depleted cells, as an 
increase in the number and length of the filopodia visualised by F-actin staining 
was observed (Figure 4.20). This was particularly striking after longer times of 
EGF stimulation, as basal filopodia seemed to grow in an uncontrolled manner. 
Uncontrolled filopodial growth correlated with the disruption of cell junctions. It is 
thus possible that the formation of cell junctions was defective because cells 
failed to control filopodial growth. 
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Figure 4.18 SH3BP1 depletion inhibits EGF-induced junctional recruitment of 
ZO-1 in A431 cells. 
Serum-starved A431 cells that had been transfected with either control or SH3BP1-specific 
siRNAs were stimulated with 100ng/ml EGF as indicated. The cells were then either  (A) fixed 
with paraformaldehyde and immunostained with ZO-1 antibodies, or (B) lysed with sample 
buffer and processed for immunoblotting. Arrows point to areas of junctional disruption. The 
levels of SH3BP1 depletion were assessed by blotting. Alpha-tubulin was used as a loading 
control. Shown are epifluorescence images. Experiment was performed three times. Scale bar 
10µm. 
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Figure 4.19 SH3BP1 depletion results in disruption of beta-catenin in A431 cells. 
Serum-starved A431 cells that had been transfected with either control or SH3BP1-specific 
siRNAs were stimulated with 100ng/ml EGF as indicated. The cells were fixed with 
paraformaldehyde and immunostained for betacatenin. Representative blot for SH3BP1 
depletion can be seen in figure 4.18. Shown are epifluorescence images. Experiment was 
performed three times. Scale bar 10µm. 
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Figure 4.20 SH3BP1 depletion results in an increase in filopodial length. 
Serum-starved A431 cells that had been transfected with either control or SH3BP1-specific 
siRNAs were stimulated with 100ng/ml EGF as indicated. (A) The cells were fixed with 
paraformaldehyde and stained with F-actin. Representative blot can be seen in figure 4.18. (B) 
Shown is a 3x zoom of control and depleted F-actin staining showing longer filopodia in 
SH3BP1 depleted cells. Shown are epifluorescence images. Experiment was performed three 
times. Scale bar 10µm. 
 
 
 
  
182 
 
In order to analyse further this increase in basal protrusions seen in fixed 
depleted samples, I made an EGFP-actin A431 cell line and recorded time 
lapse movies of depleted and control cells after EGF stimulation.  As expected, 
actin dynamics was strongly influenced by SH3BP1 depletion. In control cells, 
EGF stimulation induced dorsal ruffling and led to the formation of a strong 
cortical perijunctional actin ring; in SH3BP1 depleted cells, however, actin 
dynamics was strongly reduced and did not extend beyond the extension of 
long filopodia (Figure 4.21 and Movies S1-S4). As with the original A431 cell 
line, GAP depleted cells were very flat and spread. Hence, expression of 
SH3PB1 seems to be required to maintain actin dynamics and support EGF-
induced actin reorganisation. 
Having observed a defect in junction formation, as well as a disruption and 
decrease in dorsal ruffle formation, I next assessed if depletion had an effect on 
ruffles containing cell-cell junction markers. Depletion indeed resulted in a 
decrease in recruitment of beta-catenin and ZO-1 to EGF-induced dorsal ruffles, 
suggesting that SH3BP1 affects membrane recruitment of junctional 
components (Figure 4.22). 
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Figure 4.21 SH3BP1 depletion results in reduced actin dynamics and 
reorganisation. 
(A) A431 cells expressing EGFP-actin that had been transfected for 96 hours with control or 
SH3BP1-specific siRNAs were stimulated with 100ng/ml EGF and a time-lapse movie was 
taken. Time is shown in seconds after EGF was added. (B) Expression levels of SH3BP1 
depletion were assessed at the end of the experiment and alpha-tubulin was used as a loading 
control. Experiment was performed three times. Scale bar 10µm. 
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Figure 4.22 SH3BP1 depletion results in a decrease in dorsal ruffles. 
Serum-starved A431 cells that had been transfected with either control or SH3BP1-specific 
siRNAs were stimulated with 100ng/ml EGF as indicated. The cells were fixed with 
paraformaldehyde and immunostained for SH3BP1 (Red), ZO-1 (Green) and beta-catenin 
(blue). Shown are epifluorescence images. Representative blot can be seen in figure 4.18. 
Experiment was performed three times. Scale bar 10µm. 
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Dorsal ruffles have been linked to EGF receptor internalisation [278]; hence, I 
next analysed EGF internalisation using fluorescently labelled growth factor. 
Stimulation led to the appearance of EGF positive dorsal ruffles within 3 
minutes followed by internalisation and vesicular staining within 15 minutes. In 
SH3BP1 depleted cells, the dorsal labelling was disorganised, but the ligand 
was still internalised, although apparently more slowly (Figure 4.23). SH3BP1 
expression was not required for EGF receptor signalling as such, as ERK was 
activated with similar kinetics in control and GAP depleted cells. This suggests 
that inhibition of EGF receptor signalling per se was not causing the lack of 
dorsal ruffling in SH3BP1 depleted cells (Figure 4.24).  
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Figure 4.23 Effect of SH3BP1 depletion on EGF internalisation. 
(A) Serum-starved A431 cells that had been transfected with either control or SH3BP1-specific 
siRNAs were stimulated with 100ng/ml EGF tagged with Cy5 as indicated. The cells cells were 
either fixed with paraformaldehyde or lysed with sample buffer and processed for 
immunoblotting. (B) The levels of depletion were assessed by blotting for SH3BP1. Alpha-
tubulin was used as a loading control. Shown are epifluorescence images. Experiment was 
performed twice. Scale bar 10µm. 
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Figure 4.24 SH3BP1 depletion and ERK 1/2 activation. 
Serum-starved A431 cells that had been transfected with either control or SH3BP1-specific 
siRNAs were stimulated with 100ng/ml EGF as indicated. Extracts were then collected and 
immunoblotted for SH3BP1, and total and phosphorylated ERK. Alpha-tubulin was used as a 
loading control. Experiment was performed twice. 
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SH3BP1 functions as a GAP for Cdc42 and Rac1 
 
SH3BP1 is a known GAP that can stimulate GTP hydrolysis by Rac and Cdc42 
in vitro [187]. In order to assess the levels of the main Rho GTPases, I 
performed a G-LISA assay, which measures global levels of active Rho 
GTPases. Using Caco-2 cells, I found that there was no apparent increase in 
any of the Rho GTPases, in depleted cells in comparison to control cells thus 
indicating that the GAP activity of SH3BP1 does not affect overall levels of Rho 
GTPases in this cell type (data not shown).  
I next decided to use serum-starved A431 cells that were stimulated with EGF 
in order to assess the effect of SH3BP1 depletion on Rho GTPase activity in 
this model and to test whether the effect of the GAP activity of SH3BP1 may be 
transient. I found that EGF stimulation led to an increase in active Cdc42 within 
15 minutes as expected (Figure 4.25). In SH3BP1 depleted cells, the levels of 
active Cdc42 was increased throughout all timepoints and gradually increased 
with increasing time of EGF stimulation, indicating that depletion of the GAP 
leads to enhanced Cdc42 activity. Increased Cdc42 activity thus corresponds 
with the increase of filopodial length described above. Upon depletion and 
measuring levels of active Rac1, only at 15 minutes of EGF stimulation a 
significant increase in active Rac1 was observed, suggesting that the effect on 
Rac1 is more modest (Figure 4.25). Previously, it was shown that upon EGF 
stimulation, Rac1 activation is transient, while Cdc42 activation is sustained, 
which may contribute to this difference between the two GTPases [256]. 
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Figure 4.25 SH3BP1 depletion leads to enhanced Cdc42 and Rac1 activity. 
A G-LISA assay was performed to assess active Rho GTPase levels in extracts from serum-
starved or EGF stimulated (100ng/ml) A431 cells 96 hours after transfection with either control 
siRNA or a pool of SH3BP1 specific siRNAs. Levels of active (A) Cdc42 and (B) Rac1 are 
displayed normalized to control levels at time zero for the respective Rho GTPase. The bar 
graphs represent the average of three independent experiments, each using triplicate samples. 
Addition of recombinant Cdc42 as a positive control gives a value of 9.255 (Normalised to 
control). Addition of recombinant Rac1 as a positive control gave a value of 4.134 (Normalised 
to control). Error bars represent ± 1 SD. 
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Deregulation of Rho GTPase activity may not only involve altered total levels of 
activity but may lead to a spatial disorganisation. Therefore, I next determined 
whether depletion of SH3BP1 affected the subcellular localization of active 
Cdc42 and Rac1. Using an antibody raised against a GTP-bound form of 
Cdc42, we found that transfection of active Cdc42 GEFs stimulated increased 
fluorescent signals, indicating that the antibody indeed recognised active Cdc42 
(Figure 4.26d and e). In Caco-2 cells, this antibody stained cell-cell 
junctions,and this signal disappeared when Cdc42 was depleted by transfecting 
siRNAs, indicating that it was due to junctional Cdc42 (Figure 4.26f). SH3BP1 
depletion resulted in characteristically spread cells with a loss of the well-
defined linear distribution of GTP-bound Cdc42 along cell junctions.  Active 
Cdc42 appeared more diffuse and was spread away from the junction, 
suggesting that SH3BP1 is required to confine active Cdc42 at cell-cell contacts 
(Figure 4.26a).  
Using the active Cdc42 antibody in EGF stimulated A431 cells, I found that 
Cdc42-GTP localized to dorsal ruffles within 5 minutes of stimulation; whereas 
in SH3BP1 depleted cells dorsal ruffles were disorganized and contained less 
GTP-bound Cdc42, and Cdc42-GTP was spread throughout the cells including 
filopodia (Figure 4.27). Moreover, stimulation with EGF led to clearly increased 
levels of staining. Active Rac1 also increased in response to EGF and was 
more prominent along the apical membrane of the cells, but did not accumulate 
in the large ruffles like in Cdc42. In depleted cells, active Rac1 often 
accumulated in perinuclear cup-like structures, indicating that the spatial 
organisation of Rac1 signalling was also disrupted (Figure 4.28). These 
observations thus indicate that SH3BP1 is required for the proper spatial 
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organisation of Cdc42 activity in A431 and Caco-2 cells. Whereas the GAP also 
regulates Rac1 in A431 cells, no effect on Rac1 activity was observed in Caco-2 
cells (not shown).  
I next assessed the levels of phosphorylated cofilin in depleted cell lysates, as 
this protein is important for the regulation of actin dynamics and it is regulated 
by phosphorylation in response to Rho GTPase activation [279]. Unstimulated 
and EGF stimulated SH3BP1 depleted A431 cells showed an increase in the 
levels of phosphorylated cofilin, confirming increased Rho GTPase activity 
(Figure 4.29).  As the phosphorylated form of cofilin is inactive, cofilin 
inactivation may be at least one of the reasons why filopodia became so large 
and, as suggested by the videos of GFP-actin expressing cells, there seemed to 
be a general reduction in actin dynamics upon SH3BP1 depletion.  
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Figure 4.26 Loss of junctional confinement of active Cdc42 in SH3BP1 depleted 
cells. 
Caco-2 cells were transfected with either control siRNA or a pool of SH3BP1 specific siRNAs. 
After 96 hours, the cells were either fixed with methanol and (A) immunostained with active 
Cdc42 (green) and ZO-1 (Red) or (B) lysed with sample buffer and processed for 
immunoblotting. The levels of depletion were assessed by blotting for SH3BP1. Alpha-tubulin 
was used as a loading control. (C) Levels of lateral staining in control and depleted samples 
were assessed. (D and E) HCE cells were transfected with either flag-tagged ASEF2 or myc-
tagged DBL, two GEFs that stimulate Cdc42. The cells were then fixed with either methanol or 
PFA followed by processing for immunofluorescence with antibodies against the epitope tags 
and GTP-bound Cdc42. (F) For Cdc42 siRNA, Caco-2 cells were transfected with either control 
siRNA or a pool of Cdc42 specific siRNAs before fixation with methanol and staining with 
anti-GTP–bound Cdc42 and ZO-1 antibodies. Shown are epifluorescent images. Experiment 
was performed three times. Scale bar 10µm. 
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Figure 4.27 Dispersal of active Cdc42 in SH3BP1 depleted cells. 
(A) Serum-starved A431 cells were stimulated with 100ng/ml EGF for specified timepoints 
after transfection with either control siRNA or a pool of SH3BP1 specific siRNAs. The cells 
were then fixed with paraformaldehyde and immunostained with the antibody against active 
Cdc42. (B) Depletion was assessed by blotting for SH3BP1. Alpha-tubulin was used as a 
loading control. (C) A 2x zoom of control and SH3BP1 depleted basal shots in EGF stimulated 
conditions is shown to emphasise the filopodia elongation induced by depletion. Shown are 
epifluorescent images. Experiment was performed three times. Scale bar 10µm. 
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Figure 4.28 Active Rac1 is increased apically in SH3BP1 depleted cells. 
Serum-starved A431 cells were stimulated with 100ng/ml EGF for specified timepoints after 
transfection with either control siRNA or a pool of SH3BP1 specific siRNAs. After 96 hours, 
the cells were fixed with paraformaldehyde and immunostained with the antibody against active 
Rac1. Depletion was assessed by blotting for SH3BP1. Alpha-tubulin was used as a loading 
control. Shown are epifluorescence images. Experiment was performed three times. Scale bar 
10µm. 
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Figure 4.29 SH3BP1 depletion results in higher levels of cofilin and p-cofilin. 
Whole cell lysates of A431 cells that had been transfected with either control siRNA or a pool 
of SH3BP1 specific siRNAs. After 72 hours extracts were serum-starved for 16 hours, before 
being stimulated with EGF, collected and immunoblotted for SH3BP1, cofilin and p-cofilin. 
Alpha tubulin was used as a loading control. The experiment was performed three times. 
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Finally, I assessed the effect SH3BP1 depletion on active Cdc42 in live cells 
using a FRET-based biosensor for Cdc42 [280]. In control Caco-2 cells, the 
FRET signal was enriched along cell-cell junctions and preferentially apical as 
opposed to basal; in depleted cells, the enrichment along cell-cell contacts was 
lost and the signal was more basal (Figure 4.30). In EGF-stimulated A431 cells, 
higher mean FRET activities were also measured along the apical surface than 
along the base of the cells and activity along cell-cell contacts was reduced 
upon depletion of SH3BP1 (Figure 4.31). As the transiently transfected FRET 
sensors are expressed at different levels in different cells, only the relative 
FRET levels were determined as the absolute levels are concentration 
dependent; hence, no conclusions about total levels of activity can be drawn. 
Taken together, these data suggest that SH3BP1 is a functionally important 
GAP for Cdc42 in two epithelial model cell lines and that depletion of the GAP 
results in a spatial disorganisation of Cdc42 signalling. 
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Figure 4.30 SH3BP1 regulates the spatial distribution of active Cdc42 in Caco-2 
cells. 
(A) Caco-2 cells were transfected with either control siRNA or a pool of SH3BP1 directed 
siRNAs, and 48 hours later with a plasmid encoding the Cdc42 FRET biosensor. FRET was 
imaged by gain of donor fluorescence after acceptor bleaching. (B) Scale representing the 
colour coding of the FRET efficiency. Note, areas of highest FRET efficiency are encoded in 
red. (C) Quantification of images was prepared by normalizing FRET activity in specific 
cellular regions to the total FRET activity of quantified cells (cell-cell contacts, grey bars; 
internal cytoplasm, red bars; apical/basal ratio, purple bars). Yellow arrows represent areas of 
high FRET efficiency in GAP depleted cells as they are coloured in red (see FRET efficiency 
scale). Shown are means of different fields +/- 1 SD (n= 12). The experiment was performed 
three times. Scale bar 10µm. 
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Figure 4.31 SH3BP1 regulates the spatial distribution of active Cdc42 in A431 
cells. 
(A) A431 cells were transfected with either control siRNA or a pool of SH3BP1 directed 
siRNAs, and 48 hours later with a plasmid encoding the Cdc42 FRET biosensor. Cells were 
stimulated with 100ng/ml EGF. (B) Scale representing the colour coding of the FRET 
efficiency. (C) FRET was imaged and quantified as in figure 4.30. Yellow arrows point to areas 
of high and medium FRET efficiency, as they are coloured in red and green respectively (see 
FRET efficiency scale). Shown are means of 11 different fields +/- 1 SD (n= 11). The 
experiment was performed three times. Scale bar 10µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
202 
 
Effect of SH3BP1 overexpression on cell junctions 
 
SH3BP1 is a 701 amino acid protein that contains three main domains. A 
Bin/Amphiphysin/Rvs(BAR) domain located near the N-terminus, a RhoGAP 
domain, and, finally, an SH3 binding domain found in the C-terminus (Figure 
4.32). Using the full length cDNA as a template for PCR reactions, a full length 
HA-tagged cDNA was generated and inserted into an expression vector. An 
analogous construct was generated in which the catalytic activity of the GAP 
domain was inactivated by substituting an evolutionarily conserved catalytic 
arginine residue. This type of mutation has previously been shown to result in a 
GAP inactive construct [159, 189].  
I first checked expression of the constructs by transfecting them in both Caco-2 
and A431 cells. Immunoblotting with antibodies against the HA-epitope tag 
revealed that both constructs were expressed well and at comparable levels 
(Figure 4.32). Transfection of the wild-type protein did not have any obvious 
morphological consequences on the cells. However transfecting the mutant 
protein induced changes in the organisation of the actin cytoskeleton, such as 
filopodia-like structures (Figure 4.33), suggesting that this construct exerts a 
dominant-negative effect and that the GAP activity is required for the normal 
function of SH3BP1. 
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Figure 4.32 Expression of HA-tagged SH3BP1 cDNAs in Caco-2 and A431 cells. 
(A) Diagram of structure of full length SH3BP1. (B) cDNAs encoding HA-tagged wild-type or 
GAP deficient SH3BP1 were overexpressed in Caco-2 and A431 cells for 24 hours before 
extracts were collected. Expression of SH3BP1 was analysed by immunoblotting with HA tag 
antibodies. Alpha-tubulin was used as a loading control. Experiment was performed three times. 
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Figure 4.33 SH3BP1 R312A expression affects organisation of the actin 
cytoskeleton. 
(A) cDNAs encoding HA-tagged wild-type or GAP deficient SH3BP1 were transiently 
expressed in Caco-2 cells for 24 hours before being fixed in paraformaldehyde and 
immunostained with HA tag (green), beta-catenin (red) and F-actin (blue). (B) 2x zoom of 
R312A mutant emphasising the filopodia-like protrusions produced. Shown are epifluorescent 
images. The experiment was performed twice. Scale bar 10µm. 
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As depletion of SH3BP1 caused activation of Cdc42 and defects in junction 
assembly, I next asked whether the two processes are indeed related using the 
GAP deficient mutant. Therefore, I generated a SH3BP1 cDNA resistant to one 
of the SH3BP1 siRNAs in order to perform complementation experiments. 
Three silent point mutations were required in order to generate this construct 
(see material and methods). I first assessed the efficiency of the rescue by 
transfecting the siRNA resistant cDNA into control and SH3BP1 depleted cells. 
This construct was expressed efficiently in the presence of control and SH3BP1 
specific siRNAs (Figure 4.34b). I next overexpressed the wild type construct in 
serum-starved, EGF stimulated A431 cells, which are forming junctions. 
Overexpression indeed rescued the broken junctional ZO-1 distribution normally 
seen in depleted cells (Figure 4.34a). I next assessed the efficiency of the 
expression and rescue of the R312A siRNA resistant construct. This construct 
was also expressed independent of the siRNA transfected (4.35b). Strikingly, 
expression of the GAP deficient mutant failed to rescue junction formation 
(Figure 4.35a). Quantification suggested this to be significant (Figure 4.35c). 
Thus, these complementation assay results indicate that the GAP activity is 
crucial for SH3BP1’s role in junction formation. 
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Figure 4.34 Junction formation is rescued by full length siRNA resistant mutant. 
(A) Serum-starved A431 cells were stimulated with 100ng/ml EGF to allow junction formation, 
following transfection with an SH3BP1 specific siRNA or control siRNA, and transient 
expression of the siRNA resistant full length construct. The cells were then fixed with 
paraformaldehyde and immunostained with antibodies against ZO-1 (red) and the HA-epitope 
(green), or (B) lysed and analysed by immunoblotting. Experiment performed three times. Scale 
bar 10µm. 
 
207 
 
 
 
Figure 4.35 Junction formation is not rescued by GAP deficient SH3BP1.  
(A) Serum-starved A431 cells were stimulated with 100ng/ml EGF to allow junction formation, 
following transfection with an SH3BP1 specific siRNA or control siRNA, and transient 
expression of the siRNA resistant and GAP deficient full length construct. The cells were then 
fixed with paraformaldehyde and immunostained with antibodies against ZO-1 (red) and the 
HA-epitope (green), or (B) lysed and analysed by immunoblotting. The experiments in this 
figure were performed at the same time as the ones in figure 4.36. (C) The experiments were 
quantified by analysing junctional ZO-1 staining. Shown are means ± 1 SD, representing the 
cells in at least seven different fields per condition (n≥ 7). Experiment performed three times. 
Scale bar 10µm. 
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Chapter 4 - Discussion 
 
In this chapter, I have presented data that indicate that SH3BP1, a GAP that 
was identified with a functional siRNA library screen, regulates the formation of 
the AJC, epithelial differentiation and signalling by the Rho GTPases Cdc42 
and, depending on the cellular model, Rac1.  
Depletion of SH3BP1 compromised formation of both components of the AJC: 
tight and adherens junctions. This is supported by results from 
immunofluorescence and functional assays demonstrating loss of normal 
epithelial barrier properties. The severity of the effect depended on the protein 
analysed, suggesting that junction assembly occurs partially but that junctions 
don’t fully form in the absence of SH3BP1. This might have two reasons. Firstly, 
it could be that initiation of junction formation occurs normally but that junctional 
maturation is blocked by the lack of SH3BP1. This is supported by my 
observations that initial cell spreading and cell-cell contact formation occurs 
normally during a calcium switch assay, but that then junctions don’t seem to 
mature by SH3BP1 depletion. Secondly, it could also be that some junctional 
components are more sensitive to deregulation of Rho GTPase signalling. This 
possibility is supported by my observations that both the TJ protein cingulin and 
the AJ protein p120 catenin were more strongly affected and both proteins have 
previously been connected to Rho GTPase signalling mechanisms [270, 281, 
282]. 
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SH3BP1 does not only regulate junction assembly but also associates with the 
junctional complex. Similar to its effect on junction assembly, localisation of the 
protein overlaps with markers of AJs and TJs. Nevertheless, its distribution 
resembles more closely those of AJ proteins, suggesting that it may bind AJ 
components. Interestingly, a GAP with a similar structure, Rich1, has previously 
been linked to TJs and cell polarisation [193]. Although both proteins share a 
similar structure, they play two fundamentally different roles. SH3BP1 is 
recruited early to forming junctions, and is critical for the assembly of the AJC; 
while Rich1 has been found to be important for cellular polarisation once the 
AJC has been assembled and is not required for membrane dynamics or AJ 
assembly. This is supported by the screening results, as we could not detect a 
defect in junction formation upon Rich1 siRNA transfection in the siRNA screen 
that we performed (as it was a functional screen, depletion of targets was not 
assessed and, hence, the efficiency of Rich1 depletion is not known). 
Depletion of SH3BP1 had striking effects on the organisation and dynamics of 
the actin cytoskeleton. Time-lapse recordings of EGFP-actin expressing and 
EGF stimulated A431 cells suggested that actin dynamics was dramatically 
reduced. Although long filopodia-like structures could still be seen, they grew 
slowly and no EGF-induced actin remodelling leading to dorsal ruffling and 
junction formation was observed in SH3BP1 depleted cells. This is compatible 
with the increase in cofilin phosphorylation, as active actin remodelling requires 
active cofilin.  
In the absence of the GAP, A431 cells formed long filopodia-like structures at 
their basal side. A431 cells have previously been shown to form extensive 
filopodia [254]. As I found drastically increased Cdc42 activation in depleted 
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cells and filopodia are positively regulated by Cdc42 signalling [133, 283], it is 
thus likely that their growth is a direct consequence of Cdc42 deregulation. As I 
did not stain for filopodial markers, it could be that these filopodia-like structures 
are another type of finger-like actin-enriched membrane protrusion.  One 
similarly shaped structure are retraction fibres [284]. However, SH3BP1 
depleted cells did not retract but were more spread and still in contact with each 
other, which is incompatible with retraction fibres. Moreover, these filopodia-like 
structures were also seen during early stages of calcium-induced junction 
assembly in A431 cells, a phase of junction assembly when cells spread and 
approach each other that then persisted in GAP depleted cells. Hence, they 
were again associated with cell spreading and not retraction. I did also not 
detect any retracting cells in time lapse recordings of GFP-actin expressing 
cells; however, I could observe slowly growing protrusions. My observations are 
thus compatible with the conclusion that these protrusions are filopodia. Some 
authors differentiate between microspikes and filopodia; others treat them as 
the same. However, microspikes (in the stricter terminology) tend to be 
associated with leading edges of migrating cells and are thinner than what I 
observed. As Cdc42 was strongly activated in SH3BP1 depleted cells and this 
Rho GTPase drives filopodia formation, it seems thus most likely that the 
filopodia-like structures that I observed were indeed filopodia. This is also 
compatible with a previous report from Elaine Fuchs’ laboratory reporting that 
filopodia can induce junction formation in keratinocytes in vitro and in vivo [106].  
My experiments demonstrated that depletion of SH3BP1 strongly deregulated 
Cdc42 activity. Active Cdc42 was normally more closely associated with cell-cell 
junctions, but depletion of the GAP led to a loss of this spatial confinement. In 
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A431 cells, there was also a strong increase in the overall levels of Cdc42 
activity. SH3BP1 can also function as a GAP for Rac1 and there was indeed an 
effect on Rac1-GTP levels and distribution in A431 cells [186, 187, 189]. In 
Caco-2 cells we could not detect an effect on Rac1 (not shown) and various 
attempts in the laboratory to identify a role for Rac in junction formation in Caco-
2 cells failed (Karl Matter, personal communication). SH3BP1 depletion also led 
to an apparent increase in stress fibre formation, a process that has been linked 
to RhoA signalling. However, published attempts to demonstrate an effect of 
SH3BP1 on the GTP hydrolysis by RhoA did not reveal a clear effect on RhoA 
and it is thus generally assumed that SH3BP1 does not target RhoA. As 
junction formation is known to lead to a downregulation of RhoA signalling along 
the base of the cells and reduced stress fibre formation [198, 203], it thus 
seems more likely that the increase in stress fibres was caused indirectly by the 
defect in junction formation.  
Junction formation is strongly regulated by Rho GTPase signalling [60, 195, 
285]. It is thus not surprising that depletion of a junction-associated GAP led to 
a defect in junction assembly, and, as my complementation assay 
demonstrated, the GAP activity is essential for the cellular function of SH3BP1. 
In the case of Caco-2 cells, this seems to be mainly due to an effect on Cdc42, 
whereas there was also a minor effect on Rac1 in A431 cells. In fact, both 
GTPases have been linked to junction assembly in different experimental model 
systems. In some cases, the conditions under which junction assembly is 
analysed may even affect the role of a particular Rho GTPase, which might 
explain the contradictory reports on the role of Cdc42 in keratinocytes [204, 
235]. Nevertheless, my data demonstrate that the GAP activity of SH3BP1 is 
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crucial for the regulation of junction formation in two different epithelial model 
cell lines.  
In A431 cells, depletion of SH3BP1 inhibited the EGF-induced formation of 
dorsal ruffles that occurs prior to junction formation; most likely since the cells 
had lost their potential to reorganise the actin cytoskeleton, as suggested by the 
time-lapse movies of fluorescently labelled actin. Several junctional proteins 
were recruited to these ruffles including active Cdc42. It is unlikely this 
recruitment reflects an imaging artefact and that all proteins recruited to the 
apical membrane appear concentrated in these ruffles, as active Rac1, which 
also stained the apical membrane, was not enriched in the large ruffles. 
However, electron microscopy would be needed to clearly determine the 
relative concentrations of proteins in specific apical structures, as the folded 
double membrane of a ruffle cannot be resolved by epifluorescence and 
confocal microscopy. Moreover, there is currently no evidence for a direct role 
of dorsal ruffles in junction formation, as the observed kinetics of junctional 
protein recruitment might imply.  
Based on my observations, I propose a model according to which SH3BP1 is 
recruited to forming cell-cell junctions to regulate Cdc42 and the remodelling of 
the actin cytoskeleton required for junctional maturation. In cell types in which 
junction formation is Rac1-dependent, this may also involve regulation of Rac; 
however, this has not been tested yet. Inactivation of Cdc42 is required for the 
remodelling of the actin cytoskeleton to allow cells to adapt to each other and 
assemble the typical junctional cytoskeletal network. In cells such as A431 cells 
that form pronounced filopodia, inactivation of Cdc42 is required for the 
morphological transition from interlocked neighbouring filopodia (i.e, the 
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adhesion zipper) to a continuous junctional actin belt. Other cells such as Caco-
2, do not form such pronounced filopodia despite the deregulated Cdc42 activity 
(overall active Cdc42 levels did not increase in this model); However, their actin 
cytoskeleton was affected in a superficially similar manner by depletion of 
SH3BP1, as they failed to reorganise their actin cytoskeleton from the 
organisation required for cell spreading to the one supporting junctional 
maturation and polarisation.  
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Chapter 5 
 
SH3BP1 is Part of a Multimeric 
Signalling Complex  
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Chapter 5: SH3BP1 is Part of a Multimeric 
Signalling Complex  
 
Part of this chapter was published: J Cell Biol. 2012 Aug 20;198(4):677-93.  
 
Introduction to chapter 5 
 
Given the importance of SH3BP1 in the regulation of Cdc42 and epithelial 
junction assembly, I next wanted to determine how it is recruited to cell-cell 
junctions and whether it is part of a signalling module with different activities. 
Here, I will show that SH3BP1 is part of a novel complex that regulates junction 
formation. This complex comprises SH3BP1, JACOP (junction-associated 
coiled-coil protein)/paracingulin, CD2AP and CapZThe SH3BP1 complex is 
recruited to sites of actin remodelling and cell junctions, and depletion of any 
member of this complex affects the apical junctional complex. CapZ1 adds 
another activity to the complex that affects the actin cytoskeleton as it is a 
barbed end capping protein and is required for controlled actin remodelling. My 
data indicates that epithelial junction formation requires an SH3BP1-based dual 
activity complex that becomes recruited to sites of active membrane 
remodelling to guide Cdc42 signalling and actin dynamics.  
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Results – Chapter 5 
 
SH3BP1 forms a complex with JACOP, CD2AP and CapZ1 
 
SH3BP1 is important for junction formation and associates with cell-cell 
junctions; therefore, I decided to search for interaction partners that might 
mediate junctional recruitment. I first tested whether known TJ and AJ proteins 
co-immunoprecipitate with SH3BP1 in Caco-2 cells. Out of several TJ and AJ 
proteins tested, I found an interaction with the scaffold protein 
JACOP/paracingulin, a protein that can associate with both TJ and AJs (Figure 
5.0) [61, 63]. As JACOP is a known to regulate Rho GTPase activity [63], it was 
an excellent candidate to analyse further. The interaction with JACOP also 
suggested that SH3BP1 might be recruited to cell-cell junctions by JACOP as I 
could not detect co-immunoprecipitation of SH3BP1 with any other of the TJ or 
AJ proteins tested. 
Depletion of SH3BP1 results in elongated filopodia and failure of cell junctions 
to form correctly. Having identified a protein that may mediate junctional 
recruitment, I tested next proteins linked to the regulation of actin remodelling. I 
found that SH3BP1 was able to co-immunoprecipitate with the scaffold and 
actin capping regulator CD2AP, which has also been implicated in actin 
remodelling (Figure 5.1) [151, 286, 287]. Moreover, CD2AP also was found to 
co-immunoprecipitate with JACOP, suggesting that SH3BP1, JACOP and 
CD2AP form a tripartite complex.  
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Figure 5.0 SH3BP1 interacts with the cell-cell junctional protein 
JACOP/paracingulin. 
Caco-2 cell extracts were incubated with antibodies against the indicated proteins bound to 
beads. IgG refers to a sample with a non-specific rabbit IgG that was used as a negative control. 
Indicated proteins were analysed by immunoblotting. In panel A, TJ proteins were analysed and 
in panel B, AJ proteins. The experiment was performed three times. 
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Figure 5.1 JACOP immunoprecipitates contain SH3BP1 and CD2AP. 
Caco-2 cell extracts were subjected to immunoprecipitation using antibodies against the 
indicated proteins. As they were from three different species, respective control IgG were 
included as negative controls. The presence of the indicated proteins in immunoprecipitates was 
analysed by immunoblotting. Experiment was performed three times. 
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As I had found that the recruitment of SH3BP1 to sites of actin remodelling and 
cell-cell junctions is regulated by EGF signalling, I next used A431 cells to test 
whether the complex exists in these cells as well and, if yes, whether it was a 
constitutive complex or stimulated by EGF. Figure 5.2 shows that I could 
reproduce the same co-immunoprecipitations in A431 as in Caco-2 cells, 
suggesting that it is a complex common to different types of epithelial cells. 
Moreover, co-immunoprecipitation was not EGF-dependent, indicating that 
SH3BP1, JACOP and CD2AP form a constitutive protein complex (Figure 5.2). 
The observation that SH3BP1 or CD2AP IPs did not contain JACOP, may be 
due to the JACOP antibody not blotting efficiently, as if one is to observe the 
input levels of JACOP in comparison to SH3BP1 and CD2AP it can be seen as 
being considerably weaker. Taking into account the efficiency of, for example 
the CD2AP co-immunoprecipitations, then theoretically one would no longer see 
JACOP in the SH3BP1 immunoprecipitations. 
To further corroborate the existence of a complex containing the three proteins, 
I next tested their subcellular distribution. Initial assessment indicated that they 
were all present along the AJC (Figure 5.3a). A more detailed analysis by 
confocal microscopy indicated that the three proteins co-localised at cell-cell 
junctions, with the majority of the overlap occurring with the AJ (Figure 5.3b).  
 
 
 
  
220 
 
 
 
Figure 5.2 JACOP, SH3BP1 and CD2AP form a constitutive protein complex. 
Cell extracts from serum starved or EGF-stimulated A431 cells were subjected to 
immunoprecipitation using the indicated antibodies. Mouse, goat and rabbit IgGs were used as 
negative controls. Proteins present in the precipitates were analysed by immunoblotting as 
indicated. Experiment was performed three times. 
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Figure 5.3 SH3BP1 co-localises with JACOP and CD2AP in Caco-2 cells. 
Caco-2 cells were immunostained with antibodies against SH3BP1, JACOP and CD2AP after 
fixation with paraformaldehyde and permeabilisation with Triton X-100. Shown are: (A) 
epifluorescent and (B) confocal microscopy images with corresponding representative Z-line 
scans. Experiment was performed three times. Scale bar 10µm. 
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I next asked whether the three proteins also co-localised in A431 cells. As 
previously shown, SH3BP1 localised to apical dorsal ruffle structures within 5 
minutes of EGF stimulation. Staining of JACOP or CD2AP, respectively, and F-
actin along with SH3BP1 revealed co-localisation with SH3BP1 in dorsal 
structures (Figure 5.4), Therefore, the three proteins do not only form a 
biochemical complex, they also co-localise in the cells during actin remodelling 
and at cell junctions. 
 
JACOP is a scaffold for SH3BP1 and CD2AP 
 
The next question I addressed was whether the junctional adaptor JACOP was 
important for the junctional localization of SH3BP1 and CD2AP. Depletion of 
JACOP in Caco-2 cells indeed resulted in a strong decrease of junctional 
SH3BP1 and CD2AP staining (Figure 5.5). This suggests that JACOP may act 
as scaffold for both SH3BP1 and CD2AP that mediates junctional recruitment. 
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Figure 5.4 SH3BP1 co-localises with CD2AP and JACOP in EGF-stimulated A431 
cells. 
Serum starved A431 cells were stimulated for 5 minutes with 100ng/ml EGF and 
subsequently fixed and permeabilised before immunostaining with antibodies against 
SH3BP1 (red), F-actin (blue), and CD2AP or JACOP (green). Shown are epifluorescent 
images. Scale bar 10µm. 
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Figure 5.5 Depletion of JACOP affects SH3BP1 and CD2AP junctional 
localization. 
Caco-2 cells were transfected with either control siRNA or a pool of JACOP directed siRNAs. 
After 96 hours, the cells were either (A) fixed with paraformaldehyde and permeabilised with 
Triton X-100 and immunostained for SH3BP1, CD2AP and JACOP; or (B) extracted and 
immunoblotted for JACOP. Alpha-tubulin was used as a loading control.The 
immunofluorescence images were taken with an epifluorescent microscope. Experiment was 
performed three times. Scale bar 10µm. 
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I next assessed if depletion of JACOP affected the expression levels of 
SH3BP1 and CD2AP by immunoblotting. Interestingly, depletion of JACOP led 
to a reduction in the expression levels of SH3BP1 but not CD2AP in both A431 
and Caco-2 cells (Figure 5.6). This suggests that formation of a complex with 
JACOP may be important for SH3BP1 stabilisation. 
I next tested the importance of JACOP for the junctional recruitment of SH3BP1 
and CD2AP using an overexpresion approach. Overexpression of an HA-
tagged JACOP construct in Caco-2 cells resulted in an increase in junctional 
CD2AP (Figure 5.7) and SH3BP1 (Figure 5.8), which further supports a model 
in which JACOP recruits SH3BP1 and CD2AP to cell-cell junctions. 
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Figure 5.6 JACOP depletion affects SH3BP1 expression levels. 
Caco-2 and A431 cells were transfected with siRNAs as indicated. After 96 hours, extracts were 
collected and immunoblotted for JACOP, CD2AP and SH3BP1. Experiment was performed 
three times. Alpha-tubulin was used as a loading control. 
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Figure 5.7 JACOP overexpression results in increased junctional staining for 
CD2AP. 
Caco-2 cells were transfected with full length JACOP for 24 hours and then fixed with 
methanol. Cells were stained with antibodies against the HA-tag (green) and CD2AP 
(red).Shown are epifluorescent images. Experiment performed twice. Scale bar 10µm. 
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Figure 5.8 JACOP overexpression results in increased junctional staining for 
SH3BP1.  
Caco-2 cells were transfected with full length JACOP for 24 hours and then fixed with 
methanol. Coverslips were stained with antibodies against the HA-tag (green), SH3BP1 
(red) and ZO-1 (blue). Shown are epifluorescent images. Experiment was performed 
twice. Scale bar 10µm. 
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I next asked whether JACOP depletion affected assembly of the AJC. I firstly 
depleted JACOP in Caco-2 cells and noted that the continuous junctional 
distribution of ZO-1 was often disrupted. There was also apparently stronger 
staining for ZO-1 in some places, but this is likely to be due to the partial 
disassembly of junctions causing an unequal distribution of the protein. I also 
used individual siRNAs to confirm that the effect was not the result of off-target 
effects (Figure 5.9a and Figure 5.9b).  
I next tested the role of JACOP in A431 cells. In EGF-stimulated A431 cells 
depletion of JACOP resulted in a disorganization of TJ formation based on the 
broken and diffuse appearance of ZO-1 in JACOP depleted cells (5.10). F-actin 
distribution was also affected, but this was less severe as when SH3BP1 was 
depleted and there was no increase in filopodial length (Figure 5.11).  This lack 
in increased filopodial growth suggests that Cdc42 signalling is not increased in 
response to JACOP depletion. 
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Figure 5.9 JACOP depletion effects TJ assembly and the actin cytoskeleton. 
Caco-2 cells were transfected with siRNAs as indicated. After 96 hours, the cells were either 
(A) fixed with paraformaldehyde and permeabilised with Triton X-100, followed by staining for 
JACOP, ZO-1 and F-actin, or (B) collected and immunoblotted for JACOP. Alpha-tubulin was 
used as a loading control. The immunofluorescence were acquired with an epifluorescent 
microscope. Yellow arrows indicate areas of disruption.  Experiment was performed three 
times. Scale bar 10µm. 
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Figure 5.10 JACOP depletion affects the recruitment of ZO-1 to cell-cell junctions 
in EGF-stimulated A431 cells. 
A431 cells were transfected with siRNAs as indicated. After 72 hours, the cells were serum-
starved for 16 hours and subsequently stimulated with 100ng/ml  EGF before being (A) fixed 
with paraformaldehyde and permeabilised with Triton X-100, or (B) collected and 
immunoblotted for JACOP expression. For the immunoblot, alpha-tubulin was used as a loading 
control. For the immunofluorescence, cells were stained for ZO-1. Yellow arrows show areas of 
ZO-1 disruption. Shown are epifluorescent images. Scale bar 10µm. 
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Figure 5.11 Effects of JACOP depletion on the actin cytoskeleton. 
A431 cells were transfected with either control siRNAs or a pool of JACOP directed siRNAs. 
After 72 hours, the cells were serum starved for 16 hours and subsequently stimulated with 
100ng/ml  EGF, before being fixed with paraformaldehyde and permeabilised with Triton X-
100. Cells were stained for F-actin using fluorescent phalloidin. Yellow arrows show areas of 
actin disruption. Shown are epifluorescent images. Representative blot is shown in figure 5.10.  
Experiment was performed twice. Scale bar 10µm. 
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JACOP depletion affected junctional recruitment and expression levels of 
SH3BP1, suggesting that it might lead to a deregulation of Cdc42 activation. 
Therefore, I measured the effect of depletion of JACOP on the levels of active 
Cdc42 using the G-LISA assay. Figure 5.12 shows that depletion of JACOP led 
to a decrease in active Cdc42 levels, indicating that reducing the expression of 
JACOP indeed leads to a deregulation of Cdc42 signalling. These data are in 
agreement with the observation that JACOP depletion did not lead to increase 
filopodial growth and suggest that SH3BP1 released from the complex may lead 
to uncontrolled Cdc42 inactivation throughout the cells.  
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Figure 5.12 JACOP depletion in A431 cells results in lower levels of active Cdc42. 
A G-LISA assay for active Cdc42 was performed using serum-starved and EGF-stimulated 
A431 cells 96 hours after transfection with either control siRNA or a pool of JACOP directed 
siRNAs. Levels of active Cdc42 are displayed normalized to control levels. The bar graphs 
represent the average of triplicate samples. Addition of recombinant Cdc42 as a positive control 
gave a value of 4.17 (Normalised to control). The experiment was performed three times. Error 
bars represent ± 1 SD. 
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CD2AP localization with JACOP is dependent on SH3BP1 
 
The next question I addressed was how CD2AP and SH3BP1 interact with 
JACOP and whether one was dependent on the other. Depletion of SH3BP1 
resulted in no change in the expression levels of both JACOP and CD2AP in 
both Caco-2 and A431 cells (Figure 5.13). If analysed by immunofluorescence, 
SH3BP1 depleted Caco-2 cells exhibited decreased junctional CD2AP staining 
but junctional JACOP did not seem to be decreased (Figure 5.14). Further 
evidence for the existence of a SH3BP1/CD2AP complex was obtained when 
cells overexpressing full length SH3BP1 were analysed and revealed a striking 
apparent upregulation and co-localization of CD2AP with the GAP (Figure 5.15). 
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Figure 5.13 SH3BP1 depletion does not affect JACOP and CD2AP expression 
levels. 
Caco-2 or A431 cells were transfected with siRNAs as indicated. After 96 hours extracts were 
collected and immunoblotted for JACOP, CD2AP and SH3BP1. Experiment was performed 
three times. Alpha-tubulin was used as a loading control. 
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Figure 5.14 SH3BP1 depletion affects CD2AP localization. 
Caco-2 cells were transfected siRNAs as indicated. After 96 hours, the cells were either (A) 
fixed with paraformaldehyde, permeabilised with Triton X-100, and immunostained for 
SH3BP1, CD2AP and JACOP; or (B) collected and immunoblotted for JACOP. Alpha-tubulin 
was used as a loading control. Panel A shows epifluorescent images. Note: this particular batch 
of SH3BP1 antibody resulted in increased non-specific staining of nuclei, which hindered the 
display of junctional staining because of its brightness. Yellow arrows denote CD2AP 
junctional staining, while green arrows denote SH3BP1 junctional staining. The experiment was 
performed three times. Scale bar 10µm. 
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Figure 5.15 SH3BP1 overexpression results in increase CD2AP staining. 
Caco-2 cells were transfected with full length HA-tagged SH3BP1 and fixed with methanol. 
Cells were stained for the HA tag (green), alpha-catenin (blue) and CD2AP (red). Shown are 
epifluorescent images. Scale bar 10µm. 
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I finally tested whether the interaction between CD2AP and JACOP was 
dependent on SH3BP1. So, I performed a co-immunoprecipitation experiment 
using A431 cells that were transfected with either control or SH3BP1-directed 
siRNAs. Figure 5.16 shows that JACOP antibodies precipitated SH3BP1 and 
CD2AP efficiently from control extracts but not from extracts of SH3BP1-
depleted cells. This thus indicates that SH3BP1 is required for CD2AP to form 
complexes with JACOP.  
I next addressed the role of CD2AP in the SH3BP1 complex and junction 
formation. As determined by immunoblotting, depletion of CD2AP affected the 
SH3BP1 expression levels in both A431 and Caco-2 cells, which seems to 
suggest that CD2AP may be required for SH3BP1 stabilisation (Figure 5.17). 
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Figure 5.16 SH3BP1 depletion prevents co-immunoprecipitation of CD2AP with 
JACOP. 
A431 cells that had been transfected with control or SH3BP-directed siRNAs were extracted 
with PBS and 0.5% Triton X-100, and subjected to immunoprecipitation with anti-
JACOP antibodies. The precipitates were then analysed by immunoblotting for the indicated 
proteins. The experiment was performed three times. 
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Figure 5.17 CD2AP depletion affects SH3BP1 expression levels. 
Caco-2 or A431 cells were transfected with either two different individual CD2AP directed 
siRNAs or a pool of CD2AP directed siRNAs. After 96 hours cell extracts were collected and 
immunoblotted for JACOP, CD2AP and SH3BP1. Alpha-tubulin was used as a loading control. 
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I next asked whether CD2AP also affected the subcellular distribution of 
SH3BP1. Figure 5.18 shows that depletion of CD2AP in Caco-2 cells resulted in 
strongly reduced junctional SH3BP1 staining. However, the junctional 
association of JACOP was not visibly affected. As CD2AP depletion strongly 
affected the expression level of SH3BP1, it is not clear whether the reduced 
junctional staining is only due to the reduced expression or also to a 
redistribution of the GAP.  
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Figure 5.18 CD2AP depletion reduces junctional association of SH3BP1. 
Caco-2 cells were transfected with control siRNA or a pool of CD2AP directed siRNAs. After 
96 hours, the cells were (A) fixed with paraformaldehyde, permeabilised with Triton X-100, and 
stained with the indicated antibodies;or (B) collected and immunoblotted for JACOP (alpha-
tubulin was used as a loading control). Shown are epifluorescent images. Note: junctional 
SH3BP1 is reduced, cytoplasmic staining is in part non-specific. The experiment was performed 
three times. Scale bar 10µm. 
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I next asked whether depletion of CD2AP had an effect on AJC assembly in 
Caco-2 and A431 cells. In Caco-2 cells depletion of CD2AP resulted in flatter 
cells and strongly irregular staining of the TJ protein ZO-1 (Figure 5.19). This 
effect was observed with a pool as well as individual siRNAs, supporting its 
specificity. Depletion of CD2AP in A431 cells also resulted in disruption of ZO-1, 
but the effect seemed to be weaker (Figure 5.20). There was also a 
disorganisation of F-actin evident particularly when cells had been treated with 
EGF (Figure 5.21). This thus indicates that CD2AP is functionally important for 
the regulation of junction assembly and EGF-induced actin reorganisation.  
I next determined whether the interaction between SH3BP1 and JACOP was 
independent or dependent of CD2AP. Performing a co-immunoprecipitation with 
control and CD2AP-depleted lysates revealed decreased levels of SH3BP1 but 
no effect on the interaction between JACOP and SH3BP1 (Figure 5.22). As the 
remaining pool of expressed SH3BP1 still interacted with JACOP in CD2AP-
depleted cells, the interaction between the two proteins is independent of 
CD2AP. 
As depletion of CD2AP affects SH3BP1 expression, it may also affect the levels 
of active Cdc42. Therefore, I employed again the G-LISA assay to determine 
Cdc42 activity. Figure 5.23 shows that levels of active Cdc42 decreased with 
CD2AP depletion, thus indicating that reducing either of the two SH3BP1 
binding partners affects Cdc42 activity (Figure 5.23). 
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Figure 5.19 CD2AP depletion affects TJ and actin organisation. 
Caco-2 cells were transfected with either control siRNA, individual CD2AP siRNAs or a pool 
of CD2AP directed siRNAs. After 96 hours, the cells were fixed with paraformaldehyde and 
permeabilised with Triton X-100. Cells were stained for JACOP (green), ZO-1 (red) and F-actin 
(blue). Yellow arrows show areas of ZO-1 disruption. Shown are epifluorescent images. 
Representative Caco-2 blot is shown in figure 5.17. Experiment was performed three times. 
Scale bar 10µm. 
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Figure 5.20 CD2AP depletion affects the junctional recruitment of ZO-1 in EGF-
stimulated A431 cells. 
A431 cells were transfected with either control siRNA or a pool of CD2AP directed siRNAs. 
After 72 hours, the cells were serum-starved for 16 hours and subsequently stimulated with 
100ng/ml  EGF before being (A) fixed with paraformaldehyde, permeabilised with Triton X-
100, and stained for ZO-1; or (B) collected and immunoblotted for CD2AP. For the 
immunoblot, alpha-tubulin was used as a loading control. Panel A shows epifluorescent images. 
Yellow arrows denote areas of ZO-1 disruption. Experiment performed three times. Scale bar 
10µm. 
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Figure 5.21 Effect of CD2AP depletion on the actin cytoskeleton. 
A431 cells were transfected with either control siRNA or a pool of CD2AP directed siRNAs. 
After 72 hours, the cells were serum starved for 16 hours and subsequently stimulated with 
100ng/ml  EGF, before being fixed with paraformaldehyde and permeabilised with Triton X-
100. Cells were stained with fluorescent phalloidin to visualise F-actin. Yellow arrows denote 
disrupted actin. Shown are epifluorescent images. Scale bar 10µm. 
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Figure 5.22 CD2AP depletion does not affect the interaction between SH3BP1 and 
JACOP. 
A431 cells transfected with control siRNA or a pool of CD2AP directed siRNA were extracted 
in PBS and 0.5% Triton X-100. JACOP immunoprecipitates were analysed by immunoblotting 
for the indicated proteins. The experiment was performed twice. 
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Figure 5.23 CD2AP depletion in A431 cells results in lower levels of active Cdc42. 
A G-LISA assay was performed in serum starved and EGF-stimulated A431 cells 96 hours after 
transfection with either control siRNA or a pool of CD2AP directed siRNAs. Levels of active 
Cdc42 were normalised to control levels. The bar graphs represent the average of triplicates. 
The experiment was performed three times. Addition of recombinant Cdc42 as a positive 
control gave a value of 6 (Normalised to control). Error bars represent ± 1 SD. 
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The co-immunoprecipitation analysis suggested that SH3BP1 may form a 
bridge between JACOP and CD2AP as it was required for the two proteins to 
co-immunoprecipitate. Therefore, I next generated recombinant GST fusion 
proteins to map the interacting domains in SH3BP1 (Figure 5.24).  
Recombinant full-length SH3BP1 as well as a fusion protein containing the C-
terminal domain, which contains the SH3 binding domain, pulled down CD2AP 
(Figure 5.30). In contrast, JACOP was only pulled down by the N-terminal 
domain. The reason for the full-length protein not interacting with JACOP is not 
clear, but it could be due to the quality of the protein, which was found to be 
partially degraded. However, multiple attempts did not increase the quality of 
the fusion protein. However, JACOP binds to the N-terminal region, which is 
closer to GST, whereas CD2AP binds to the C-terminal domain, which is farther 
away from GST; as we used GST-bound to glutathione agarose, one would 
expect the pull-down of CD2AP to be affected and not the one of JACOP if 
protein degradation were a problem. It is thus more likely that full-length 
SH3BP1 is in a confirmation that does not allow efficient binding and that the 
protein may have to become activated for binding. As I had also degradation 
problems with the C-terminal domain construct, I cannot exclude that there is a 
second binding site for JACOP in that domain. Nevertheless, the construct was 
good enough to pull down CD2AP, indicating that it retained at least some 
activity. The pull-down data are compatible with the co-immunoprecipitation 
analysis and support a model according to which SH3BP1 functions as a bridge 
between CD2AP and JACOP.  
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Finally, I tested whether EGF signalling affects junctional recruitment of 
SH3BP1, CD2AP and JACOP the same way as they form a biochemical 
complex. Indeed, upon inhibition of EGFR, there was a strong reduction in the 
amount of junctional CD2AP and JACOP in Caco-2 cells in comparison to 
control cells (Figure 5.25). This correlates with the result with A431 cells 
described above that EGF stimulates recruitment of JACOP, CD2AP, and 
SH3BP1 to dorsal ruffles. 
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Figure 5.24 Recombinant GST fusion protein pull down assays. 
 (A) Diagram showing protein domains of SH3BP1 used for GST fusion proteins pull-
down assays. (B) Fusion proteins were bound to beads and used in GST pull-down 
experiments using A431 cell extracts. The precipitates were analysed by 
immunoblotting for CD2AP, JACOP or GST. The experiment was performed twice. 
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Figure 5.25 JACOP and CD2AP are relocalised upon EGFR inhibition. 
Caco-2 cells were inhibited with 3M PD153035 for 24 hours or a solvent control (DMSO) 
before being fixed with paraformaldehyde and permeabilised with Triton X-100. Samples were 
immunostained for JACOP and CD2AP. Shown are epifluorescent images. The experiment was 
performed twice. Scale bar 10µm. 
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The actin capping protein CapZ1 interacts with the SH3BP1 
complex 
  
Previous work had shown that CD2AP binds and modulates the activity of 
CapZ1, an F-actin capping protein that regulates filopodial growth [150, 286, 
288]. Therefore, I tested whether the SH3BP1 complex also contained this 
protein and, hence, contains two activities that can regulate the actin 
cytoskeleton: a Cdc42 GAP and an actin filament capping protein. 
Immunoblotting revealed that CapZindeed co-immunoprecipitated with 
CD2AP, JACOP and SH3BP1 from extracts of A431 cells that had been 
stimulated with EGF for 30 minutes (Figure 5.26). It is intriguing to note that 
serum-starved unstimulated cells did not show co-immunoprecipitation of 
CapZsuggesting that the capping protein is recruited later to the complex. 
In SH3BP1 depleted samples, expression levels of CapZwere decreased in 
comparison to control cells, both by immunofluorescence (Figure 5.27a) and by 
immunoblotting (Figure 5.27b). This may imply that SH3BP1 may function in the 
stabilization of the capping protein. However, whether this is a direct effect of 
the complex or an indirect one via SH3BP’s effect on the actin cytoskeleton is 
not known.  
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Figure 5.26 CapZ1 is part of the SH3BP1 complex in EGF-stimulated A431 cells. 
Serum-starved, EGF-stimulated (30 minute EGF-stimulation) A431 whole cell lysates were 
extracted in PBS and 0.5% Triton X-100. Immunoprecipitates were performed with the 
antibodies indicated. Mouse, Goat and Rabbit IgG were used as negative controls. Co-
immunoprecipitating proteins were analysed by immunoblotting as indicated.  
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Figure 5.27 Effects of SH3BP1 depletion on CapZ1. 
A431 cells were transfected with siRNAs as indicated. After 72 hours, the cells were serum-
starved for 16 hours and subsequently stimulated with 100ng/ml EGF before being (A) fixed 
with paraformaldehyde and permeabilised with Triton X-100, or (B) collected and 
immunoblotted for SH3BP1 and CapZ1. For the immunoblot, alpha-tubulin was used as a 
loading control. (A) For the immunofluorescence, SH3BP1, CapZ1 and F-actin were stained. 
Shown are epifluorescent images. Scale bar 10µm. 
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Finally, I assessed whether knockdown of CapZ1 in A431 cells affects 
SH3BP1 expression and F-actin organisation. Depletion of CapZ1 in A431 
cells resulted in an increase in filopodial length in a similar manner as SH3BP1 
depletion (Figure 5.28a). By immunoblotting, depletion of CapZ1 had no effect 
on JACOP and CD2AP expression levels, while SH3BP1 levels were reduced, 
suggesting that SH3BP1 may also require CapZ1 for stabilization (Figure 
5.28b).  
My data thus indicate that the SH3BP1 complex contains two activities that 
regulate the actin cytoskeleton: the GAP SH3BP1 and the F-actin capping 
protein CapZ.  
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Figure 5.28 CapZ1 depletion phenocopies SH3BP1 depletion. 
A431 cells were transfected with either control siRNA or a pool of CapZ1 directed siRNAs. 
After 72 hours, the cells were serum-starved for 16 hours and subsequently stimulated with 
100ng/ml  EGF, before either being (A) fixed with paraformaldehyde and permeabilised with 
Triton X-100, or (B) collected and immunoblotted for the indicated proteins. For the 
immunoblot, alpha-tubulin was used as a loading control. In panel A, F-actin was stained with 
fluorescent phalloidin. Yellow arrows denote filopodia. Shown are epifluorescent images. Scale 
bar 10µm. 
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Chapter 5 – Discussion 
 
In this chapter, I have presented evidence that SH3BP1 forms a stable complex 
with the junctional adaptor JACOP/paracingulin, and the signalling scaffold 
CD2AP. If stimulated, this complex also recruits the actin capping protein 
CapZ1. Together with the results from chapter 4 indicating that SH3BP1 
regulates Cdc42 signalling and junction assembly, these data demonstrate that 
SH3BP1 is part of a dual activity complex that regulates Rho GTPase activity 
and actin dynamics, and that the complex is recruited to sites of active actin 
remodelling and cell-cell junctions.  
JACOP had been previously reported to be important for the regulation of the 
Rho GTPases RhoA and Rac1 in the canine kidney cell line MDCK [63]. 
Depletion of JACOP had an effect on the AJC and the actin cytoskeleton, 
although not as severe as depletion of SH3BP1. Upon assessment of global 
levels of active Cdc42, I found that JACOP depletion decreased levels of active 
Cdc42. This suggests that JACOP is required for the correct recruitment of 
SH3BP1 to sites of Rho GTPase induced dynamic actin remodelling and, if 
SH3BP1 is mislocalised, it maybe that upon depletion of JACOP, the GAP 
promotes uncontrolled inactivation of Cdc42. In MDCK cells, reduced Rac1 
signalling upon JACOP depletion was attributed to reduce the junctional 
associated GEF for Rac, TIAM-1, although it was not possible to determine the 
distribution of endogenous TIAM-1 [63]. As SH3BP1 can also act on Rac1, it 
could be that it also contributes to Rac1 regulation downstream of JACOP in 
MDCK cells.  
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JACOP not only enhanced the junctional recruitment of SH3BP1 but also of 
CD2AP, a protein that requires SH3BP1 to form a complex with JACOP. In the 
AJC, the three proteins exhibit a promiscuous distribution as they neither 
localise specifically to the TJ or the AJ. It is interesting to note that already the 
first description of JACOP pointed out that, by immunofluorescence, this protein 
exhibits great plasticity in its localisation and, depending on the tissue analysed, 
can appear more closely associated with TJ or AJ, respectively [61]. Although 
my data suggest that JACOP mediates recruitment of the SH3BP1 complex, 
what determines the subjunctional distribution within the AJC remains to be 
identified.  
The second SH3BP1 binding partner identified, CD2AP, was previously shown 
to be important for the regulation of the actin cytoskeleton, which may contribute 
to its role in podocytes and kidney function  [289]. CD2AP had been proposed 
to function as an inhibitor of actin capping [286]; therefore, upon depletion of 
CD2AP, there was expected to be more capping and subsequently less actin 
dynamics. My observation that depletion of CD2AP interfers with junction 
assembly but did not lead to enhanced filopodial growth is thus in agreement 
with these data. Depletion of CD2AP also resulted in less global levels of active 
Cdc42, suggesting that regulates SH3BP1 activity. However, the molecular 
mechanism by which it regulates SH3BP1 remains to be determined as it also 
reduced the total expression levels of the GAP. 
It is intriguing that the interaction between JACOP and CD2AP is dependent on 
SH3BP1, as upon depletion of the GAP, JACOP and CD2AP no longer co-
immunoprecipitated. So, SH3BP1 seems to act as a bridge between JACOP 
and CD2AP (Figure 5.29). This model is supported by GST pull-down assays 
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that show that JACOP can bind to the BAR domain of SH3BP1 whereas 
CD2AP can interact with the SH3 binding domain of SH3BP1.  
The fourth protein that I found in the SH3BP1 complex is CapZ1. CapZ1 is a 
subunit of a protein complex that regulates actin filament capping [290]. 
Because of lack of appropriate antibodies, I did not determine whether other 
subunits of this complex are also present in the SH3BP1 precipitates. As CapZ 
seems to form a stable complex, it is likely that the entire complex is present. 
Since CD2AP is thought to function as a CapZ inhibitor [291, 292], it would be 
feasible that the SH3BP1 complex regulates the function of CapZ by 
sequestration of one of its subunits. 
Of the components of the SH3BP1 complex that I have identified, CapZ1 is the 
only one that was only associated with the complex in cells that had been 
stimulated. The molecular basis of the regulatory mechanisms that regulates 
this association is not known yet. CapZ1 is a known interaction partner of 
CD2AP, which is the reason why I investigated whether it is part of the SH3BP1 
complex. It is not clear if and how this interaction is regulated. I have also not 
further investigated whether there are any other interactions between CapZ and 
SH3BP1 complex components. Based on the interactions known today, 
however, the complex seems to assembly as proposed in Figure 5.29, with 
SH3BP1 forming a bridge between JACOP and CD2AP, and the latter protein 
forming as a scaffold that recruits CapZ.  
The components of the identified SH3BP1 complex thus seem to have concrete 
specific functions. JACOP is primarily responsible for the junctional recruitment 
of the complex; whereas SH3BP1 regulates the activity of the Rho GTPases 
Cdc42 and Rac, and serves as a structural linker to CD2AP. CD2AP then 
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recruits CapZ and, thereby regulates actin filament capping. The SH3BP1 
complex thus regulates actin dynamics, membrane remodelling and junction 
formation via two mechanisms: regulation of Cdc42 and Rac, and regulation of 
actin filament dynamics.  
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Figure 5.29 The SH3BP1 complex and regulation of junction formation. 
The BAR domain-containing N-terminal domain of SH3BP1 binds to JACOP/paracingulin, a 
junctional adaptor, and the C-terminal domain to CD2AP, a scaffolding protein. The complex is 
required for normal Cdc42 signaling and junction formation. The filamentous actin-capping 
protein CapZ also associates with the SH3BP1 complex through binding to CD2AP and is 
required for the control of actin remodelling. Epithelial junction formation and morphogenesis 
thus require a dual activity complex that is recruited to sites of active membrane remodelling, 
containing SH3BP1 to guide Cdc42 signaling and CapZ to regulate cytoskeletal dynamics. 
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Chapter 6 
 
SH3BP1 in Epithelial 
Morphogenesis  
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Chapter 6: The Role of SH3BP1 in Epithelial 
Morphogenesis 
 
Part of this chapter was published: J Cell Biol. 2012 Aug 20;198(4):677-93.  
 
Introduction to chapter 6 
 
Given the importance of SH3BP1 in the regulation of junction assembly and 
epithelial differentiation, I next wanted to determine the importance of SH3BP1 
in epithelial morphogenesis using three dimensional (3D) cultures. I will show in 
this chapter the effect of SH3BP1 during longer depletion and how upon 
depletion of SH3BP1, cysts development in 3D cultures become more 
disorganised and smaller suggesting that SH3BP1 is important for the 
development of normal cysts and epithelial morphogenesis. 
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Results – Chapter 6 
 
SH3BP1 depletion results in disorganised epithelial cysts 
 
Analysis of epithelial cyst formation by Caco-2 cells requires longer incubation 
times than the experiments in previous chapters. It was thus necessary to test 
first whether the siRNA-mediated depletion protocol was sufficient to suppress 
expression of SH3BP1 until the end of the experiment. Figure 6.0 shows that 
depletion even 120 hours after the siRNA transfection was still efficient, 
indicating that the depletion protocol could be used for the 3D morphogenesis 
studies. 
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Figure 6.0 Long-term depletion of SH3BP1. 
Caco-2 cells were transfected with either control siRNA, individual SH3BP1 directed siRNAs  
or a pool of SH3BP1 specific siRNAs. After 120 hours the cells were collected and 
immunoblotted for SH3BP1. Alpha-tubulin was used as a loading control. 
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Next, I performed the 3D morphogenesis experiments using the same depletion 
protocol. After the 120 hours of incubation, I first analyzed the phenotype by 
phase contrast before fixation in order to establish the primary phenotype. This 
revealed that SH3BP1-depleted samples formed smaller cysts, with evident 
disruption of the normal structure of cysts seen in control samples. The cysts 
did not exhibit their normal rounded shape and had a more disorganised 
structure. The lumen was not well-rounded as seen in the controls but was 
more warped with multiple lumens (Figure 6.1). These phase contrast images 
thus already indicate that SH3BP1 is required for normal cyst formation in 3D 
cultures. 
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Figure 6.1 Depletion of SH3BP1 in 3D cultures interfers with normal cyst 
morphogenesis. 
Caco-2 cells were transfected with either control siRNA, individual SH3BP1 directed siRNAs 
or a pool of SH3BP1 specific siRNAs. Every 48 hours cholera toxin (0.1ug/ml) was added in 
order to facilitate rapid lumen expansion. After 120 hours the cells were photographed using 
phase contrast with a 20x lens before being fixed. Scale bar 30µm. 
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I next stained the samples for F-actin using fluorescent phalloidin to visualise 
the outlines of the lumens, which are normally enriched in F-actin. Analysing the 
samples with a confocal microscope further displayed the extent of the 
phenotype. The F-actin staining highlighted two effects of the SH3BP1 
depletion. Firstly, quantification revealed that the cysts were significantly smaller 
if SH3BP1 was depleted: the majority of the SH3BP1 depleted cysts were below 
75m in diameter whereas the majority of the cysts were above this size in 
control samples (Figures 6.2 and 6.3). Secondly, the cysts displayed a 
disrupted organisation and were not clearly defined.  It was difficult to identify a 
ring of apical F-actin around a centralised lumen; there were often cells left 
within the lumen (Figure 6.3) [1]. I quantified these experiments by counting the 
number of lumens in cysts from images obtained from quadruplicate coverslips, 
performing two independent experiments (as the cyts from SH3BP1 depleted 
cells were smaller, only cysts that had a diameter of >30µm were considered; 
Figure 6.4).  These observations thus demonstrate that SH3BP1 regulates cyst 
size as well as normal epithelial morphogenesis. 
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Figure 6.2 Depletion of SH3BP1 in 3D cultures results in disruption of normal F-
actin organisation. 
Caco-2 cells were transfected with either control siRNA, individual SH3BP1 directed siRNAs 
or a pool of SH3BP1 specific siRNAs. Every 48 hours cholera toxin (0.1ug/ml) was added in 
order to facilitate rapid lumen expansion. After 120 hours the cells were fixed with 
paraformaldehyde, and permeabilised with 1% Triton-X100/0.1% SDS. Cysts were stained for 
F-actin (Blue) and DNA (Grey). Shown are confocal images. Scale bar 10µm. 
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Figure 6.3 Quantification of cysts size. 
Cysts were quantified from triplicate coverslips from two experiments. The diameters of the 
cysts were quantified using ImageJ as described in the materials and methods. Bars represent 
averages of 4 images per sample (Error bars ± 1 SD).  
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Figure 6.4 Quantification of lumen type.  
Cysts were quantified from quadruplicate coverslips from two experiments. Cysts above 30m 
in diameter were used to quantify lumen structures. Shown are averages ± 1 SD. 
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Chapter 6 - Discussion 
 
In 3D extracelluar matrix cultures, epithelial cell lines such as Caco-2 cells 
develop cysts that resemble the normal organisation in tissues with a central 
lumen. My experiments show that SH3BP1 is also functionally important for 
epithelial morphogenesis and normal F-actin organisation in such organotypic 
cultures. Upon depletion of the GAP, there was a severe effect on the 
organisation of the cysts, with F-actin staining that was disrupted and dispersed, 
as well as cysts with either multiple or disorganised lumens and the remained 
lumen was smaller. This implies that SH3BP1, as with 2D cultures, is important 
for 3D epithelial morophogenesis. 
SH3BP1 functions as a GAP for Cdc42 in Caco-2 cells and this Rho GTPase 
has been shown to be important for epithelial morphogenesis of this cell line, as 
it regulates the orientation of the spindle during mitosis [137]. This is a 
conserved mechanism as Cdc42 has also been shown to regulate the 
orientation of the spindle in early mouse oocytes and C elegan embryos [293, 
294]. Regulation of Cdc42 is an important aspect of organogenesis as 
previously it was shown that the Cdc42 GEF tuba was important for spindle 
alignment [231]. Overactivation of Cdc42 due to SH3BP1 depletion may thus 
result in misorientation of the mitotic spindle. This would explain why there were 
more cells left inside the lumens and why the cells struggle to assemble a single 
apical lumen [116, 137]. It is further possible that the reason for the smaller 
cysts seen in SH3BP1 depleted cells is the misorientation of the spindle as the 
cell cycle may get retarded if the spindle is not oriented properly. Another 
possibility is that depletion of SH3BP1 results in a delay in proliferation and, 
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therefore, leads to smaller cysts. Rho GTPase signalling has been shown to be 
involved in cellular proliferation, with the GAP, Deleted in Liver Cancer 1 (DLC1) 
shown to surpress cell proliferation [295]. Conversley, IQGAP, an effector of 
Cdc42 was shown to regulate proliferation in conjunction with the 
serine/threonine kinase, mTOR [296, 297]. Although siRNA mediated depletion 
of SH3BP1 also leads to enhanced Rho GTPase signalling, it could be that it 
leads to a decrease in proliferation and thus smaller cysts due to deregulated 
Rho GTPase signalling. 
Formation of lumens is an important aspect in organogenesis [118]. The 
formation of organs is due in part to a number of signals, which ultimately result 
in the correct formation of polarised structures and subsequently formation of an 
organ. Many of these pathways include Rho GTPases; hence, a protein that 
regulates Cdc42 activity and cell-cell adhesion was a likely candidate for a 
regulator of 3D morphogenesis. My experiments confirm this hypothesis and 
demonstrate that SH3BP1 is important for epithelial differentiation in 3D 
cultures. 
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Final Discussion 
 
Rho GTPase regulation is an important component of a number of biological 
processes, including, crucially in the context of this project, regulation of the 
actin cytoskeleton. Rho GTPases had already been established as being part of 
several distinct signalling mechanisms that link the actin cytoskeleton to the 
AJC (Chapter 1). However, how they are regulated in the context of junction 
formation and function is not completely understood. Therefore, the initial 
question of my project was which negative regulators of Rho GTPases regulate 
epithelial differentiation and junction formation. Hence, we performed a 
functional siRNA screen to identify GAPs that play a role in junction assembly 
and epithelial differentiation in the columnar epithelial cell line Caco-2. 
 
siRNA screen of GTPase activating proteins in Caco-2 cells 
 
For the functional siRNA screen, we employed a library targeting all Rho 
GTPases and most known Rho GAPs. This screen revealed that siRNA 
mediated depletion of the Rho GTPases Cdc42 and RhoA had the strongest 
effects on the integrity of the AJC: depletion of either perturbed the morphology 
of the AJC considerably. From the GAPs screened, five had an effect on 
junction morphology that could be confirmed in a secondary screen, which used 
different sets of siRNAs that were chemically modified to enhance specificity 
(On-Target plus). These five hits were the Cdc42/Rac1 GAP SH3BP1, the 
RhoA GAPs OPHN1 and MYO9A, and two RasGAPs, PLXNA1 and PLXNB1 
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that function as Rho GTPase effectors. Of course, the screen does not rule out 
other GAPs important for epithelial differentiation as a few were missing from 
our library and we did not determine whether GAPs whose depletion did not 
affect junction formation were indeed depleted during the screen. Therefore, a 
more complete assessment of GAPs involved in junction formation in the future 
will need determinations of depletion efficiencies and, possibly, optimisation of 
the depletion protocol as different proteins may have different stability [298]. Of 
the GAPs identified, only two, SH3BP1 and MYO9A, have been analysed in 
detail. MYO9A also localises to the junctional complex and regulates junction 
formation and has recently been linked to the regulation of collective cell 
migration [213-215]. 
A possible future aim thus is to explore the other GAPs, which also provided a 
strong hit in the screen and characterize further how they regulate epithelial 
differentiation. However, due to time constraints, this was not possible during 
my thesis. Nevertheless, it is interesting that the screen generally led to the 
identification of junctional regulatory proteins. As SH3BP1 and MYO9A have 
now both been established as junctional components, and OPHN1, another 
positive hit from the screen, also associates with cell-cell contacts. 
 
SH3BP1 is important for epithelial junction formation and Rho 
GTPase regulation  
 
In the second experimental part of my thesis, I explored the function of SH3BP1 
in junction formation in more detail. I made a number of key observations. 
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SH3BP1 was found to be an important regulator of Cdc42 and, to a lesser 
extent, Rac1, during epithelial junction formation in distinct epithelial cell lines. I 
also discovered that signalling induced by the growth factor EGF is important for 
the localization of SH3BP1 to the plasma membrane and the junctional 
complex. Depletion of SH3BP1 resulted in increased numbers and longer 
filopodia in ectodermal epithelial cell lines. As filopodia have been proposed to 
mediate initial cell-cell contact and thus represent an intermediate step in 
junction assembly, overactivation of Cdc42 seems to prevent the transition from 
early, immature cell-cell contacts to fully formed junctional complexes [299, 
300]. Regulation of Rho GTPases is the central function of SH3BP1, as 
complementation experiments revealed that its GAP activity is required for 
normal junction formation. As active Cdc42 failed to localise normally in GAP 
depleted cells, I conclude that SH3BP1 represents an important regulator of 
Cdc42 signalling in epithelial cells and that it is a crucial regulator of epithelial 
junction formation by confining Cdc42 activity. 
Two important aspects to investigate in future experiments are to elucidate how 
EGF receptor stimulation activates SH3BP1 and which mechanisms control 
SH3BP1 to regulate junction localisation and GAP activation. An obvious 
candidate maybe c-Abl. SH3BP1 was initially identified from a cDNA library 
screen, which used a c-Abl probe to identify potential binding partners to the 
protein [186]. Therefore, to understand whether and how manipulation of c-Abl 
could mimic some the SH3BP1 phenotypes or whether depletion of the GAP 
can affect some of the c-Abl described roles could be interesting future 
directions. Another possible mechanism to control SH3BP1 is ERK 1/2 [301]. 
SH3BP1 has five potential ERK binding sites and potential phosphorylation 
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sites, all predicted to be in the SH3 binding domain (Scansite), and the 
activation of the EGFR results in the stimulation of MAP kinase signalling, 
leading to phosphorylation and activation of ERK. Hence ERK may possibly 
represent an important regulator of SH3BP1, guiding its activation, localization 
to the junction and, subsequently, regulation of Cdc42 to control actin 
remodelling and formation of the AJC [302]. One particular potential 
phosphorylation site is conserved in all species and is a serine located at 
position S544 in the SH3 binding domain (ClustalW). Thus, it would be 
interesting to determine whether this residue is phosphorylated in response to 
EGFR activation and in an Erk-dependent manner, and if yes, to determine 
whether phosphorylation regulates activation by substituting the serine with 
either an alanine to prevent activation or a negatively charged amino acid to 
mimic constitutive phosphorylation. 
 
SH3BP1 is part of a complex that regulates membrane 
remodelling and Cdc42 
 
In the second part of my study of SH3BP1, I assessed mechanistic aspects of 
SH3BP1 in regard to the formation of the AJC and regulation of Rho GTPases. 
Several interesting observations were made. Firstly, SH3BP1 was found to 
interact with the junctional scaffold JACOP, which is important for the 
localization of SH3BP1 to the AJC. We also found that the actin capping 
inhibitor CD2AP is part of the complex, and, finally, the actin capping protein 
CapZ1 can also associate with the SH3BP1 complex. This suggests that the 
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complex can regulate two processes: Cdc42 signalling via the GAP activity of 
SH3BP1 and actin capping via the capping activity of CapZ1. Moreover, both 
JACOP and CD2AP are scaffolding proteins and can interact with other 
proteins. Hence, SH3BP1 may be part of a large multimeric complex with 
multiple activities that guides junction formation and morphogenesis. It would 
thus be interesting to use a proteomics approach to identify additional 
components and interactors of the SH3BP1 complex in the future.  
SH3BP1 supports processes driven by Cdc42, demonstrating the importance of 
terminating the GTPase cycle for normal Rho GTPase signalling and 
cytoskeletal remodelling. Inactivation of the GAP did not prevent cells to initiate 
adhesion, but prevented them from assembling junctional complexes, 
underlining the importance of the temporal control of Cdc42 regulation for 
epithelial morphogenesis The SH3BP1 complex represents a dual activity 
feedback complex required for the coordination of actin-driven morphological 
processes that is recruited to sites of active membrane remodelling by the 
scaffolding components JACOP and CD2AP to terminate individual 
morphological steps, enabling activation of subsequent GTPase activated 
processes and junctional maturation. CapZ1 and SH3BP1 depletion resulted 
in the same actin disruption, and increase in filopodia. Therefore in possible 
future work, it would be interesting to determine how filopodia are disregulated 
and whether known regulators of filopodia are affected.  A possible candidate is 
insulin-receptor substrate p53 (IRSp53). This protein has already been shown 
to interact with Cdc42, Rac1 and various actin-linked proteins. Therefore it is a 
likely candidate for a protein to be affected by disruption of the SH3BP1 
complex [303-305]. 
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SH3BP1 depletion in a 3D culture system 
 
In the final part of my thesis, I assessed the importance of SH3BP1 in the 
formation of 3D epithelial structures. As such 3D culture systems are thought to 
represent conditions more similar to the situation in vivo than normal plastic 
substrates, it was important to test whether SH3BP1 also regulates 
differentiation in such organotypic cultures. I discovered that depletion of 
SH3BP1 led to an attenuation of normal cyst formation. Depletion affected two 
different aspects of epithelial morphogenesis: many cysts lost their normal 
organisation and developed into multilumen structures, and, generally, the cysts 
remained smaller in the absence of the GAP. Overactivation of Cdc42 had been 
shown to produce a misalignment of the mitotic spindle and affect cell polarity; 
therefore, it is likely that SH3BP1 importance for the formation of 3D cysts is 
because of its role in the confinement of Cdc42.  
Another possible mechanism by which SH3BP1 may affect junction assembly is 
by affecting the function of polarity protein Par6, as it has previously been 
shown that deregulation of Cdc42 leads to delocalization of PAR6 in C.elegans 
embryos [306]. The interplay between polarity proteins and Rho GTPases is of 
general importance and occurs bidirectionally, as Par3 is known to regulate Rac 
activation by interacting with TIAM1 [113, 235, 307].   
Further experiments could be performed in the future to characterise the role of 
SH3BP1 in cysts morphogenesis. For example, to deplete the other proteins 
associated in the complex, such as CD2AP, CapZ1or JACOP in order to 
assess what is their effect in cysts morphogenesis, if any; they have on the 
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correct formation of lumen and cyst structures. Other possible experiments 
would be to test whether SH3BP1 depleted cells have changes in cell 
proliferation, death and/or migration and if so, to analyse the cell cycle phase 
that is affected and at which extent such changes could correlated to the defect 
in cysts organisation. 
 
Final summary 
 
 
Rho GTPases are small G proteins that have an important role in a number of 
regulatory mechanisms linked to the assembly and function of the AJC. My 
thesis focused on how Rho GTPases are regulated during the control of actin 
reorganisation and junction formation. I approached this question by performing 
a screen of negative regulators of Rho GTPases known as GAPs and 
characterized one of them, SH3BP1. I demonstrated that SH3BP1 regulates the 
actin cytoskeleton and subsequent junction formation via the confinement of 
Cdc42 signalling. I also showed that SH3BP1 is part of a complex, which 
contains the scaffolds JACOP, and CD2AP as well as the actin capping protein 
CapZ1. This novel complex regulates junction formation and filopodial 
dynamics. I finally showed that the effect of SH3BP1 depletion seen in 2D 
cultures also affected the epithelial morphogenesis potential in 3D culture 
system, supporting the physiological relevance of SH3BP1. As shown 
previously, membrane dynamics underlies initiation of cell contacts in various 
epithelial models; different types of epithelia can make use of different 
mechanisms of actin-driven processes. Some cells use filopodia and others rely 
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on lamellipodia [106, 107]. As for some cell types (e.g., keratinocytes), both 
mechanisms have been reported, it may even depend on the conditions 
analysed whether junction formation is initiated by filopodia or Lamellipodia 
[106, 204, 308, 309].  As filopodia are induced by Cdc42 whereas lamellipodia 
require Rac, different GTPases can initiate cell-cell contacts and, as they can 
both regulate polarity complexes, lead to successful epithelial differentiation [66, 
310]. SH3BP1 was originally identified as a GAP with similar activities towards 
Cdc42 and Rac1 in vitro [187]. This was recently confirmed using cell-based 
assays for Cdc42 and Rac [189].  The latter paper also demonstrated that 
SH3BP1 regulates Rac at the front of migrating cells. Together with our data, 
this indicates that SH3BP1 can stimulate GTP hydrolysis by both Rac and 
Cdc42 in vitro and in vivo, and that the activities towards both GTPases are 
relevant for specific biological processes. Moreover, it could be that SH3BP1 
regulates junction formation not only in epithelia that rely on filopodia but also of 
those that use lamellipodia. However, we could not detect clear morphological 
effects in response to expressing dominant-negative SH3BP1 in MDCK cells, 
suggesting that it is not of central importance in this cell type (data not shown). 
Nevertheless, it will be important to test the role of SH3BP1 in this cell line using 
a siRNA approach.  
The observations that the GAP activity of SH3BP1 towards Rac and Cdc42 is 
differentially employed in specific cellular processes highlights the importance of 
the subcellular targeting of the GAP. While during migration SH3BP1 is targeted 
to the front of the cells and regulates Rac, which is active at the leading edge, it 
is targeted to cell-cell contacts during junction formation, and leads to 
deregulation of Cdc42, which is active at cell junctions. Targeting to subcellular 
sites that are enriched in the active form of either Cdc42 or Rac thus seems to 
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be a major determinant of the cellular GTPase selectivity of the GAP. Complex 
formation seems to play a fundamental role for junctional targeting of SH3BP1, 
as depletion of JACOP and, to a lesser extent; CD2AP resulted in loss of 
junctional SH3BP1.  
The experiments I performed during my thesis thus led to the identification of a 
novel dual activity protein complex that regulates actin dynamics and junction 
formation. This complex contains SH3BP1 whose GAP activity is crucial for 
junction formation and Cdc42 regulation, and also functions as a structural 
linker between the junctional adaptor JACOP and the scaffold CD2AP, which 
binds and regulates the actin capping protein CapZ. 
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